The Coca-Cola Company (KO) 10-Q 26 Oct 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 29, 2017	Oct. 23, 2017
Entity Registrant Name	COCA COLA CO
Entity Central Index Key	21,344
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 29, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		4,260,667,316

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
NET OPERATING REVENUES		$ 9,078	$ 10,633	$ 27,898	$ 32,454
Cost of goods sold		3,395	4,131	10,567	12,671
GROSS PROFIT		5,683	6,502	17,331	19,783
Selling, general and administrative expenses		3,203	4,009	9,660	11,682
Other operating charges		360	222	1,491	830
OPERATING INCOME		2,120	2,271	6,180	7,271
Interest income		175	164	495	472
Interest expense		208	182	631	485
Equity income (loss) - net		358	281	883	678
Other income (loss) - net		(771)	(1,106)	(1,122)	(315)
INCOME BEFORE INCOME TAXES		1,674	1,428	5,805	7,621
Income taxes		230	378	1,805	1,618
CONSOLIDATED NET INCOME		1,444	1,050	4,000	6,003
Less: Net income (loss) attributable to noncontrolling interests		(3)	4	0	26
NET INCOME ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY		$ 1,447	$ 1,046	$ 4,000	$ 5,977
BASIC NET INCOME PER SHARE (in dollars per share)	[1]	$ 0.34	$ 0.24	$ 0.94	$ 1.38
DILUTED NET INCOME PER SHARE (in dollars per share)	[1]	0.33	0.24	0.92	1.37
DIVIDENDS PER SHARE (in dollars per share)		$ 0.37	$ 0.35	$ 1.11	$ 1.05
AVERAGE SHARES OUTSTANDING (in shares)		4,266	4,315	4,275	4,322
Effect of dilutive securities (in shares)		54	49	52	52
AVERAGE SHARES OUTSTANDING ASSUMING DILUTION (in shares)		4,320	4,364	4,327	4,374
[1]	Calculated based on net income attributable to shareowners of The Coca-Cola Company.

CONDENSED CONSOLIDATED STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
CONSOLIDATED NET INCOME	$ 1,444	$ 1,050	$ 4,000	$ 6,003
Other comprehensive income:
Net foreign currency translation adjustment	693	86	1,511	415
Net gain (loss) on derivatives	(96)	(101)	(394)	(666)
Net unrealized gain (loss) on available-for-sale securities	1	(82)	165	79
Net change in pension and other benefit liabilities	49	39	82	128
TOTAL COMPREHENSIVE INCOME (LOSS)	2,091	992	5,364	5,959
Less: Comprehensive income (loss) attributable to noncontrolling interests	(2)	2	2	17
TOTAL COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	$ 2,093	$ 990	$ 5,362	$ 5,942

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 29, 2017	Dec. 31, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 12,528	$ 8,555
Short-term investments	9,691	9,595
TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS	22,219	18,150
Marketable securities	5,138	4,051
Trade accounts receivable, less allowances of $488 and $466, respectively	3,664	3,856
Inventories	2,608	2,675
Prepaid expenses and other assets	2,993	2,481
Assets held for sale	1,782	2,797
TOTAL CURRENT ASSETS	38,404	34,010
EQUITY METHOD INVESTMENTS	21,644	16,260
OTHER INVESTMENTS	1,117	989
OTHER ASSETS	4,480	4,248
PROPERTY, PLANT AND EQUIPMENT, less accumulated depreciation of $8,424 and $10,621, respectively	8,306	10,635
TRADEMARKS WITH INDEFINITE LIVES	6,575	6,097
BOTTLERS' FRANCHISE RIGHTS WITH INDEFINITE LIVES	138	3,676
GOODWILL	9,473	10,629
OTHER INTANGIBLE ASSETS	378	726
TOTAL ASSETS	90,515	87,270
CURRENT LIABILITIES
Accounts payable and accrued expenses	10,212	9,490
Loans and notes payable	13,398	12,498
Current maturities of long-term debt	3,231	3,527
Accrued income taxes	355	307
Liabilities held for sale	437	710
TOTAL CURRENT LIABILITIES	27,633	26,532
LONG-TERM DEBT	32,471	29,684
OTHER LIABILITIES	3,946	4,081
DEFERRED INCOME TAXES	4,313	3,753
THE COCA-COLA COMPANY SHAREOWNERS' EQUITY
Common stock, $0.25 par value; Authorized — 11,200 shares; Issued — 7,040 and 7,040 shares, respectively	1,760	1,760
Capital surplus	15,699	14,993
Reinvested earnings	64,759	65,502
Accumulated other comprehensive income (loss)	(9,843)	(11,205)
Treasury stock, at cost — 2,778 and 2,752 shares, respectively	(50,256)	(47,988)
EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	22,119	23,062
EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS	33	158
TOTAL EQUITY	22,152	23,220
TOTAL LIABILITIES AND EQUITY	$ 90,515	$ 87,270

CONDENSED CONSOLIDATED BALANCE5

CONDENSED CONSOLIDATED BALANCE SHEETS Parentheticals - USD ($) shares in Millions, $ in Millions	Sep. 29, 2017	Dec. 31, 2016
Allowance for Doubtful Accounts	$ 488	$ 466
Accumulated Depreciation	$ 8,424	$ 10,621
Common Stock - Par Value	$ 0.25	$ 0.25
Common Stock - Shares Authorized	11,200	11,200
Common Stock - Issued	7,040	7,040
Treasury Stock - Cost	2,778	2,752

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016
OPERATING ACTIVITIES
Consolidated net income	$ 4,000	$ 6,003
Depreciation and amortization	926	1,323
Stock-based compensation expense	167	191
Deferred income taxes	606	(98)
Equity (income) loss - net of dividends	(559)	(417)
Foreign currency adjustments	322	193
Significant (gains) losses on sales of assets - net	942	364
Other operating charges	918	277
Other items	(9)	(205)
Net change in operating assets and liabilities	(1,395)	(908)
Net cash provided by operating activities	5,918	6,723
INVESTING ACTIVITIES
Purchases of investments	(12,925)	(12,733)
Proceeds from disposals of investments	12,161	13,210
Acquisitions of businesses, equity method investments and nonmarketable securities	(538)	(767)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities	2,790	745
Purchases of property, plant and equipment	(1,194)	(1,561)
Proceeds from disposals of property, plant and equipment	72	92
Other investing activities	(122)	(319)
Net cash provided by (used in) investing activities	244	(1,333)
FINANCING ACTIVITIES
Issuances of debt	24,899	22,667
Payments of debt	(22,424)	(20,406)
Issuances of stock	1,320	1,295
Purchases of stock for treasury	(3,087)	(2,509)
Dividends	(3,165)	(3,028)
Other financing activities	(42)	198
Net cash provided by (used in) financing activities	(2,499)	(1,783)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	310	231
CASH AND CASH EQUIVALENTS
Net increase (decrease) during the period	3,973	3,838
Balance at beginning of period	8,555	7,309
Balance at end of period	$ 12,528	$ 11,147

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 29, 2017
Summary of significant accounting policies
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2016 . When used in these notes, the terms "The Coca-Cola Company," "Company," "we," "us" and "our" mean The Coca-Cola Company and all entities included in our Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 29, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017 . Sales of our nonalcoholic ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters accounting for the highest sales volumes. The volume of sales in the beverage business may be affected by weather conditions. Each of our interim reporting periods, other than the fourth interim reporting period, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The third quarter of 2017 and the third quarter of 2016 ended on September 29, 2017 and September 30, 2016 , respectively. Our fourth interim reporting period and our fiscal year end on December 31 regardless of the day of the week on which December 31 falls. Advertising Costs The Company's accounting policy related to advertising costs for annual reporting purposes, as disclosed in Note 1 of our 2016 Annual Report on Form 10-K, is to expense production costs of print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred. For interim reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple interim periods to each of our interim reporting periods. We use the proportion of each interim period's actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard rate per unit case. At the end of each interim reporting period, we review our estimated full year unit case volume and our estimated full year marketing expenditures that benefit multiple interim periods in order to evaluate if a change in estimate is necessary. The impact of any changes in these full year estimates is recognized in the interim period in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy. Hyperinflationary Economies A hyperinflationary economy is one that has cumulative inflation of 100 percent or more over a three-year period. In accordance with U.S. GAAP, local subsidiaries in hyperinflationary economies are required to use the U.S. dollar as their functional currency and remeasure the monetary assets and liabilities not denominated in U.S. dollars using the rate applicable to conversion of a currency for purposes of dividend remittances. All exchange gains and losses resulting from remeasurement are recognized currently in income. Venezuela has been designated as a hyperinflationary economy. During the nine months ended September 30, 2016 , the Venezuelan government devalued its currency and changed its official and most preferential exchange rate, which should be used for purchases of certain essential goods, to 10 bolivars per U.S. dollar from 6.3 . The official and most preferential rate is now known as DIPRO. The Venezuelan government also announced a new rate known as DICOM, which is allowed to float freely and is expected to fluctuate based on supply and demand. Management determined that the DICOM rate was the most appropriate legally available rate to remeasure the net monetary assets of our Venezuelan subsidiary. In addition to the foreign currency exchange exposure related to our Venezuelan subsidiary's net monetary assets, we also sell concentrate to our bottling partner in Venezuela from outside the country. These sales are denominated in U.S. dollars. As a result of the continued lack of liquidity and our revised assessment of the U.S. dollar value we expected to realize upon the conversion of Venezuelan bolivars into U.S. dollars by our bottling partner to pay our concentrate sales receivables, we recorded a write-down of $76 million during the three and nine months ended September 30, 2016 in the line item other operating charges in our condensed consolidated statements of income. We also have certain U.S. dollar-denominated intangible assets associated with products sold in Venezuela. As a result of weaker sales and the volatility of foreign currency exchange rates resulting from continued political instability, we recorded impairment charges of $34 million during the nine months ended September 29, 2017 in the line item other operating charges in our condensed consolidated statement of income. As a result of these impairment charges, the remaining carrying value of all U.S. dollar-denominated intangible assets associated with products sold in Venezuela is zero. Recently Issued Accounting Guidance In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers , which will replace most existing revenue recognition guidance in U.S. GAAP and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures about the nature, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. ASU 2014-09 allows for adoption either on a full retrospective basis to each prior reporting period presented or on a modified retrospective basis with the cumulative effect of initially applying the new guidance recognized at the date of initial application, which will be effective for the Company beginning January 1, 2018. The Company plans to adopt ASU 2014-09 and its amendments on a modified retrospective basis. We expect that ASU 2014-09's broad definition of variable consideration will require the Company to estimate and record certain variable payments resulting from collaborative funding arrangements, rebates and other pricing allowances earlier than it currently does. While we do not expect this change to have a material impact on our net operating revenues on an annual basis, we do expect that it will have an impact on our revenue in interim periods. Additionally, as a result of electing certain of the practical expedients available under the ASU, the Company expects there will be some reclassifications to or from net operating revenues, cost of goods sold, and selling, general and administrative expenses. As we continue our assessment, the Company is also identifying and preparing to implement changes to our accounting policies and practices, business processes, systems and controls to support the new revenue recognition and disclosure requirements. We are in the process of quantifying the impacts that will result from applying the new guidance. Our assessment will be completed during fiscal year 2017. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes . The amendments in this update are intended to simplify the presentation of deferred income taxes and require that deferred tax liabilities and assets be classified as noncurrent in a consolidated statement of financial position. The standard was prospectively adopted by the Company on January 1, 2017. Had the Company retrospectively adopted the standard as of December 31, 2016, the line items prepaid expenses and other assets and accounts payable and accrued expenses in our condensed consolidated balance sheet would have been reduced by $80 million and $692 million , respectively, as a result of reclassifying the current deferred tax assets and liabilities. The offsetting impact for the reclassifications as of December 31, 2016 would have increased the noncurrent line items other assets and deferred income taxes in our condensed consolidated balance sheet by $54 million and $666 million , respectively. In January 2016, the FASB issued ASU 2016-01, Financial Instruments — Overall: Recognition and Measurement of Financial Assets and Financial Liabilities , which addresses certain aspects of the recognition, measurement, presentation and disclosure of financial instruments. The amendment will be effective for the Company beginning January 1, 2018 and will require us to recognize any changes in the fair value of certain equity investments in net income. These changes are currently recognized in other comprehensive income ("OCI"). In February 2016, the FASB issued ASU 2016-02, Leases , which requires lessees to recognize on the balance sheet a right-of-use asset, representing their right to use the underlying asset for the lease term, and a lease liability for all leases with terms greater than 12 months. The guidance also requires qualitative and quantitative disclosures designed to assess the amount, timing and uncertainty of cash flows arising from leases. The standard requires the use of a modified retrospective transition approach, which includes a number of optional practical expedients that entities may elect to apply. ASU 2016-02 is effective for the Company beginning January 1, 2019 and we are currently evaluating the impact that ASU 2016-02 will have on our consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting . The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the income tax impact, classification on the statement of cash flows and forfeitures. The Company adopted ASU 2016-09 on January 1, 2017 by prospectively recognizing excess tax benefits and tax deficiencies in our consolidated statement of income as the awards vested or were settled. Effective January 1, 2017, the Company also prospectively presented excess tax benefits as an operating activity, rather than a financing activity, in our consolidated statement of cash flows. Had these changes been required to be adopted retrospectively, during the three and nine months ended September 30, 2016 , the Company would have recognized an additional $20 million and $140 million , respectively, of excess tax benefits in our condensed consolidated statements of income. Additionally, during the nine months ended September 30, 2016 , the Company would have reduced our financing activities and increased our operating activities by $140 million in our condensed consolidated statement of cash flows. The Company has elected, consistent with past practice, to estimate the number of awards that are expected to vest to determine the amount of stock-based compensation expense recognized in earnings. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Measurement of Credit Losses on Financial Instruments , which requires measurement and recognition of expected credit losses for financial assets held. ASU 2016-13 is effective for the Company beginning January 1, 2020 and we are currently evaluating the impact that ASU 2016-13 will have on our consolidated financial statements. In October 2016, the FASB issued ASU 2016-16, Intra-Entity Transfers of Assets Other Than Inventory , which requires the Company to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. ASU 2016-16 is effective for the Company beginning January 1, 2018 and will be applied using a modified retrospective basis. We currently expect the cumulative-effect adjustment will result in a net deferred tax asset of approximately $2.8 billion . This amount will primarily be recorded as a deferred tax asset in the line item other assets in our consolidated balance sheet. In November 2016, the FASB issued ASU 2016-18, Restricted Cash . The amendments in this update address diversity in practice that exists in the classification and presentation of changes in restricted cash and require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for the Company beginning January 1, 2018 and is required to be applied using a retrospective transition method to each period presented. The Company is currently evaluating the impact that ASU 2016-18 will have on our consolidated statement of cash flows. In January 2017, the FASB issued ASU 2017-01, Clarifying the Definition of a Business , which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. ASU 2017-01 is required to be applied prospectively and will be effective for the Company beginning January 1, 2018. The impact on our consolidated financial statements will depend on the facts and circumstances of any specific future transactions. In March 2017, the FASB issued ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which requires that the service cost component of the Company's net periodic pension cost and net periodic postretirement benefit cost be included in the same line item as other compensation costs arising from services rendered by employees, with the other components of net periodic benefit cost being classified outside of a subtotal of income from operations. Of the components of net periodic benefit cost, only the service cost component will be eligible for asset capitalization. ASU 2017-07 is effective for the Company beginning January 1, 2018 and is required to be applied retrospectively for the presentation of the service cost component and the other components of net periodic pension cost and net periodic postretirement benefit cost in our income statement. ASU 2017-07 allows a practical expedient for the estimation basis for applying the retrospective presentation requirements and requires the prospective adoption, on and after the effective date, for the capitalization of the service cost component of net periodic pension cost and net periodic postretirement benefit cost in assets. In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities , which eliminates the requirement to separately measure and report hedge ineffectiveness and requires companies to recognize all elements of hedge accounting that impact earnings in the same income statement line item where the hedged item resides. The amendments include new alternatives for measuring the hedged item for fair value hedges of interest rate risk and ease the requirements for effectiveness testing, hedge documentation and applying the critical terms match method. Finally, the standard introduces new alternatives that permit companies to reduce the risk of material error if the shortcut method is misapplied. ASU 2017-12 is effective for the Company beginning January 1, 2019 and is required to be applied prospectively. The Company is currently evaluating the impact that ASU 2017-12 will have on our consolidated financial statements.

Acquisitions and Divestitures

Acquisitions and Divestitures	9 Months Ended
	Sep. 29, 2017
Acquisition and Divestures [Abstract]
Acquisition and Divestitures [Text Block]	ACQUISITIONS AND DIVESTITURES Acquisitions During the nine months ended September 29, 2017 , our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $ 538 million , which primarily related to the acquisition of AdeS, a plant-based beverage business, by the Company and several of its bottling partners in Latin America. Additionally, in conjunction with the refranchising of Coca-Cola Refreshments' ("CCR") Southwest operating unit ("Southwest Transaction"), we obtained an equity interest in AC Bebidas, S. de R.L. de C.V. ("AC Bebidas"), a subsidiary of Arca Continental, S.A.B. de C.V. ("Arca"). During the nine months ended September 30, 2016 , our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $ 767 million , which primarily related to our acquisition of Xiamen Culiangwang Beverage Technology Co., Ltd. ("China Green"), a maker of plant-based protein beverages in China, and a minority investment in CHI Limited ("CHI"), a Nigerian producer of value-added dairy and juice beverages, which is accounted for under the equity method of accounting. Under the terms of the agreement for our investment in CHI, the Company is obligated to acquire the remaining ownership interest from the existing shareowners in 2019 based on an agreed-upon formula. Divestitures During the nine months ended September 29, 2017 , proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $2,790 million , primarily related to proceeds from the refranchising of certain bottling territories in North America and our China bottling operations. During the nine months ended September 30, 2016 , proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $745 million , primarily related to proceeds from the refranchising of certain bottling territories in North America. Refranchising of China Bottling Operations In November 2016, the Company entered into definitive agreements for the sale of the Company-owned bottling operations in China to the two existing local franchise bottlers, one of which is an equity method investee, and to sell a related cost method investment to one of the franchise bottlers. As a result, the Company's bottling operations in China and a related cost method investment were classified as held for sale as of December 31, 2016. On April 1, 2017, the Company sold a substantial portion of its bottling operations in China to the two local franchise bottlers. The remaining bottling operations and cost method investment were sold on July 1, 2017. We received net proceeds of $963 million as a result of these sales and recognized gains of $79 million and $88 million during the three and nine months ended September 29, 2017 , respectively, which were included in the line item other income (loss) — net in our condensed consolidated statements of income. North America Refranchising In conjunction with implementing a new beverage partnership model in North America, the Company refranchised bottling territories that were previously managed by CCR to certain of our unconsolidated bottling partners. These territories generally border these bottlers' existing territories, allowing each bottler to better service local customers and provide more efficient execution. By entering into comprehensive beverage agreements ("CBAs") with each of the bottlers, we granted certain exclusive territory rights for the distribution, promotion, marketing and sale of Company-owned and licensed beverage products as defined by the CBA. In some cases, the Company has entered into, or agreed to enter into, manufacturing agreements that authorize certain bottlers that have executed a CBA to manufacture certain beverage products. If a bottler has not entered into a specific manufacturing agreement, then under the CBA for these territories, CCR retains the rights to produce these beverage products, and the bottlers will purchase from CCR (or other Company-authorized manufacturing bottlers) substantially all of the related finished products needed in order to service the customers in these territories. Each CBA generally has a term of 10 years and is renewable, in most cases by the bottler and in some cases by the Company, indefinitely for successive additional terms of 10 years each. Under the CBA, except for the CBA entered into in conjunction with the Southwest Transaction and for additional territories sold to AC Bebidas, the bottlers will make ongoing quarterly payments to the Company based on their gross profit in the refranchised territories throughout the term of the CBA, including renewals, in exchange for the grant of the exclusive territory rights. Contemporaneously with the grant of these rights, the Company sold the distribution assets, certain working capital items, and the exclusive rights to distribute certain beverage brands not owned by the Company, but distributed by CCR, in each of these territories, excluding the territory included in the Southwest Transaction, to the respective bottlers in exchange for cash. In 2016, the Company formed a new National Product Supply System ("NPSS") to facilitate optimal operation of the U.S. product supply system. Under the NPSS, the Company and several of its existing independent producing bottlers administer key national product supply activities for these bottlers. Additionally, we have sold or are in the process of selling certain production facilities from CCR to these independent producing bottlers in exchange for cash, excluding production facilities included in the Southwest Transaction. During the nine months ended September 29, 2017 and September 30, 2016 , cash proceeds from these sales totaled $1,814 million and $732 million , respectively. Included in the cash proceeds for the nine months ended September 29, 2017 and September 30, 2016 , was $279 million and $181 million , respectively, from Coca-Cola Bottling Co. Consolidated ("CCBCC"), an equity method investee. Also included in the cash proceeds for the nine months ended September 29, 2017 , was $216 million from AC Bebidas, an equity method investee. Under the applicable accounting guidance, we were required to derecognize all of the tangible assets sold as well as the intangible assets transferred, including distribution rights, customer relationships and an allocated portion of goodwill related to these territories. We recognized losses of $762 million and $1,089 million during the three months ended September 29, 2017 and September 30, 2016 , respectively. During the nine months ended September 29, 2017 and September 30, 2016 , the Company recognized losses of $2,533 million and $1,657 million , respectively. These losses primarily related to the derecognition of the intangible assets transferred or reclassified as held for sale and were included in the line item other income (loss) — net in our condensed consolidated statements of income. See further discussion of assets and liabilities held for sale below. In total, we expect to recover the value of the intangible assets transferred to the bottlers under the CBAs through the future quarterly payments; however, as the payments for the territory rights are dependent on the bottlers' future gross profit in these territories, they are considered a form of contingent consideration. There is diversity in practice as it relates to the accounting for contingent consideration by the seller. The seller can account for the future contingent payments received as a gain contingency, recognizing the amounts in the income statement only after the related contingencies are resolved and the gain is realized, which in this arrangement will be quarterly as the bottlers earn gross profit in the transferred territories. Alternatively, the seller can record a receivable for the contingent consideration at fair value on the date of sale and record any future differences between the payments received and this receivable in the income statement as they occur. We elected the gain contingency treatment since the quarterly payments will be received throughout the terms of the CBAs, including all subsequent renewals, regardless of the cumulative amount received as compared to the value of the intangible assets transferred. During the three and nine months ended September 29, 2017 , the Company recorded charges of $72 million and $287 million , respectively, primarily related to payments made to certain of our unconsolidated bottling partners in order to convert the bottling agreements for their legacy territories and any previously refranchised territories to a single form of CBA with additional requirements. The additional requirements generally include a binding national governance model, mandatory incidence pricing and additional core performance requirements, among other things. As a result of these conversions, the legacy territories and any previously refranchised territories for each of the related bottling partners will be governed under similar CBAs, which will provide consistency across each such bottler's respective territory, and consistency with other U.S. bottlers that have been granted or converted to this form of CBA. The expense related to these payments was included in the line item other income (loss) — net in our condensed consolidated statement of income during the three and nine months ended September 29, 2017 . On April 1, 2017, the Company refranchised the Southwest operating unit of CCR, which includes Texas and parts of Oklahoma, New Mexico and Arkansas, in the Southwest Transaction. In conjunction with the Southwest Transaction, Arca contributed its existing beverage business to AC Bebidas. CCR contributed its Southwest operating unit, including all of its assets and liabilities, to AC Bebidas in exchange for an approximate 20 percent interest in AC Bebidas. Arca owns the remaining interest in AC Bebidas. After post-closing adjustments, CCR will have made cash payments of approximately $112 million , net of cash received. As a result of the Southwest Transaction, the Company recognized a gain of $1,060 million due to the difference in the recorded carrying value of the net assets transferred compared to the value of the interest it obtained in AC Bebidas of $2,960 million , which was determined using an income and market approach (a Level 3 measurement). This gain was recorded in the line item other income (loss) — net in our condensed consolidated statement of income. AC Bebidas will participate in the NPSS as it relates to its U.S. territory. The Company accounts for its interest in AC Bebidas as an equity method investment based on our equity ownership percentage, our representation on AC Bebidas' Board of Directors, material intercompany transactions and other governance rights. Coca-Cola European Partners In August 2015, the Company entered into an agreement to merge our German bottling operations with Coca-Cola Enterprises, Inc. ("CCE") and Coca-Cola Iberian Partners, S.A.U., formerly known as Coca-Cola Iberian Partners, S.A. ("CCIP"), to create Coca-Cola European Partners plc ("CCEP"). On May 28, 2016, the transaction closed and we exchanged our German bottling operations for an 18 percent interest in CCEP. As a result of recording our interest in CCEP at fair value based on its quoted market price, the deconsolidation of our German bottling operations, and the related reversal of its cumulative translation adjustments, we recognized a gain of $1,400 million . This gain was partially offset by a $77 million loss incurred as a result of reclassifying losses related to our net investment hedges of our German bottling operations from accumulated other comprehensive income (loss) ("AOCI") into earnings as well as transaction costs incurred resulting in a net gain of $1,288 million during the nine months ended September 30, 2016 . Refer to Note 8. With the exception of the transaction costs, the net gain was recorded in the line item other income (loss) — net in our condensed consolidated statement of income. The Company accounts for its 18 percent interest in CCEP as an equity method investment based on our equity ownership percentage, our representation on CCEP's Board of Directors, material intercompany transactions and other governance rights. Coca-Cola Beverages Africa Proprietary Limited In November 2014, the Company, SABMiller plc and Gutsche Family Investments entered into an agreement to combine the bottling operations of each of the parties' nonalcoholic ready-to-drink beverage businesses in Southern and East Africa. In connection with the July 2, 2016 closing of the transaction to form the new bottler, which is called Coca-Cola Beverages Africa Proprietary Limited ("CCBA"), the Company: (1) contributed its South African bottling operations to CCBA, which included certain wholly owned subsidiaries and an equity method investment, (2) paid $150 million in cash, (3) obtained a 12 percent interest in CCBA and a 3 percent interest in CCBA's South African subsidiary and (4) acquired several trademarks that are generally indefinite-lived. As a result of recording our interests in CCBA and its South African subsidiary at fair value, the deconsolidation of our South African bottling operations, the derecognition of the equity method investment, and the reversal of related cumulative translation adjustments, we recognized a loss of $21 million . The fair values of the equity investments in CCBA and CCBA's South African subsidiary, along with the acquired trademarks, were determined using income approaches, including discounted cash flow models, and the Company believes the inputs and assumptions used are consistent with those hypothetical marketplace participants would use. The loss recognized resulted primarily from the reversal of the related cumulative translation adjustments. This loss is recorded in the line item other income (loss) — net in our condensed consolidated statement of income during the three and nine months ended September 30, 2016. Through the Company's 12 percent interest in CCBA, the Company is represented by two directors on CCBA's 10-member Board of Directors. Based on the level of equity ownership, the Company’s representation on the Board of Directors and other governance rights, the Company is accounting for its interests in CCBA and CCBA's South African subsidiary as equity method investments. The Company’s interest in CCBA provides it with a call option to acquire the ownership interest of SABMiller plc at fair value upon the occurrence of certain events, including upon a change in control of SABMiller plc. Refer to Note 16 for more information. Keurig Green Mountain, Inc. In March 2016, a JAB Holding Company-led investor group acquired Keurig Green Mountain, Inc. ("Keurig"), including the shares held by the Company, for $92 per share. As a result of the transaction, the Company received proceeds of $2,380 million , which were recorded in the line item proceeds from disposals of investments in our condensed consolidated statement of cash flows, and recorded a gain of $18 million related to the disposal of our shares of Keurig in the line item other income (loss) — net in our condensed consolidated statement of income during the nine months ended September 30, 2016 . Assets and Liabilities Held for Sale As of September 29, 2017 , the Company had entered into agreements, or otherwise approved plans, to refranchise its remaining U.S. bottling territories. For bottling territories that met the criteria to be classified as held for sale, we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price and present the related assets and liabilities as separate line items in our condensed consolidated balance sheet. The Company expects that these bottling territories will be refranchised by December 31, 2017. The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our condensed consolidated balance sheets (in millions): September 29, December 31, 2016 Cash, cash equivalents and short-term investments $ 10 $ 49 Trade accounts receivable, less allowances 300 43 Inventories 181 264 Prepaid expenses and other assets 34 114 Equity method investments — 1 Other investments — 42 Other assets 7 17 Property, plant and equipment — net 1,145 1,780 Bottlers' franchise rights with indefinite lives 1,121 1,388 Goodwill 296 390 Other intangible assets 154 51 Allowance for reduction of assets held for sale (1,466 ) (1,342 ) Total assets $ 1,782 1 $ 2,797 2 Accounts payable and accrued expenses $ 381 $ 393 Accrued income taxes 4 13 Other liabilities 52 1 Deferred income taxes — 303 Total liabilities $ 437 1 $ 710 3 1 Consists of total assets and total liabilities relating to North America refranchising of $1,782 million and $437 million , respectively, which are included in the Bottling Investments operating segment. 2 Consists of total assets relating to North America refranchising of $1,247 million , China bottling operations of $1,533 million and other assets held for sale of $17 million , which are included in the Bottling Investments operating segment and Corporate. 3 Consists of total liabilities relating to North America refranchising of $224 million , China bottling operations of $483 million and other liabilities held for sale of $3 million , which are included in the Bottling Investments operating segment and Corporate. We determined that the operations included in the table above did not meet the criteria to be classified as discontinued operations under the applicable guidance.

Investments

Investments	9 Months Ended
	Sep. 29, 2017
Investments [Abstracts]
Investments	INVESTMENTS Investments in debt and marketable securities, other than investments accounted for under the equity method, are classified as trading, available-for-sale or held-to-maturity. Our marketable equity investments are classified as either trading or available-for-sale with their cost basis determined by the specific identification method. Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in net income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our condensed consolidated balance sheets as a component of AOCI, except for the change in fair value attributable to the currency risk being hedged. Refer to Note 5 for additional information related to the Company's fair value hedges of available-for-sale securities. Trading Securities As of September 29, 2017 and December 31, 2016 , our trading securities had a fair value of $427 million and $ 384 million , respectively, and consisted primarily of equity securities. The Company had net unrealized gains on trading securities of $ 74 million and $ 39 million as of September 29, 2017 and December 31, 2016 , respectively. The Company's trading securities were included in the following line items in our condensed consolidated balance sheets (in millions): September 29, December 31, 2016 Marketable securities $ 318 $ 282 Other assets 109 102 Total $ 427 $ 384 Available-for-Sale and Held-to-Maturity Securities As of September 29, 2017 and December 31, 2016 , the Company did not have any held-to-maturity securities. As of September 29, 2017 , available-for-sale securities consisted of the following (in millions): Gross Unrealized Estimated Cost Gains Losses Fair Value Available-for-sale securities: 1 Equity securities $ 1,326 $ 602 $ (35 ) $ 1,893 Debt securities 6,550 169 (21 ) 6,698 Total $ 7,876 $ 771 $ (56 ) $ 8,591 1 Refer to Note 14 for additional information related to the estimated fair value. As of December 31, 2016 , available-for-sale securities consisted of the following (in millions): Gross Unrealized Estimated Cost Gains Losses Fair Value Available-for-sale securities: 1 Equity securities $ 1,252 $ 425 $ (22 ) $ 1,655 Debt securities 4,700 89 (31 ) 4,758 Total $ 5,952 $ 514 $ (53 ) $ 6,413 1 Refer to Note 14 for additional information related to the estimated fair value. The sale and/or maturity of available-for-sale securities resulted in the following realized activity (in millions): Three Months Ended Nine Months Ended September 29, September 30, September 29, September 30, Gross gains $ 11 $ 21 $ 51 $ 131 Gross losses (7 ) (6 ) (21 ) (42 ) Proceeds 4,210 2,072 10,760 8,889 As of September 29, 2017 and December 31, 2016 , the Company had investments classified as available-for-sale in which our cost basis exceeded the fair value of our investment. Management assessed each of the available-for-sale securities that were in a gross unrealized loss position on an individual basis to determine if the decline in fair value was other than temporary. Management's assessment as to the nature of a decline in fair value is based on, among other things, the length of time and the extent to which the market value has been less than our cost basis; the financial condition and near-term prospects of the issuer; and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value. As a result of these assessments, management determined that the decline in fair value of these investments was not other than temporary and did not record any impairment charges. The Company uses two of its consolidated insurance captives to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European and Canadian pension plans. In accordance with local insurance regulations, our insurance captives are required to meet and maintain minimum solvency capital requirements. The Company elected to invest its solvency capital in a portfolio of available-for-sale securities, which are classified in the line item other assets in our condensed consolidated balance sheets because the assets are not available to satisfy our current obligations. As of September 29, 2017 and December 31, 2016 , the Company's available-for-sale securities included solvency capital funds of $ 1,112 million and $ 985 million , respectively. The Company's available-for-sale securities were included in the following line items in our condensed consolidated balance sheets (in millions): September 29, December 31, Cash and cash equivalents $ 1,682 $ 682 Marketable securities 4,820 3,769 Other investments 971 849 Other assets 1,118 1,113 Total $ 8,591 $ 6,413 The contractual maturities of these available-for-sale securities as of September 29, 2017 , were as follows (in millions): Cost Estimated Fair Value Within 1 year $ 2,301 $ 2,353 After 1 year through 5 years 3,722 3,799 After 5 years through 10 years 208 223 After 10 years 319 323 Equity securities 1,326 1,893 Total $ 7,876 $ 8,591 The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations. Cost Method Investments Cost method investments are initially recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our condensed consolidated balance sheets, and dividend income from cost method investments is reported in other income (loss) — net in our condensed consolidated statements of income. We review all of our cost method investments quarterly to determine if impairment indicators are present; however, we are not required to determine the fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally use discounted cash flow analyses to determine the fair value. We estimate that the fair values of our cost method investments approximated or exceeded their carrying values as of September 29, 2017 and December 31, 2016 . Our cost method investments had carrying values of $ 146 million and $ 140 million as of September 29, 2017 and December 31, 2016 , respectively.

Inventories

Inventories	9 Months Ended
	Sep. 29, 2017
Inventories
Inventories	INVENTORIES Inventories consist primarily of raw materials and packaging (which include ingredients and supplies) and finished goods (which include concentrates and syrups in our concentrate operations and finished beverages in our finished product operations). Inventories are valued at the lower of cost or net realizable value. We determine cost on the basis of the average cost or first-in, first-out methods. Inventories consisted of the following (in millions): September 29, December 31, Raw materials and packaging $ 1,639 $ 1,565 Finished goods 741 844 Other 228 266 Total inventories $ 2,608 $ 2,675

Hedging Transactions and Deriva

Hedging Transactions and Derivative Financial Instruments	9 Months Ended
	Sep. 29, 2017
Hedging Transactions and Derivative Financial Instruments
Hedging Transactions and Derivative Financial Instruments	HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company's financial performance and are referred to as "market risks." When deemed appropriate, our Company uses derivatives as a risk management tool to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative and non-derivative financial instruments are foreign currency exchange rate risk, commodity price risk and interest rate risk. The Company uses various types of derivative instruments including, but not limited to, forward contracts, commodity futures contracts, option contracts, collars and swaps. Forward contracts and commodity futures contracts are agreements to buy or sell a quantity of a currency or commodity at a predetermined future date, and at a predetermined rate or price. An option contract is an agreement that conveys the purchaser the right, but not the obligation, to buy or sell a quantity of a currency or commodity at a predetermined rate or price during a period or at a time in the future. A collar is a strategy that uses a combination of options to limit the range of possible positive or negative returns on an underlying asset or liability to a specific range, or to protect expected future cash flows. To do this, an investor simultaneously buys a put option and sells (writes) a call option, or alternatively buys a call option and sells (writes) a put option. A swap agreement is a contract between two parties to exchange cash flows based on specified underlying notional amounts, assets and/or indices. We do not enter into derivative financial instruments for trading purposes. The Company may also designate certain non-derivative instruments, such as our foreign-denominated debt, in hedging relationships. All derivative instruments are carried at fair value in our condensed consolidated balance sheets in the following line items, as applicable: prepaid expenses and other assets; other assets; accounts payable and accrued expenses; and other liabilities. The carrying values of the derivatives reflect the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. These master netting agreements allow the Company to net settle positive and negative positions (assets and liabilities) arising from different transactions with the same counterparty. The accounting for gains and losses that result from changes in the fair values of derivative instruments depends on whether the derivatives have been designated and qualify as hedging instruments and the type of hedging relationships. Derivatives can be designated as fair value hedges, cash flow hedges or hedges of net investments in foreign operations. The changes in the fair values of derivatives that have been designated and qualify for fair value hedge accounting are recorded in the same line item in our condensed consolidated statement of income as the changes in the fair values of the hedged items attributable to the risk being hedged. The changes in the fair values of derivatives that have been designated and qualify as cash flow hedges or hedges of net investments in foreign operations are recorded in AOCI and are reclassified into the line item in our condensed consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. Due to the high degree of effectiveness between the hedging instruments and the underlying exposures being hedged, fluctuations in the value of the derivative instruments are generally offset by changes in the fair values or cash flows of the underlying exposures being hedged. The changes in the fair values of derivatives that were not designated and/or did not qualify as hedging instruments are immediately recognized into earnings. For derivatives that will be accounted for as hedging instruments, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the strategy for undertaking the hedge transaction. In addition, the Company formally assesses, both at the inception and at least quarterly thereafter, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair values or cash flows of the related underlying exposures. Any ineffective portion of a financial instrument's change in fair value is immediately recognized into earnings. The Company determines the fair values of its derivatives based on quoted market prices or pricing models using current market rates. Refer to Note 14 . The notional amounts of the derivative financial instruments do not necessarily represent amounts exchanged by the parties and, therefore, are not a direct measure of our exposure to the financial risks described above. The amounts exchanged are calculated by reference to the notional amounts and by other terms of the derivatives, such as interest rates, foreign currency exchange rates, commodity rates or other financial indices. The Company does not view the fair values of its derivatives in isolation but rather in relation to the fair values or cash flows of the underlying hedged transactions or other exposures. Virtually all of our derivatives are straightforward over-the-counter instruments with liquid markets. The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions): Fair Value 1,2 Derivatives Designated as Hedging Instruments Balance Sheet Location 1 September 29, December 31, 2016 Assets: Foreign currency contracts Prepaid expenses and other assets $ 210 $ 400 Foreign currency contracts Other assets 95 60 Interest rate contracts Other assets 71 105 Total assets $ 376 $ 565 Liabilities: Foreign currency contracts Accounts payable and accrued expenses $ 120 $ 40 Foreign currency contracts Other liabilities 8 54 Commodity contracts Accounts payable and accrued expenses — 1 Interest rate contracts Accounts payable and accrued expenses 33 36 Interest rate contracts Other liabilities 34 47 Total liabilities $ 195 $ 178 1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 14 for the net presentation of the Company's derivative instruments. 2 Refer to Note 14 for additional information related to the estimated fair value. The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions): Fair Value 1,2 Derivatives Not Designated as Hedging Instruments Balance Sheet Location 1 September 29, December 31, 2016 Assets: Foreign currency contracts Prepaid expenses and other assets $ 39 $ 284 Foreign currency contracts Other assets 25 — Commodity contracts Prepaid expenses and other assets 15 27 Commodity contracts Other assets 1 1 Other derivative instruments Prepaid expenses and other assets 8 4 Other derivative instruments Other assets 1 1 Total assets $ 89 $ 317 Liabilities: Foreign currency contracts Accounts payable and accrued expenses $ 59 $ 60 Foreign currency contracts Other liabilities 41 16 Commodity contracts Accounts payable and accrued expenses 16 16 Commodity contracts Other liabilities 1 1 Interest rate contracts Accounts payable and accrued expenses — 8 Interest rate contracts Other liabilities — 1 Other derivative instruments Accounts payable and accrued expenses 1 2 Other derivative instruments Other liabilities — 5 Total liabilities $ 118 $ 109 1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 14 for the net presentation of the Company's derivative instruments. 2 Refer to Note 14 for additional information related to the estimated fair value. Credit Risk Associated with Derivatives We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring collateral for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial instrument increases. In addition, the Company's master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the risk of counterparty default to be minimal. Cash Flow Hedging Strategy The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in AOCI and are reclassified into the line item in our condensed consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. The changes in fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings. The maximum length of time for which the Company hedges its exposure to future cash flows is typically three years. The Company maintains a foreign currency cash flow hedging program to reduce the risk that our eventual U.S. dollar net cash inflows from sales outside the United States and U.S. dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase foreign currency options (principally euros and Japanese yen) and collars to hedge certain portions of forecasted cash flows denominated in foreign currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualify for the Company's foreign currency cash flow hedging program were $ 4,495 million and $ 6,074 million as of September 29, 2017 and December 31, 2016 , respectively. The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt due to changes in foreign currency exchange rates. For this hedging program, the Company records the change in carrying value of the foreign currency denominated debt due to changes in exchange rates into earnings each period. The changes in fair value of the cross-currency swap derivatives are recorded in AOCI with an immediate reclassification into earnings for the change in fair value attributable to fluctuations in foreign currency exchange rates. The total notional values for the Company's cross-currency swaps were $1,851 million as of both September 29, 2017 and December 31, 2016 . The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted purchases of materials used in our manufacturing process. These derivative instruments have been designated and qualify as part of the Company's commodity cash flow hedging program. The objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional values of derivatives that have been designated and qualify for this program were $ 2 million and $ 12 million as of September 29, 2017 and December 31, 2016 , respectively. Our Company monitors our mix of short-term debt and long-term debt regularly. From time to time, we manage our risk to interest rate fluctuations through the use of derivative financial instruments. The Company has entered into interest rate swap agreements and has designated these instruments as part of the Company's interest rate cash flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company's future interest payments. The total notional values of these interest rate swap agreements that were designated and qualified for the Company's interest rate cash flow hedging program were $500 million and $1,500 million as of September 29, 2017 and December 31, 2016 , respectively. The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the three months ended September 29, 2017 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (35 ) Net operating revenues $ 116 $ — 2 Foreign currency contracts (11 ) Cost of goods sold (4 ) — 2 Foreign currency contracts — Interest expense (2 ) — Foreign currency contracts 100 Other income (loss) — net 100 7 Interest rate contracts (1 ) Interest expense (9 ) — Commodity contracts — Cost of goods sold (1 ) — Total $ 53 $ 200 $ 7 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income. 2 Includes a de minimis amount of ineffectiveness in the hedging relationship. The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the nine months ended September 29, 2017 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (216 ) Net operating revenues $ 339 $ (1 ) Foreign currency contracts (27 ) Cost of goods sold 1 — 2 Foreign currency contracts — Interest expense (7 ) — Foreign currency contracts 113 Other income (loss) — net 152 7 Interest rate contracts (25 ) Interest expense (26 ) 2 Commodity contracts (1 ) Cost of goods sold — — Total $ (156 ) $ 459 $ 8 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income. 2 Includes a de minimis amount of ineffectiveness in the hedging relationship. The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the three months ended September 30, 2016 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (48 ) Net operating revenues $ 141 $ (2 ) Foreign currency contracts 9 Cost of goods sold 8 — Foreign currency contracts — Interest expense (2 ) — Foreign currency contracts 36 Other income (loss) — net 40 — Interest rate contracts 26 Interest expense (2 ) 3 Commodity contracts (1 ) Cost of goods sold — — Total $ 22 $ 185 $ 1 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income. The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the nine months ended September 30, 2016 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (348 ) Net operating revenues $ 419 $ (3 ) Foreign currency contracts (34 ) Cost of goods sold 41 (1 ) Foreign currency contracts — Interest expense (6 ) — Foreign currency contracts 25 Other income (loss) — net 38 — Interest rate contracts (226 ) Interest expense (6 ) 3 Commodity contracts — Cost of goods sold — — Total $ (583 ) $ 486 $ (1 ) 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income. As of September 29, 2017 , the Company estimates that it will reclassify into earnings during the next 12 months $175 million of gains from the pretax amount recorded in AOCI as the anticipated cash flows occur. Fair Value Hedging Strategy The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that results from fluctuations in benchmark interest rates. The Company also uses cross-currency interest rate swaps to hedge the changes in the fair value of foreign currency denominated debt relating to changes in foreign currency exchange rates and benchmark interest rates. The changes in fair values of derivatives designated as fair value hedges and the offsetting changes in fair values of the hedged items are recognized in earnings. The ineffective portions of these hedges are immediately recognized in earnings. As of September 29, 2017 , such adjustments had cumulatively increased the carrying value of our long-term debt by $ 25 million . When a derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured. The total notional values of derivatives that related to our fair value hedges of this type were $ 8,123 million and $6,158 million as of September 29, 2017 and December 31, 2016 , respectively. The Company also uses fair value hedges to minimize exposure to changes in the fair value of certain available-for-sale securities from fluctuations in foreign currency exchange rates. The changes in fair values of derivatives designated as fair value hedges and the offsetting changes in fair values of the hedged items due to changes in foreign currency exchange rates are recognized in earnings. As a result, any difference is reflected in earnings as ineffectiveness. The total notional values of derivatives that related to our fair value hedges of this type were $ 1,002 million and $ 1,163 million as of September 29, 2017 and December 31, 2016 , respectively. The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions): Hedging Instruments and Hedged Items Location of Gain (Loss) Recognized in Income Gain (Loss) Recognized in Income 1 Three Months Ended September 29, September 30, Interest rate contracts Interest expense $ 19 $ — Fixed-rate debt Interest expense (15 ) (1 ) Net impact to interest expense $ 4 $ (1 ) Foreign currency contracts Other income (loss) — net $ (23 ) $ (67 ) Available-for-sale securities Other income (loss) — net 26 66 Net impact to other income (loss) — net $ 3 $ (1 ) Net impact of fair value hedging instruments $ 7 $ (2 ) 1 The net impacts represent the ineffective portions of the hedge relationships and the amounts excluded from the assessment of hedge effectiveness. The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions): Hedging Instruments and Hedged Items Location of Gain (Loss) Recognized in Income Gain (Loss) Recognized in Income 1 Nine Months Ended September 29, September 30, Interest rate contracts Interest expense $ (46 ) $ 398 Fixed-rate debt Interest expense 42 (364 ) Net impact to interest expense $ (4 ) $ 34 Foreign currency contracts Other income (loss) — net $ (66 ) $ (37 ) Available-for-sale securities Other income (loss) — net 72 34 Net impact to other income (loss) — net $ 6 $ (3 ) Net impact of fair value hedging instruments $ 2 $ 31 1 The net impacts represent the ineffective portions of the hedge relationships and the amounts excluded from the assessment of hedge effectiveness. Hedges of Net Investments in Foreign Operations Strategy The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial instrument, to protect the value of our investments in a number of foreign subsidiaries. For derivative instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in fair values of the derivative instruments are recognized in net foreign currency translation adjustment, a component of AOCI, to offset the changes in the values of the net investments being hedged. For non-derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the change in the carrying value of the designated portion of the non-derivative financial instrument due to changes in foreign currency exchange rates is recorded in net foreign currency translation adjustment. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions): Notional Amount Gain (Loss) Recognized in OCI as of Three Months Ended Nine Months Ended September 29, December 31, 2016 September 29, September 30, September 29, September 30, Foreign currency contracts $ 170 $ 100 $ (4 ) $ (9 ) $ (19 ) $ (235 ) Foreign currency denominated debt 13,118 11,113 (549 ) (67 ) (1,475 ) (323 ) Total $ 13,288 $ 11,213 $ (553 ) $ (76 ) $ (1,494 ) $ (558 ) The Company did not reclassify any gains or losses related to net investment hedges from AOCI into earnings during the three and nine months ended September 29, 2017 . In addition, the Company did not have any ineffectiveness related to net investment hedges during the three and nine months ended September 29, 2017 . The cash inflows and outflows associated with the Company's derivative contracts designated as net investment hedges are classified in the line item other investing activities in our condensed consolidated statements of cash flows. The Company reclassified net deferred losses of $77 million related to the deconsolidation of our German bottling operations from AOCI into earnings during the nine months ended September 30, 2016 . Refer to Note 2 . Economic (Nondesignated) Hedging Strategy In addition to derivative instruments that are designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign currency, interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic hedges. The changes in fair value of economic hedges are immediately recognized into earnings. The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. The changes in fair value of economic hedges used to offset those monetary assets and liabilities are immediately recognized into earnings in the line item other income (loss) — net in our condensed consolidated statements of income. In addition, we use foreign currency economic hedges to minimize the variability in cash flows associated with fluctuations in foreign currency exchange rates. The changes in fair values of economic hedges used to offset the variability in U.S. dollar net cash flows are recognized into earnings in the line items net operating revenues or cost of goods sold in our condensed consolidated statements of income, as applicable. The total notional values of derivatives related to our foreign currency economic hedges were $ 6,026 million and $ 5,276 million as of September 29, 2017 and December 31, 2016 , respectively. The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and for vehicle fuel. The changes in fair values of these economic hedges are immediately recognized into earnings in the line items net operating revenues, cost of goods sold, and selling, general and administrative expenses in our condensed consolidated statements of income, as applicable. The total notional values of derivatives related to our economic hedges of this type were $ 402 million and $ 447 million as of September 29, 2017 and December 31, 2016 , respectively. The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions): Three Months Ended Derivatives Not Designated Location of Gain (Loss) September 29, September 30, Foreign currency contracts Net operating revenues $ (5 ) $ (6 ) Foreign currency contracts Other income (loss) — net 47 — Interest rate contracts Interest expense — 2 Commodity contracts Net operating revenues 12 — Commodity contracts Cost of goods sold (15 ) (9 ) Commodity contracts Selling, general and administrative expenses 3 (1 ) Other derivative instruments Selling, general and administrative expenses 8 3 Other derivative instruments Other income (loss) — net 1 — Total $ 51 $ (11 ) The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions): Nine Months Ended Derivatives Not Designated Location of Gain (Loss) September 29, September 30, Foreign currency contracts Net operating revenues $ (23 ) $ (34 ) Foreign currency contracts Cost of goods sold — 4 Foreign currency contracts Other income (loss) — net 149 (116 ) Interest rate contracts Interest expense — 2 Commodity contracts Net operating revenues 7 3 Commodity contracts Cost of goods sold 13 68 Commodity contracts Selling, general and administrative expenses — 3 Other derivative instruments Selling, general and administrative expenses 33 11 Other derivative instruments Other income (loss) — net 2 (14 ) Total $ 181 $ (73 )

Debt and Borrowing Arrangements

Debt and Borrowing Arrangements	9 Months Ended
	Sep. 29, 2017
Debt and Borrowing Arrangements Disclosure [Abstract]
Debt Disclosure [Text Block]	DEBT AND BORROWING ARRANGEMENTS During the nine months ended September 29, 2017 , the Company issued U.S. dollar- and euro-denominated debt of $1,000 million and €2,500 million , respectively. The carrying value of this debt as of September 29, 2017 , was $3,967 million . The general terms of the notes issued are as follows: • $500 million total principal amount of notes due May 25, 2022, at a fixed interest rate of 2.20 percent ; • $500 million total principal amount of notes due May 25, 2027, at a fixed interest rate of 2.90 percent ; • €1,500 million total principal amount of notes due March 8, 2019, at a variable interest rate equal to the three-month Euro Interbank Offered Rate ("EURIBOR") plus 0.25 percent ; • €500 million total principal amount of notes due March 9, 2021, at a fixed interest rate of 0.00 percent ; and • €500 million total principal amount of notes due March 8, 2024, at a fixed interest rate of 0.50 percent . During the nine months ended September 29, 2017 , the Company retired upon maturity $206 million total principal amount of notes due August 1, 2017, at a fixed interest rate of 7.125 percent and €2,000 million total principal amount of notes due March 9, 2017, at a variable interest rate equal to the three-month EURIBOR plus 0.15 percent . The Company also extinguished a portion of the long-term debt that was assumed in connection with our acquisition of CCE's former North America business ("Old CCE"). The extinguished notes had a carrying value of $417 million , which included fair value adjustments recorded as part of purchase accounting. The general terms of the notes extinguished were as follo ws: • $95.6 million total principal amount o f notes due August 15, 2019, at a fixed interest rate of 4.50 percent ; • $38.6 million total principal amount of notes due February 1, 2022, at a fixed interest rate of 8.50 percent ; • $11.7 million total principal amount of notes due September 15, 2022, at a fixed interest rate of 8.00 percent ; • $36.5 million total principal amount of notes due September 15, 2023, at a fixed interest rate of 6.75 percent ; • $9.9 million total principal amount of notes due October 1, 2026, at a fixed interest rate of 7.00 percent ; • $53.8 million total principal amount of notes due November 15, 2026, at a fixed interest rate of 6.95 percent ; • $41.3 million total principal amount of notes due September 15, 2028, at a fixed interest rate of 6.75 percent ; • $32.0 million total principal amount of notes due October 15, 2036, at a fixed interest rate of 6.70 percent ; • $3.4 million total principal amount of notes due March 18, 2037, at a fixed interest rate of 5.71 percent ; • $24.3 million total principal amount of notes due January 15, 2038, at a fixed interest rate of 6.75 percent ; and • $4.7 million total principal amount of notes due May 15, 2098, at a fixed interest rate of 7.00 percent . The Company recorded a net charge of $38 million in the line item interest expense in our condensed consolidated statement of income during the nine months ended September 29, 2017 . This net charge was due to the extinguishment of long-term debt described above.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 29, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Guarantees As of September 29, 2017 , we were contingently liable for guarantees of indebtedness owed by third parties of $ 690 million , of which $ 351 million related to variable interest entities. These guarantees are primarily related to third-party customers, bottlers, vendors and container manufacturing operations and have arisen through the normal course of business. These guarantees have various terms, and none of these guarantees was individually significant. The amount represents the maximum potential future payments that we could be required to make under the guarantees; however, we do not consider it probable that we will be required to satisfy these guarantees. We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations. Legal Contingencies The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities to the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole. Tax Audits The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. We establish reserves to remove some or all of the tax benefit of any of our tax positions at the time we determine that it becomes uncertain based upon one of the following conditions: (1) the tax position is not "more likely than not" to be sustained, (2) the tax position is "more likely than not" to be sustained, but for a lesser amount, or (3) the tax position is "more likely than not" to be sustained, but not in the financial period in which the tax position was originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be examined by the relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived from authorities such as legislation and statutes, legislative intent, regulations, rulings and case law and their applicability to the facts and circumstances of the tax position; and (3) each tax position is evaluated without consideration of the possibility of offset or aggregation with other tax positions taken. A number of years may elapse before a particular uncertain tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments varies depending on the tax jurisdiction. The tax benefit that has been previously reserved because of a failure to meet the "more likely than not" recognition threshold would be recognized in our income tax expense in the first interim period when the uncertainty disappears under any one of the following conditions: (1) the tax position is "more likely than not" to be sustained, (2) the tax position, amount, and/or timing is ultimately settled through negotiation or litigation, or (3) the statute of limitations for the tax position has expired. Refer to Note 13 . On September 17, 2015, the Company received a Statutory Notice of Deficiency ("Notice") from the Internal Revenue Service ("IRS") for the tax years 2007 through 2009, after a five-year audit. In the Notice, the IRS claims that the Company's United States taxable income should be increased by an amount that creates a potential additional federal income tax liability of approximately $3.3 billion for the period, plus interest. No penalties were asserted in the Notice. The disputed amounts largely relate to a transfer pricing matter involving the appropriate amount of taxable income the Company should report in the United States in connection with its licensing of intangible property to certain related foreign licensees regarding the manufacturing, distribution, sale, marketing and promotion of products in overseas markets. The Company has followed the same transfer pricing methodology for these licenses since the methodology was agreed with the IRS in a 1996 closing agreement that applied back to 1987. The closing agreement provides prospective penalty protection as long as the Company follows the prescribed methodology and material facts and circumstances and relevant federal tax law have not changed. On February 11, 2016, the IRS notified the Company, without further explanation, that the IRS has determined that material facts and circumstances and relevant federal tax law have changed and that it may assert penalties. The Company does not agree with this determination. The Company's compliance with the closing agreement was audited and confirmed by the IRS in five successive audit cycles covering the subsequent 11 years through 2006, with the last audit concluding as recently as 2009. The Notice represents a repudiation of the methodology previously adopted in the 1996 closing agreement. The IRS designated the matter for litigation on October 15, 2015. To the extent the matter remains designated, the Company will be prevented from pursuing any administrative settlement at IRS Appeals or under the IRS Advance Pricing and Mutual Agreement Program. The Company firmly believes that the IRS' claims are without merit and plans to pursue all available administrative and judicial remedies necessary to resolve this matter. To that end, the Company filed a petition in the U.S. Tax Court on December 14, 2015, and the IRS filed its answer on February 12, 2016. On October 4, 2017, the IRS filed an amended answer to the Company's petition in which it increased its transfer pricing adjustment by $385 million resulting in an additional potential tax liability of $135 million . This increases the potential additional federal income tax liability to approximately $3.4 billion for the period, plus interest. A trial date has been set for March 5, 2018. The Company intends to vigorously defend its position and is confident in its ability to prevail on the merits. On June 20, 2017, the Company filed a motion for summary judgment on the portion of the IRS' adjustments related to our licensee in Mexico. That motion is still pending. The Company regularly assesses the likelihood of adverse outcomes resulting from examinations such as this to determine the adequacy of its tax reserves. The Company believes that the final adjudication of this matter will not have a material impact on its consolidated financial position, results of operations or cash flows. However, the ultimate outcome of disputes of this nature is uncertain, and if the IRS were to prevail on its assertions, the additional tax, interest and any potential penalties could have a material adverse impact on the Company's financial position, results of operations and cash flows. Risk Management Programs The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company's risk of catastrophic loss. Our reserves for the Company's self-insured losses are estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on our claim history. Our self-insurance reserves totaled $ 514 million and $ 527 million as of September 29, 2017 and December 31, 2016 , respectively.

Comprehensive Income

Comprehensive Income	9 Months Ended
	Sep. 29, 2017
Comprehensive Income
Comprehensive Income	OTHER COMPREHENSIVE INCOME AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our condensed consolidated balance sheets as a component of The Coca-Cola Company's shareowners' equity, which also includes our proportionate share of equity method investees' AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our condensed consolidated balance sheets as part of the line item equity attributable to noncontrolling interests. AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions): September 29, December 31, 2016 Foreign currency translation adjustments $ (8,271 ) $ (9,780 ) Accumulated derivative net gains (losses) (80 ) 314 Unrealized net gains (losses) on available-for-sale securities 470 305 Adjustments to pension and other benefit liabilities (1,962 ) (2,044 ) Accumulated other comprehensive income (loss) $ (9,843 ) $ (11,205 ) The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions): Nine Months Ended September 29, 2017 Shareowners of The Coca-Cola Company Noncontrolling Interests Total Consolidated net income $ 4,000 $ — $ 4,000 Other comprehensive income: Net foreign currency translation adjustments 1,509 2 1,511 Net gain (loss) on derivatives 1 (394 ) — (394 ) Net change in unrealized gain (loss) on available-for-sale securities 2 165 — 165 Net change in pension and other benefit liabilities 3 82 — 82 Total comprehensive income $ 5,362 $ 2 $ 5,364 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Refer to Note 3 for additional information related to the net unrealized gain or loss on available-for-sale securities. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI (in millions): Three Months Ended September 29, 2017 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ 162 $ (174 ) $ (12 ) Reclassification adjustments recognized in net income (17 ) — (17 ) Gains (losses) on intra-entity transactions that are of a long-term-investment nature 1,063 — 1,063 Gains (losses) on net investment hedges arising during the period 1 (553 ) 211 (342 ) Net foreign currency translation adjustments 655 37 692 Derivatives: Gains (losses) arising during the period 54 (19 ) 35 Reclassification adjustments recognized in net income (207 ) 76 (131 ) Net gains (losses) on derivatives 1 (153 ) 57 (96 ) Available-for-sale securities: Unrealized gains (losses) arising during the period 20 (17 ) 3 Reclassification adjustments recognized in net income (4 ) 2 (2 ) Net change in unrealized gain (loss) on available-for-sale securities 2 16 (15 ) 1 Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period (120 ) 49 (71 ) Reclassification adjustments recognized in net income 193 (73 ) 120 Net change in pension and other benefit liabilities 3 73 (24 ) 49 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ 591 $ 55 $ 646 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 and Note 10 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. Nine Months Ended September 29, 2017 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ (793 ) $ (142 ) $ (935 ) Reclassification adjustments recognized in net income 103 (6 ) 97 Gains (losses) on intra-entity transactions that are of a long-term-investment nature 3,270 — 3,270 Gains (losses) on net investment hedges arising during the period 1 (1,494 ) 571 (923 ) Net foreign currency translation adjustments 1,086 423 1,509 Derivatives: Gains (losses) arising during the period (159 ) 56 (103 ) Reclassification adjustments recognized in net income (466 ) 175 (291 ) Net gains (losses) on derivatives 1 (625 ) 231 (394 ) Available-for-sale securities: Unrealized gains (losses) arising during the period 365 (123 ) 242 Reclassification adjustments recognized in net income (117 ) 40 (77 ) Net change in unrealized gain (loss) on available-for-sale securities 2 248 (83 ) 165 Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period (161 ) 73 (88 ) Reclassification adjustments recognized in net income 266 (96 ) 170 Net change in pension and other benefit liabilities 3 105 (23 ) 82 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ 814 $ 548 $ 1,362 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 and Note 10 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. Three Months Ended September 30, 2016 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ (130 ) $ 41 $ (89 ) Reclassification adjustments recognized in net income 242 (18 ) 224 Gains (losses) on net investment hedges arising during the period 1 (76 ) 29 (47 ) Net foreign currency translation adjustments 36 52 88 Derivatives: Gains (losses) arising during the period 22 (8 ) 14 Reclassification adjustments recognized in net income (186 ) 71 (115 ) Net gains (losses) on derivatives 1 (164 ) 63 (101 ) Available-for-sale securities: Unrealized gains (losses) arising during the period (98 ) 31 (67 ) Reclassification adjustments recognized in net income (19 ) 4 (15 ) Net change in unrealized gain (loss) on available-for-sale securities 2 (117 ) 35 (82 ) Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period 13 (2 ) 11 Reclassification adjustments recognized in net income 43 (15 ) 28 Net change in pension and other benefit liabilities 3 56 (17 ) 39 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ (189 ) $ 133 $ (56 ) 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. Nine Months Ended September 30, 2016 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ 332 $ 39 $ 371 Reclassification adjustments recognized in net income 368 (18 ) 350 Gains (losses) on net investment hedges arising during the period 1 (558 ) 214 (344 ) Reclassification adjustments for net investment hedges recognized in net income 1 77 (30 ) 47 Net foreign currency translation adjustments 219 205 424 Derivatives: Gains (losses) arising during the period (585 ) 221 (364 ) Reclassification adjustments recognized in net income (485 ) 183 (302 ) Net gains (losses) on derivatives 1 (1,070 ) 404 (666 ) Available-for-sale securities: Unrealized gains (losses) arising during the period 196 (46 ) 150 Reclassification adjustments recognized in net income (93 ) 22 (71 ) Net change in unrealized gain (loss) on available-for-sale securities 2 103 (24 ) 79 Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period 1 (1 ) — Reclassification adjustments recognized in net income 192 (64 ) 128 Net change in pension and other benefit liabilities 3 193 (65 ) 128 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ (555 ) $ 520 $ (35 ) 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. The following table presents the amounts and line items in our condensed consolidated statements of income where adjustments reclassified from AOCI into income were recorded (in millions): Amount Reclassified from AOCI into Income Description of AOCI Component Financial Statement Line Item Three Months Ended September 29, 2017 Nine Months Ended September 29, 2017 Foreign currency translation adjustments: Divestitures, deconsolidations and other 1 Other income (loss) — net $ (17 ) $ 103 Income before income taxes (17 ) 103 Income taxes — (6 ) Consolidated net income $ (17 ) $ 97 Derivatives: Foreign currency contracts Net operating revenues $ (116 ) $ (338 ) Foreign currency and commodity contracts Cost of goods sold 5 (1 ) Foreign currency contracts Other income (loss) — net (107 ) (159 ) Divestitures, deconsolidations and other 1 Other income (loss) — net — 1 Foreign currency and interest rate contracts Interest expense 11 31 Income before income taxes (207 ) (466 ) Income taxes 76 175 Consolidated net income $ (131 ) $ (291 ) Available-for-sale securities: Divestitures, deconsolidations and other 1 Other income (loss) — net $ — $ (87 ) Sale of securities Other income (loss) — net (4 ) (30 ) Income before income taxes (4 ) (117 ) Income taxes 2 40 Consolidated net income $ (2 ) $ (77 ) Pension and other benefit liabilities: Curtailment charges (credits) 2 Other operating charges $ 1 $ (17 ) Settlement charges (credits) 2 Other operating charges 150 150 Divestitures, deconsolidations and other 1 Other income (loss) — net — 7 Recognized net actuarial loss (gain) * 46 139 Recognized prior service cost (credit) * (4 ) (13 ) Income before income taxes 193 266 Income taxes (73 ) (96 ) Consolidated net income $ 120 $ 170 1 Primarily related to the integration of Coca-Cola West Co., Ltd. ("CCW") and Coca-Cola East Japan Co., Ltd. ("CCEJ") to establish Coca-Cola Bottlers Japan Inc. ("CCBJI"). Refer to Note 10 . 2 The curtailment charges (credits) and settlement charges (credits) were primarily related to North America refranchising and the Company's productivity, restructuring and integration initiatives. * This component of AOCI is included in the Company's computation of net periodic benefit cost and is not reclassified out of AOCI into a single line item in our condensed consolidated statements of income in its entirety. Refer to Note 12 for additional information.

Changes in Equity

Changes in Equity	9 Months Ended
	Sep. 29, 2017
Changes in Equity [Abstract]
Changes in Equity	CHANGES IN EQUITY The following table provides a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and equity attributable to noncontrolling interests (in millions): Shareowners of The Coca-Cola Company Common Shares Outstanding Total Reinvested Earnings Accumulated Other Comprehensive Income (Loss) Common Stock Capital Surplus Treasury Stock Non- controlling Interests December 31, 2016 4,288 $ 23,220 $ 65,502 $ (11,205 ) $ 1,760 $ 14,993 $ (47,988 ) $ 158 Comprehensive income (loss) — 5,364 4,000 1,362 — — — 2 Dividends paid/payable to shareowners of The Coca-Cola Company — (4,743 ) (4,743 ) — — — — — Dividends paid to noncontrolling interests — (15 ) — — — — — (15 ) Deconsolidation of certain entities — (153 ) — — — — — (153 ) Purchases of treasury stock (69 ) (3,012 ) — — — — (3,012 ) — Impact related to stock compensation plans 43 1,453 — — — 709 744 — Other activities — 38 — — — (3 ) — 41 September 29, 2017 4,262 $ 22,152 $ 64,759 $ (9,843 ) $ 1,760 $ 15,699 $ (50,256 ) $ 33

Significant Operating and Nonop

Significant Operating and Nonoperating Items	9 Months Ended
	Sep. 29, 2017
Significant Operating and Nonoperating Items
Significant Operating and Nonoperating Items	SIGNIFICANT OPERATING AND NONOPERATING ITEMS Other Operating Charges During the three months ended September 29, 2017 , the Company recorded other operating charges of $360 million . These charges primarily consisted of $213 million related to costs incurred to refranchise certain of our North America bottling operations. Costs related to refranchising include, among other items, internal and external costs for individuals directly working on the refranchising efforts, severance and costs associated with the implementation of information technology systems to facilitate consistent data standards and availability throughout our North America bottling system. In addition, other operating charges included $129 million related to the Company's productivity and reinvestment program and $18 million related to tax litigation expense. Refer to Note 11 for additional information on the Company's productivity, integration and restructuring initiatives. Refer to Note 15 for the impact these charges had on our operating segments. During the nine months ended September 29, 2017 , the Company recorded other operating charges of $1,491 million . These charges primarily consisted of $737 million of CCR asset impairments and $355 million related to the Company's productivity and reinvestment program. In addition, other operating charges included $314 million related to costs incurred to refranchise certain of our bottling operations, $43 million related to tax litigation expense and $34 million related to impairments of Venezuelan intangible assets. Refer to Note 1 for additional information about the Venezuelan intangible assets and Note 14 for information on how the Company determined the asset impairment charges. Refer to Note 11 for additional information on the Company's productivity, integration and restructuring initiatives. Refer to Note 15 for the impact these charges had on our operating segments. During the three months ended September 30, 2016 , the Company incurred other operating charges of $222 million . These charges primarily consisted of a charge of $76 million due to the write-down we recorded related to our receivables from our bottling partner in Venezuela due to changes in exchange rates and charges of $73 million related to costs incurred to refranchise certain of our North America bottling territories. These costs include, among other items, internal and external costs for individuals directly working on the refranchising efforts, severance and costs associated with the implementation of information technology systems to facilitate consistent data standards and availability throughout the North America bottling system. In addition, the Company recorded charges of $59 million due to the Company's productivity and reinvestment program. Refer to Note 1 for additional information on the Venezuelan exchange rates and Note 11 for additional information on the Company's productivity, integration and restructuring initiatives. Refer to Note 15 for the impact these charges had on our operating segments. During the nine months ended September 30, 2016 , the Company incurred other operating charges of $830 million . These charges primarily consisted of $187 million due to the Company's productivity and reinvestment program and $240 million due to the integration of our German bottling operations. In addition, the Company recorded charges of $170 million related to costs incurred to refranchise certain of our North America bottling territories. The Company also recorded a charge of $100 million related to a cash contribution we made to The Coca-Cola Foundation, a charge of $76 million due to the write-down we recorded related to our receivables from our bottling partner in Venezuela due to changes in exchange rates, and charges of $37 million related to noncapitalizable transaction costs associated with pending and closed transactions. Refer to Note 11 for additional information on the Company's productivity, integration and restructuring initiatives and Note 1 for additional information on the Venezuelan exchange rates. Refer to Note 15 for the impact these charges had on our operating segments. Other Nonoperating Items Interest Expense During the nine months ended September 29, 2017 , the Company recorded a net charge of $38 million related to the extinguishment of long-term debt. Refer to Note 6 . Equity Income (Loss) — Net During the three and nine months ended September 29, 2017 , the Company recorded net charges of $16 million and $37 million , respectively. During the three and nine months ended September 30, 2016 , the Company recorded net charges of $14 million and $35 million , respectively. These amounts represent the Company's proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 15 for the impact these items had on our operating segments. Other Income (Loss) — Net During the three months ended September 29, 2017 , the Company recorded charges of $762 million due to the refranchising of certain bottling territories in North America and charges of $72 million primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. The Company also recorded an other-than-temporary impairment charge of $50 million related to one of our international equity method investees, primarily driven by foreign currency exchange rate fluctuations. These charges were partially offset by a gain of $79 million related to the refranchising of our remaining China bottling operations and related cost method investment. Refer to Note 2 for additional information on the refranchising of our China bottling operations, North America refranchising and the conversion payments. Refer to Note 15 for the impact these items had on our operating segments. During the nine months ended September 29, 2017 , the Company recognized a net charge of $1,473 million due to the refranchising of certain bottling territories in North America and charges of $287 million primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. The Company also recorded an other-than-temporary impairment charge of $50 million related to one of our international equity method investees, primarily driven by foreign currency exchange rate fluctuations. Additionally, the Company incurred a charge of $26 million related to our former German bottling operations. These charges were partially offset by a gain of $445 million related to the integration of CCW and CCEJ to establish CCBJI. In exchange for our previously existing equity interests in CCW and CCEJ, we received an approximate 17 percent equity interest in CCBJI. The Company also recognized a gain of $88 million related to the refranchising of our China bottling operations and related cost method investment and a gain of $25 million as a result of Coca-Cola FEMSA, S.A.B. de C.V. ("Coca-Cola FEMSA"), an equity method investee, issuing additional shares of its stock during the period at a per share amount greater than the carrying value of the Company's per share investment. Refer to Note 2 for additional information on the North America refranchising, the conversion payments and the refranchising of our China bottling operations. Refer to Note 15 for the impact these items had on our operating segments. During the three months ended September 30, 2016 , the Company recognized losses of $1,089 million due to the refranchising of certain bottling territories in North America and a loss of $21 million due to the deconsolidation of our South African bottling operations in exchange for investments in CCBA and CCBA's South African subsidiary. Additionally, the Company incurred charges of $17 million related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. Refer to Note 2 for additional information on the North America refranchising, the deconsolidation of our South African bottling operations and the conversion payments. Refer to Note 15 for the impact these items had on our operating segments. During the nine months ended September 30, 2016 , the Company recognized a gain of $1,323 million due to the deconsolidation of our German bottling operations and a gain of $18 million resulting from the Company's disposal of its investment in Keurig. These gains were offset by losses of $1,657 million due to the refranchising of certain bottling territories in North America and a loss of $21 million due to the deconsolidation of our South African bottling operations in exchange for investments in CCBA and CCBA's South African subsidiary. Additionally, the Company incurred charges of $17 million related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. Refer to Note 2 for additional information on the deconsolidation of our German bottling operations, the Keurig investment disposal, the deconsolidation of our South African bottling operations, the North America refranchising and the conversion payments. Refer to Note 15 for the impact these items had on our operating segments.

Productivity, Integration and R

Productivity, Integration and Restructuring Initiatives	9 Months Ended
	Sep. 29, 2017
Productivity integration and restructuring initiatives
Productivity, Integration and Restructuring Initiatives[Text Block]	PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES Productivity and Reinvestment In February 2012, the Company announced a productivity and reinvestment program designed to further enable our efforts to strengthen our brands and reinvest our resources to drive long-term profitable growth. This program is focused on the following initiatives: global supply chain optimization; global marketing and innovation effectiveness; operating expense leverage and operational excellence; data and information technology systems standardization; and the integration of Old CCE. In February 2014, the Company announced the expansion of our productivity and reinvestment program to drive incremental productivity that will primarily be redirected into increased media investments. Our incremental productivity goal consists of two relatively equal components. First, we will expand savings through global supply chain optimization, data and information technology systems standardization, and resource and cost reallocation. Second, we will increase the effectiveness of our marketing investments by transforming our marketing and commercial model to redeploy resources into more consumer-facing marketing investments to accelerate growth. In October 2014, the Company announced that we were further expanding our productivity and reinvestment program and extending it through 2019. The expansion of the productivity initiatives will focus on four key areas: restructuring the Company's global supply chain; implementing zero-based work, an evolution of zero-based budget principles, across the organization; streamlining and simplifying the Company's operating model; and further driving increased discipline and efficiency in direct marketing investments. In April 2017, the Company announced its plans to transition to a new, more agile operating model to enable growth. Under this operating model, our business units will be supported by an expanded enabling services organization and a corporate center focused on a few strategic initiatives, policy and governance. The expanded enabling services organization will focus on both simplifying and standardizing key transactional processes and providing support to business units through global centers of excellence. The Company has incurred total pretax expenses of $ 2,763 million related to this productivity and reinvestment program since it commenced. These expenses were recorded in the line item other operating charges in our condensed consolidated statements of income. Refer to Note 15 for the impact these charges had on our operating segments. Outside services reported in the table below primarily relate to expenses in connection with legal, outplacement and consulting activities. Other direct costs reported in the table below include, among other items, internal and external costs associated with the development, communication, administration and implementation of these initiatives; accelerated depreciation on certain fixed assets; contract termination fees; and relocation costs. The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts as of and for the three months ended September 29, 2017 (in millions): Accrued Balance June 30, 2017 Costs Incurred Three Months Ended September 29, 2017 Payments Noncash and Exchange Accrued Balance September 29, 2017 Severance pay and benefits $ 162 $ 43 $ (88 ) $ 2 $ 119 Outside services 11 19 (20 ) (1 ) 9 Other direct costs 16 67 (69 ) (3 ) 11 Total $ 189 $ 129 $ (177 ) $ (2 ) $ 139 The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts as of and for the nine months ended September 29, 2017 (in millions): Accrued Balance December 31, 2016 Costs Incurred Nine Months Ended September 29, 2017 Payments Noncash and Exchange Accrued Balance September 29, 2017 Severance pay and benefits $ 123 $ 143 $ (146 ) $ (1 ) $ 119 Outside services 6 62 (58 ) (1 ) 9 Other direct costs 22 150 (154 ) (7 ) 11 Total $ 151 $ 355 $ (358 ) $ (9 ) $ 139 Integration of Our German Bottling Operations In 2008, the Company began the integration of our German bottling operations acquired in 2007. The Company incurred pretax expenses of $240 million related to this initiative during the nine months ended September 30, 2016 and has incurred total pretax expenses of $ 1,367 million related to this initiative since it commenced. These charges were recorded in the line item other operating charges in our condensed consolidated statements of income and impacted the Bottling Investments operating segment. The expenses recorded in connection with these integration activities were primarily due to involuntary terminations. During the year ended December 31, 2016, the Company deconsolidated our German bottling operations. Therefore, there was no remaining accrual balance as of December 31, 2016.

Pension and Other Postretiremen

Pension and Other Postretirement Benefit Plans	9 Months Ended
	Sep. 29, 2017
Pension and Other Postretirement Benefit Plans
Pension and Other Postretirement Benefit Plans	PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS Net periodic benefit cost for our pension and other postretirement benefit plans consisted of the following (in millions): Pension Benefits Other Benefits Three Months Ended September 29, September 30, September 29, September 30, Service cost $ 49 $ 59 $ 4 $ 6 Interest cost 76 79 7 8 Expected return on plan assets 1 (163 ) (161 ) (3 ) (3 ) Amortization of prior service cost (credit) — — (4 ) (5 ) Amortization of net actuarial loss 44 46 2 2 Net periodic benefit cost 6 23 6 8 Curtailment charges (credits) 2 2 — — — Settlement charges (credits) 2 150 — — — Special termination benefits 2 15 4 — — Other — — — 31 Total cost recognized in condensed consolidated statements of income $ 173 $ 27 $ 6 $ 39 1 The weighted-average expected long-term rates of return on plan assets used in computing 2017 net periodic benefit cost are 8.0 percent for pension benefits and 4.5 percent for other benefits. 2 The curtailment charges (credits), settlement charges (credits) and special termination benefits were primarily related to North America refranchising and the Company's productivity, restructuring and integration initiatives. Refer to Note 2 and Note 11 . Pension Benefits Other Benefits Nine Months Ended September 29, September 30, September 29, September 30, Service cost $ 149 $ 178 $ 13 $ 17 Interest cost 232 239 22 23 Expected return on plan assets 1 (487 ) (490 ) (9 ) (9 ) Amortization of prior service cost (credit) — (1 ) (13 ) (14 ) Amortization of net actuarial loss 133 138 6 5 Net periodic benefit cost 27 64 19 22 Curtailment charges (credits) 2 2 — (42 ) — Settlement charges (credits) 2 150 — — — Special termination benefits 2 72 17 — — Other — — — 31 Total cost recognized in condensed consolidated statements of income $ 251 $ 81 $ (23 ) $ 53 1 The weighted-average expected long-term rates of return on plan assets used in computing 2017 net periodic benefit cost are 8.0 percent for pension benefits and 4.5 percent for other benefits. 2 The curtailment charges (credits), settlement charges (credits) and special termination benefits were primarily related to North America refranchising and the Company's productivity, restructuring and integration initiatives. Refer to Note 2 and Note 11 . During the nine months ended September 29, 2017 , the Company contributed $ 88 million to our pension plans, and we anticipate making additional contributions of approximately $ 85 million during the remainder of 2017. The Company contributed $ 519 million to our pension plans during the nine months ended September 30, 2016 .

Income Taxes

Income Taxes	9 Months Ended
	Sep. 29, 2017
Income taxes
Income Taxes	INCOME TAXES Our effective tax rate reflects the tax benefits of having significant operations outside the United States, which are generally taxed at rates lower than the U.S. statutory rate of 35.0 percent . As a result of employment actions and capital investments made by the Company, certain tax jurisdictions provide income tax incentive grants, including Brazil, Costa Rica, Singapore and Swaziland. The terms of these grants expire from 2017 to 2036 . We anticipate that we will be able to extend or renew the grants in these locations. In addition, our effective tax rate reflects the benefits of having significant earnings generated in investments accounted for under the equity method of accounting, which are generally taxed at rates lower than the U.S. statutory rate. At the end of each interim period, we make our best estimate of the effective tax rate expected to be applicable for the full fiscal year. This estimate reflects, among other items, our best estimate of operating results and foreign currency exchange rates. Based on current tax laws, the Company's estimated effective tax rate for 2017 is 24.0 percent . However, in arriving at this estimate we do not include the estimated impact of significant operating and nonoperating items, which may cause significant variations in the customary relationship between income tax expense and income before income taxes. On September 17, 2015, the Company received a Statutory Notice of Deficiency from the IRS for the tax years 2007 through 2009, after a five-year audit. Refer to Note 7 . The Company recorded income tax expense of $230 million ( 13.7 percent effective tax rate) and $378 million ( 26.5 percent effective tax rate) during the three months ended September 29, 2017 and September 30, 2016 , respectively. The Company recorded income tax expense of $1,805 million ( 31.1 percent effective tax rate) and $1,618 million ( 21.2 percent effective tax rate) during the nine months ended September 29, 2017 and September 30, 2016 , respectively. The following table illustrates the income tax expense (benefit) associated with significant operating and nonoperating items for the interim periods presented (in millions): Three Months Ended Nine Months Ended September 29, September 30, September 29, September 30, Asset impairments $ — 1 $ — $ (164 ) 1 $ — Productivity and reinvestment program (44 ) 2 (20 ) 9 (127 ) 2 (65 ) 9 Other productivity, integration and restructuring initiatives — — — — 10 Transaction gains and losses (361 ) 3 (246 ) 11 172 4 (363 ) 12 Certain tax matters (40 ) 5 7 13 (110 ) 6 84 13 Other — net (12 ) 7 8 14 (41 ) 8 (38 ) 15 1 Related to charges of $50 million and $821 million during the three and nine months ended September 29, 2017 , respectively, due to the impairment of certain assets. Refer to Note 10 and Note 14 . 2 Related to charges of $129 million and $355 million during the three and nine months ended September 29, 2017 , respectively. These charges were due to the Company's productivity and reinvestment program. Refer to Note 11 . 3 Related to a net charge of $968 million which primarily consisted of $762 million of charges as a result of the refranchising of certain bottling territories in North America, $213 million related to costs incurred to refranchise certain of our bottling operations and $72 million primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. These charges were partially offset by a $79 million gain related to the refranchising of our remaining China bottling operations and related cost method investment. Refer to Note 2 and Note 10 . 4 Related to a net charge of $1,551 million which primarily consisted of $1,473 million of net charges as a result of the refranchising of certain bottling territories in North America, $314 million of charges related to costs incurred to refranchise certain of our bottling operations, $287 million of charges primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements and a $26 million charge related to our former German bottling operations. These charges were partially offset by a $445 million gain related to the merger of CCW and CCEJ, an $88 million gain related to the refranchising of our China bottling operations and related cost method investment and a $25 million gain related to Coca-Cola FEMSA, an equity method investee, issuing additional shares of its stock. Refer to Note 2 and Note 10 . 5 Related to $40 million of excess tax benefits associated with the Company's share-based compensation arrangements. 6 Related to $122 million of excess tax benefits associated with the Company's share-based compensation arrangements and the tax benefit associated with the reversal of valuation allowances in certain of the Company's foreign jurisdictions, both of which were partially offset by changes to our uncertain tax positions, including interest and penalties. 7 Related to charges of $35 million which primarily consisted of an $18 million charge related to tax litigation expense and a $16 million net charge due to our proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 10 . 8 Related to charges of $121 million which primarily consisted of a net charge of $38 million related to the extinguishment of long-term debt, a $43 million charge related to tax litigation expense and a net charge of $37 million due to our proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 10 . 9 Related to charges of $59 million and $187 million during the three and nine months ended September 30, 2016, respectively. These charges were due to the Company's productivity and reinvestment program. Refer to Note 10 and Note 11 . 10 Related to charges of $240 million during the nine months ended September 30, 2016. These charges were due to the integration of our German bottling operations. Refer to Note 10 and Note 11 . 11 Related to charges of $1,204 million which primarily consisted of $1,089 million of charges due to the refranchising of bottling territories in North America, $73 million related to costs incurred to refranchise our North America bottling territories, charges of $17 million related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements, a loss of $21 million related to the deconsolidation of our South African bottling operations and the $80 million tax impact resulting from the accrual of tax on temporary differences related to the investment in foreign subsidiaries that are now expected to reverse in the foreseeable future. Refer to Note 2 and Note 10 . 12 Related to a net charge of $561 million which primarily consisted of $1,657 million of charges due to the refranchising of bottling territories in North America, $170 million related to costs incurred to refranchise our North America bottling territories, charges of $17 million related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements, a loss of $21 million related to the deconsolidation of our South African bottling operations and the $80 million tax impact resulting from the accrual of tax on temporary differences related to the investment in foreign subsidiaries that are now expected to reverse in the foreseeable future. These charges were partially offset by a $1,288 million net gain related to the deconsolidation of our German bottling operations and an $18 million net gain related to the disposal of our investment in Keurig. Refer to Note 2 and Note 10 . 13 Primarily related to changes to our uncertain tax positions, including interest and penalties. The components of the net change in uncertain tax positions were individually insignificant. 14 Related to charges of $99 million which included a $76 million write-down we recorded related to receivables from our bottling partner in Venezuela, a $14 million charge due to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees and a $9 million charge due to tax litigation expense. Refer to Note 10 . 15 Related to charges of $230 million which included a $100 million cash contribution to The Coca-Cola Foundation, a $76 million charge due to the write-down we recorded related to receivables from our bottling partner in Venezuela, a $35 million net charge due to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees and a $19 million charge due to tax litigation expense. Refer to Note 10 . The Company evaluates the recoverability of our deferred tax assets in accordance with U.S. GAAP. We perform our recoverability tests on a quarterly basis, or more frequently, to determine whether it is more likely than not that any of our deferred tax assets will not be realized within their life cycle based on the available evidence. The Company's deferred tax asset valuation allowances are primarily the result of uncertainties regarding the future realization of recorded tax benefits on tax loss carryforwards from operations in various jurisdictions.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 29, 2017
Fair Value Measurements [Abstract]
Fair Value Disclosures [Text Block]	FAIR VALUE MEASUREMENTS U.S. GAAP defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Additionally, the inputs used to measure fair value are prioritized based on a three-level hierarchy. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: • Level 1 — Quoted prices in active markets for identical assets or liabilities. • Level 2 — Observable inputs other than quoted prices included in Level 1. We value assets and liabilities included in this level using dealer and broker quotations, certain pricing models, bid prices, quoted prices for similar assets and liabilities in active markets, or other inputs that are observable or can be corroborated by observable market data. • Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. Recurring Fair Value Measurements In accordance with U.S. GAAP, certain assets and liabilities are required to be recorded at fair value on a recurring basis. For our Company, the only assets and liabilities that are adjusted to fair value on a recurring basis are investments in equity and debt securities classified as trading or available-for-sale and derivative financial instruments. Additionally, the Company adjusts the carrying value of certain long-term debt as a result of the Company's fair value hedging strategy. Investments in Trading and Available-for-Sale Securities The fair values of our investments in trading and available-for-sale securities using quoted market prices from daily exchange traded markets are based on the closing price as of the balance sheet date and are classified as Level 1. The fair values of our investments in trading and available-for-sale securities classified as Level 2 are priced using quoted market prices for similar instruments or non-binding market prices that are corroborated by observable market data. Inputs into these valuation techniques include actual trade data, benchmark yields, broker/dealer quotes and other similar data. These inputs are obtained from quoted market prices, independent pricing vendors or other sources. Derivative Financial Instruments The fair values of our futures contracts are primarily determined using quoted contract prices on futures exchange markets. The fair values of these instruments are based on the closing contract price as of the balance sheet date and are classified as Level 1. The fair values of our derivative instruments other than futures are determined using standard valuation models. The significant inputs used in these models are readily available in public markets, or can be derived from observable market transactions, and therefore have been classified as Level 2. Inputs used in these standard valuation models for derivative instruments other than futures include the applicable exchange rates, forward rates, interest rates, discount rates and commodity prices. The standard valuation model for options also uses implied volatility as an additional input. The discount rates are based on the historical U.S. Deposit or U.S. Treasury rates, and the implied volatility specific to options is based on quoted rates from financial institutions. Included in the fair values of derivative instruments is an adjustment for nonperformance risk. The adjustment is based on current credit default swap ("CDS") rates applied to each contract, by counterparty. We use our counterparty's CDS rate when we are in an asset position and our own CDS rate when we are in a liability position. The adjustment for nonperformance risk did not have a significant impact on the fair values of our derivative instruments. The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions): September 29, 2017 Level 1 Level 2 Level 3 Other 4 Netting Adjustment 5 Fair Value Measurements Assets: Trading securities 1 $ 233 $ 123 $ 4 $ 67 $ — $ 427 Available-for-sale securities 1 1,892 6,532 167 3 — — 8,591 Derivatives 2 7 458 — — (358 ) 6 107 8 Total assets $ 2,132 $ 7,113 $ 171 $ 67 $ (358 ) $ 9,125 Liabilities: Derivatives 2 $ (12 ) $ (301 ) $ — $ — $ 232 7 $ (81 ) 8 Total liabilities $ (12 ) $ (301 ) $ — $ — $ 232 $ (81 ) 1 Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities. 2 Refer to Note 5 for additional information related to the composition of our derivative portfolio. 3 Primarily related to debt securities that mature in 2018. 4 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 3 . 5 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5 . 6 The Company is obligated to return $138 million in cash collateral it has netted against its net asset derivative position. 7 The Company has the right to reclaim $1 million in cash collateral it has netted against its net liability derivative position. 8 The Company's derivative financial instruments are recorded at fair value in our condensed consolidated balance sheets as follows: $ 107 million in the line item other assets and $ 81 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio. December 31, 2016 Level 1 Level 2 Level 3 Other 4 Netting Adjustment 5 Fair Value Measurements Assets: Trading securities 1 $ 202 $ 115 $ 4 $ 63 $ — $ 384 Available-for-sale securities 1 1,655 4,619 139 3 — — 6,413 Derivatives 2 4 878 — — (369 ) 6 513 8 Total assets $ 1,861 $ 5,612 $ 143 $ 63 $ (369 ) $ 7,310 Liabilities: Derivatives 2 $ 11 $ 276 $ — $ — $ (192 ) 7 $ 95 8 Total liabilities $ 11 $ 276 $ — $ — $ (192 ) $ 95 1 Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities. 2 Refer to Note 5 for additional information related to the composition of our derivative portfolio. 3 Primarily related to long-term debt securities that mature in 2018. 4 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 3 . 5 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5 . 6 The Company is obligated to return $201 million in cash collateral it has netted against its derivative position. 7 The Company has the right to reclaim $17 million in cash collateral it has netted against its derivative position. 8 The Company's derivative financial instruments are recorded at fair value in our condensed consolidated balance sheets as follows: $ 347 million in the line item prepaid expenses and other assets; $ 166 million in the line item other assets; $42 million in the line item accounts payable and accrued expenses; and $ 53 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio. Gross realized and unrealized gains and losses on Level 3 assets and liabilities were not significant for the three and nine months ended September 29, 2017 and September 30, 2016 . The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not significant for the three and nine months ended September 29, 2017 and September 30, 2016 . Nonrecurring Fair Value Measurements In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a nonrecurring basis as required by U.S. GAAP. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. The gains and losses on assets measured at fair value on a nonrecurring basis are summarized in the table below (in millions): Gains (Losses) Three Months Ended Nine Months Ended September 29, 2017 September 30, September 29, 2017 September 30, Assets held for sale 1 $ (307 ) $ (1,044 ) $ (1,819 ) $ (1,490 ) Intangible assets — — (442 ) 2 — Other long-lived assets — — (329 ) 3 — Valuation of shares in equity method investee — — 25 4 — Other-than-temporary impairment charge (50 ) 5 — (50 ) 5 — Total $ (357 ) $ (1,044 ) $ (2,615 ) $ (1,490 ) 1 The Company is required to record assets and liabilities that are held for sale at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. These losses related to refranchising activities in North America, which were calculated based on Level 3 inputs. Refer to Note 2. 2 The Company recognized an impairment charge of $375 million related to CCR goodwill. This impairment charge was determined by comparing the fair value of the reporting unit, based on Level 3 inputs, to its carrying value. The Company also recognized an impairment charge of $33 million related to certain U.S. bottlers' franchise rights. This charge was determined by comparing the fair value of the asset to its current carrying value. Each of these impairment charges were primarily a result of refranchising activities in North America and management's estimates of the proceeds that are expected to be received for the remaining bottling territories upon their refranchising. Additionally, the Company recorded impairment charges of $34 million related to Venezuelan intangible assets due to weaker sales and the volatility of foreign currency exchange rates resulting from continued political instability. The fair value of these assets was derived using discounted cash flow analyses based on Level 3 inputs. 3 The Company recognized impairment charges of $310 million related to CCR property, plant and equipment and $19 million related to CCR other assets primarily as a result of refranchising activities in North America. The fair value of these assets was derived using management's estimate of the proceeds that are expected to be received for the remaining bottling territories upon their refranchising. 4 The Company recognized a gain of $25 million as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment in Coca-Cola FEMSA. These gains were determined using Level 1 inputs. 5 The Company recognized an other-than-temporary impairment charge of $50 million related to one of our international equity method investees, primarily driven by foreign currency exchange rate fluctuations. The fair value of this investment was derived using discounted cash flow analyses based on Level 3 inputs. Other Fair Value Disclosures The carrying amounts of cash and cash equivalents; short-term investments; trade accounts receivables; accounts payable and accrued expenses; and loans and notes payable approximate their fair values because of the short-term maturities of these instruments. The fair value of our long-term debt is estimated using Level 2 inputs based on quoted prices for those instruments. Where quoted prices are not available, fair value is estimated using discounted cash flows and market-based expectations for interest rates, credit risk and the contractual terms of the debt instruments. As of September 29, 2017 , the carrying amount and fair value of our long-term debt, including the current portion, were $ 35,702 million and $ 36,375 million , respectively. As of December 31, 2016 , the carrying amount and fair value of our long-term debt, including the current portion, were $ 33,211 million and $ 33,752 million , respectively.

Operating Segments

Operating Segments	9 Months Ended
	Sep. 29, 2017
Operating Segments [Abstract]
Operating Segments	OPERATING SEGMENTS Information about our Company's operations by operating segment is as follows (in millions): Europe, Middle East & Africa Latin North Asia Pacific Bottling Corporate Eliminations Consolidated As of and for the three months ended September 29, 2017 Net operating revenues: Third party $ 1,959 $ 1,009 $ 2,308 $ 1,345 $ 2,409 $ 48 $ — $ 9,078 Intersegment — 26 442 87 23 — (578 ) — Total net revenues 1,959 1,035 2,750 1,432 2,432 48 (578 ) 9,078 Operating income (loss) 936 563 646 577 (217 ) (385 ) — 2,120 Income (loss) before income taxes 962 561 583 588 (673 ) (347 ) — 1,674 Identifiable operating assets 5,475 1,909 17,224 2,146 6,433 34,567 — 67,754 Noncurrent investments 1,261 908 105 178 16,800 3,509 — 22,761 As of and for the three months ended September 30, 2016 Net operating revenues: Third party $ 1,852 $ 949 $ 1,661 $ 1,315 $ 4,809 $ 47 $ — $ 10,633 Intersegment — 16 1,003 145 31 — (1,195 ) — Total net revenues 1,852 965 2,664 1,460 4,840 47 (1,195 ) 10,633 Operating income (loss) 914 435 666 583 124 (451 ) — 2,271 Income (loss) before income taxes 922 447 653 589 (734 ) (449 ) — 1,428 Identifiable operating assets 4,337 1,964 16,406 2,257 17,390 33,546 — 75,900 Noncurrent investments 1,315 823 123 166 12,223 3,377 — 18,027 As of December 31, 2016 Identifiable operating assets $ 4,067 $ 1,785 $ 16,566 $ 2,024 $ 15,973 $ 29,606 $ — $ 70,021 Noncurrent investments 1,302 804 109 164 11,456 3,414 — 17,249 During the three months ended September 29, 2017 , the results of our operating segments were impacted by the following items: • Operating income (loss) and income (loss) before income taxes were reduced by $6 million for Europe, Middle East and Africa, $2 million for Latin America, $ 47 million for North America, $1 million for Asia Pacific, $ 15 million for Bottling Investments and $ 58 million for Corporate due to the Company's productivity and reinvestment program. Refer to Note 11 . • Operating income (loss) and income (loss) before income taxes were reduced by $213 million for Bottling Investments due to costs incurred to refranchise certain of our bottling operations. Refer to Note 2 and Note 10 . • Operating income (loss) and income (loss) before income taxes were reduced by $18 million for Corporate due to tax litigation expense. Refer to Note 7 . • Income (loss) before income taxes was reduced by $14 million for Bottling Investments and $2 million for Corporate due to the Company's proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 10 . • Income (loss) before income taxes was reduced by $72 million for North America primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. Refer to Note 2 . • Income (loss) before income taxes was reduced by $762 million for Bottling Investments due to the refranchising of certain bottling territories in North America. Refer to Note 2 . • Income (loss) before income taxes was increased by $79 million for Corporate due to a gain recognized upon refranchising our remaining China bottling operations and related cost method investment. Refer to Note 2 . • Income (loss) before income taxes was reduced by $50 million for Corporate due to an other-than-temporary impairment charge related to one of our international equity method investees. Refer to Note 10 . During the three months ended September 30, 2016 , the results of our operating segments were impacted by the following items: • Operating income (loss) and income (loss) before income taxes were reduced by $2 million for Europe, Middle East and Africa, $ 22 million for North America, $ 22 million for Bottling Investments and $ 14 million for Corporate due to the Company's productivity and reinvestment program as well as other restructuring initiatives. Operating income (loss) and income (loss) before income taxes were increased by $1 million for Latin America due to the refinement of previously established accruals related to the Company's productivity and reinvestment program. Refer to Note 11 . • Operating income (loss) and income (loss) before income taxes were reduced by $76 million for Latin America due to the write-down we recorded related to our receivables from our bottling partner in Venezuela due to changes in exchange rates. Refer to Note 1 . • Operating income (loss) and income (loss) before income taxes were reduced by $73 million for Bottling Investments due to costs incurred to refranchise certain of our North America bottling territories. Refer to Note 10 . • Income (loss) before income taxes was reduced by $14 million for Bottling Investments due to the Company's proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 10 . • Income (loss) before income taxes was reduced by $17 million for North America related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. Refer to Note 2 . • Income (loss) before income taxes was reduced by $1,089 million for Bottling Investments primarily due to the refranchising of certain bottling territories in North America. Refer to Note 2 and Note 10 . • Income (loss) before income taxes was reduced by $21 million for Corporate due to the deconsolidation of our South African bottling operations in exchange for investments in CCBA and CCBA's South African subsidiary. Refer to Note 2 . During the three months ended September 29, 2017 and September 30, 2016 , our operating segments were impacted by acquisition and divestiture activities. Refer to Note 2 . Europe, Middle East & Africa Latin North Asia Pacific Bottling Corporate Eliminations Consolidated Nine Months Ended September 29, 2017 Net operating revenues: Third party $ 5,628 $ 2,857 $ 6,216 $ 3,807 $ 9,268 $ 122 $ — $ 27,898 Intersegment — 54 1,799 340 69 — (2,262 ) — Total net revenues 5,628 2,911 8,015 4,147 9,337 122 (2,262 ) 27,898 Operating income (loss) 2,884 1,625 1,967 1,835 (979 ) (1,152 ) — 6,180 Income (loss) before income taxes 2,958 1,627 1,711 1,853 (1,730 ) (614 ) — 5,805 Nine Months Ended September 30, 2016 Net operating revenues: Third party $ 5,369 $ 2,787 $ 4,759 $ 3,818 $ 15,631 $ 90 $ — $ 32,454 Intersegment 264 50 2,978 437 116 5 (3,850 ) — Total net revenues 5,633 2,837 7,737 4,255 15,747 95 (3,850 ) 32,454 Operating income (loss) 2,897 1,470 1,982 1,892 222 (1,192 ) — 7,271 Income (loss) before income taxes 2,950 1,485 1,978 1,903 (897 ) 202 — 7,621 During the nine months ended September 29, 2017 , the results of our operating segments were impacted by the following items: • Operating income (loss) and income (loss) before income taxes were reduced by $2 million for Europe, Middle East and Africa, $3 million for Latin America, $131 million for North America, $4 million for Asia Pacific, $39 million for Bottling Investments and $176 million for Corporate due to the Company's productivity and reinvestment program. Refer to Note 11 . • Operating income (loss) and income (loss) before income taxes were reduced by $314 million for Bottling Investments due to costs incurred to refranchise certain of our bottling operations. Refer to Note 2 and Note 10 . • Operating income (loss) and income (loss) before income taxes were reduced by $737 million for Bottling Investments and $34 million for Corporate due to asset impairment charges. Refer to Note 1 and Note 10 . • Operating income (loss) and income (loss) before income taxes were reduced by $43 million for Corporate due to tax litigation expense. Refer to Note 7 . • Income (loss) before income taxes was reduced by $50 million for Corporate due to an other-than-temporary impairment charge related to one of our international equity method investees. Refer to Note 10 . • Income (loss) before income taxes was reduced by $4 million for Europe, Middle East and Africa, $29 million for Bottling Investments and $4 million for Corporate due to the Company's proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 10 . • Income (loss) before income taxes was reduced by $287 million for North America primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. Refer to Note 2 . • Income (loss) before income taxes was reduced by $1,473 million for Bottling Investments due to the refranchising of certain bottling territories in North America. Refer to Note 2 . • Income (loss) before income taxes was increased by $445 million for Corporate due to a gain recognized resulting from the merger of CCW and CCEJ. Refer to Note 10 . • Income (loss) before income taxes was increased by $88 million for Corporate due to a gain recognized upon refranchising our China bottling operations and related cost method investment. Refer to Note 2 . • Income (loss) before income taxes was increased by $25 million for Corporate due to Coca-Cola FEMSA, an equity method investee, issuing additional shares of its stock during the period at a per share amount greater than the carrying value of the Company's per share investment. • Income (loss) before income taxes was reduced by $26 million for Corporate due to a charge related to our former German bottling operations. • Income (loss) before income taxes was reduced by $38 million for Corporate due to the extinguishment of long-term debt. Refer to Note 6. During the nine months ended September 30, 2016 , the results of our operating segments were impacted by the following items: • Operating income (loss) and income (loss) before income taxes were reduced by $6 million for Europe, Middle East and Africa, $80 million for North America, $1 million for Asia Pacific, $300 million for Bottling Investments and $42 million for Corporate due to the Company's productivity and reinvestment program as well as other restructuring initiatives. Operating income (loss) and income (loss) before income taxes were increased by $2 million for Latin America due to the refinement of previously established accruals related to the Company's productivity and reinvestment program. Refer to Note 11 . • Operating income (loss) and income (loss) before income taxes were reduced by $76 million for Latin America due to the write-down we recorded related to our receivables from our bottling partner in Venezuela due to changes in exchange rates. Refer to Note 1 . • Operating income (loss) and income (loss) before income taxes were reduced by $170 million for Bottling Investments due to costs incurred to refranchise our North America bottling territories. Refer to Note 10 . • Operating income (loss) and income (loss) before income taxes were reduced by $8 million for Bottling Investments and $29 million for Corporate related to noncapitalizable transaction costs associated with pending and closed transactions. Refer to Note 10 . • Operating income (loss) and income (loss) before income taxes were reduced by $100 million for Corporate as a result of a cash contribution to The Coca-Cola Foundation. Refer to Note 10 . • Income (loss) before income taxes was reduced by $32 million for Bottling Investments and $3 million for Corporate due to the Company's proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees. Refer to Note 10 . • Income (loss) before income taxes was reduced by $17 million for North America related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. Refer to Note 2 . • Income (loss) before income taxes was reduced by $1,657 million for Bottling Investments due to the refranchising of certain bottling territories in North America. Refer to Note 2 and Note 10 . • Income (loss) before income taxes was increased by $1,323 million for Corporate as a result of the deconsolidation of our German bottling operations. Refer to Note 2 . • Income (loss) before income taxes was increased by $18 million for Corporate as a result of the disposal of our investment in Keurig. Refer to Note 2 . • Income (loss) before income taxes was reduced by $21 million for Corporate due to the deconsolidation of our South African bottling operations in exchange for investments in CCBA and CCBA's South African subsidiary. Refer to Note 2 . During the nine months ended September 29, 2017 and September 30, 2016 , our operating segments were impacted by acquisition and divestiture activities. Refer to Note 2 .

Summary of Significant Accoun22

Summary of Significant Accounting Policies Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 29, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Policy Text Block]	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2016 . When used in these notes, the terms "The Coca-Cola Company," "Company," "we," "us" and "our" mean The Coca-Cola Company and all entities included in our Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 29, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017 . Sales of our nonalcoholic ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters accounting for the highest sales volumes. The volume of sales in the beverage business may be affected by weather conditions. Each of our interim reporting periods, other than the fourth interim reporting period, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The third quarter of 2017 and the third quarter of 2016 ended on September 29, 2017 and September 30, 2016 , respectively. Our fourth interim reporting period and our fiscal year end on December 31 regardless of the day of the week on which December 31 falls.
Advertising Costs, Policy [Policy Text Block]	Advertising Costs The Company's accounting policy related to advertising costs for annual reporting purposes, as disclosed in Note 1 of our 2016 Annual Report on Form 10-K, is to expense production costs of print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred. For interim reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple interim periods to each of our interim reporting periods. We use the proportion of each interim period's actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard rate per unit case. At the end of each interim reporting period, we review our estimated full year unit case volume and our estimated full year marketing expenditures that benefit multiple interim periods in order to evaluate if a change in estimate is necessary. The impact of any changes in these full year estimates is recognized in the interim period in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.
Hyperinflationary Economies [Policy Text Block]	Hyperinflationary Economies A hyperinflationary economy is one that has cumulative inflation of 100 percent or more over a three-year period. In accordance with U.S. GAAP, local subsidiaries in hyperinflationary economies are required to use the U.S. dollar as their functional currency and remeasure the monetary assets and liabilities not denominated in U.S. dollars using the rate applicable to conversion of a currency for purposes of dividend remittances. All exchange gains and losses resulting from remeasurement are recognized currently in income. Venezuela has been designated as a hyperinflationary economy. During the nine months ended September 30, 2016 , the Venezuelan government devalued its currency and changed its official and most preferential exchange rate, which should be used for purchases of certain essential goods, to 10 bolivars per U.S. dollar from 6.3 . The official and most preferential rate is now known as DIPRO. The Venezuelan government also announced a new rate known as DICOM, which is allowed to float freely and is expected to fluctuate based on supply and demand. Management determined that the DICOM rate was the most appropriate legally available rate to remeasure the net monetary assets of our Venezuelan subsidiary. In addition to the foreign currency exchange exposure related to our Venezuelan subsidiary's net monetary assets, we also sell concentrate to our bottling partner in Venezuela from outside the country. These sales are denominated in U.S. dollars. As a result of the continued lack of liquidity and our revised assessment of the U.S. dollar value we expected to realize upon the conversion of Venezuelan bolivars into U.S. dollars by our bottling partner to pay our concentrate sales receivables, we recorded a write-down of $76 million during the three and nine months ended September 30, 2016 in the line item other operating charges in our condensed consolidated statements of income. We also have certain U.S. dollar-denominated intangible assets associated with products sold in Venezuela. As a result of weaker sales and the volatility of foreign currency exchange rates resulting from continued political instability, we recorded impairment charges of $34 million during the nine months ended September 29, 2017 in the line item other operating charges in our condensed consolidated statement of income. As a result of these impairment charges, the remaining carrying value of all U.S. dollar-denominated intangible assets associated with products sold in Venezuela is zero.
Recently Issued Accounting Guidance	Recently Issued Accounting Guidance In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers , which will replace most existing revenue recognition guidance in U.S. GAAP and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures about the nature, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. ASU 2014-09 allows for adoption either on a full retrospective basis to each prior reporting period presented or on a modified retrospective basis with the cumulative effect of initially applying the new guidance recognized at the date of initial application, which will be effective for the Company beginning January 1, 2018. The Company plans to adopt ASU 2014-09 and its amendments on a modified retrospective basis. We expect that ASU 2014-09's broad definition of variable consideration will require the Company to estimate and record certain variable payments resulting from collaborative funding arrangements, rebates and other pricing allowances earlier than it currently does. While we do not expect this change to have a material impact on our net operating revenues on an annual basis, we do expect that it will have an impact on our revenue in interim periods. Additionally, as a result of electing certain of the practical expedients available under the ASU, the Company expects there will be some reclassifications to or from net operating revenues, cost of goods sold, and selling, general and administrative expenses. As we continue our assessment, the Company is also identifying and preparing to implement changes to our accounting policies and practices, business processes, systems and controls to support the new revenue recognition and disclosure requirements. We are in the process of quantifying the impacts that will result from applying the new guidance. Our assessment will be completed during fiscal year 2017. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes . The amendments in this update are intended to simplify the presentation of deferred income taxes and require that deferred tax liabilities and assets be classified as noncurrent in a consolidated statement of financial position. The standard was prospectively adopted by the Company on January 1, 2017. Had the Company retrospectively adopted the standard as of December 31, 2016, the line items prepaid expenses and other assets and accounts payable and accrued expenses in our condensed consolidated balance sheet would have been reduced by $80 million and $692 million , respectively, as a result of reclassifying the current deferred tax assets and liabilities. The offsetting impact for the reclassifications as of December 31, 2016 would have increased the noncurrent line items other assets and deferred income taxes in our condensed consolidated balance sheet by $54 million and $666 million , respectively. In January 2016, the FASB issued ASU 2016-01, Financial Instruments — Overall: Recognition and Measurement of Financial Assets and Financial Liabilities , which addresses certain aspects of the recognition, measurement, presentation and disclosure of financial instruments. The amendment will be effective for the Company beginning January 1, 2018 and will require us to recognize any changes in the fair value of certain equity investments in net income. These changes are currently recognized in other comprehensive income ("OCI"). In February 2016, the FASB issued ASU 2016-02, Leases , which requires lessees to recognize on the balance sheet a right-of-use asset, representing their right to use the underlying asset for the lease term, and a lease liability for all leases with terms greater than 12 months. The guidance also requires qualitative and quantitative disclosures designed to assess the amount, timing and uncertainty of cash flows arising from leases. The standard requires the use of a modified retrospective transition approach, which includes a number of optional practical expedients that entities may elect to apply. ASU 2016-02 is effective for the Company beginning January 1, 2019 and we are currently evaluating the impact that ASU 2016-02 will have on our consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting . The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the income tax impact, classification on the statement of cash flows and forfeitures. The Company adopted ASU 2016-09 on January 1, 2017 by prospectively recognizing excess tax benefits and tax deficiencies in our consolidated statement of income as the awards vested or were settled. Effective January 1, 2017, the Company also prospectively presented excess tax benefits as an operating activity, rather than a financing activity, in our consolidated statement of cash flows. Had these changes been required to be adopted retrospectively, during the three and nine months ended September 30, 2016 , the Company would have recognized an additional $20 million and $140 million , respectively, of excess tax benefits in our condensed consolidated statements of income. Additionally, during the nine months ended September 30, 2016 , the Company would have reduced our financing activities and increased our operating activities by $140 million in our condensed consolidated statement of cash flows. The Company has elected, consistent with past practice, to estimate the number of awards that are expected to vest to determine the amount of stock-based compensation expense recognized in earnings. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Measurement of Credit Losses on Financial Instruments , which requires measurement and recognition of expected credit losses for financial assets held. ASU 2016-13 is effective for the Company beginning January 1, 2020 and we are currently evaluating the impact that ASU 2016-13 will have on our consolidated financial statements. In October 2016, the FASB issued ASU 2016-16, Intra-Entity Transfers of Assets Other Than Inventory , which requires the Company to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. ASU 2016-16 is effective for the Company beginning January 1, 2018 and will be applied using a modified retrospective basis. We currently expect the cumulative-effect adjustment will result in a net deferred tax asset of approximately $2.8 billion . This amount will primarily be recorded as a deferred tax asset in the line item other assets in our consolidated balance sheet. In November 2016, the FASB issued ASU 2016-18, Restricted Cash . The amendments in this update address diversity in practice that exists in the classification and presentation of changes in restricted cash and require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for the Company beginning January 1, 2018 and is required to be applied using a retrospective transition method to each period presented. The Company is currently evaluating the impact that ASU 2016-18 will have on our consolidated statement of cash flows. In January 2017, the FASB issued ASU 2017-01, Clarifying the Definition of a Business , which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. ASU 2017-01 is required to be applied prospectively and will be effective for the Company beginning January 1, 2018. The impact on our consolidated financial statements will depend on the facts and circumstances of any specific future transactions. In March 2017, the FASB issued ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which requires that the service cost component of the Company's net periodic pension cost and net periodic postretirement benefit cost be included in the same line item as other compensation costs arising from services rendered by employees, with the other components of net periodic benefit cost being classified outside of a subtotal of income from operations. Of the components of net periodic benefit cost, only the service cost component will be eligible for asset capitalization. ASU 2017-07 is effective for the Company beginning January 1, 2018 and is required to be applied retrospectively for the presentation of the service cost component and the other components of net periodic pension cost and net periodic postretirement benefit cost in our income statement. ASU 2017-07 allows a practical expedient for the estimation basis for applying the retrospective presentation requirements and requires the prospective adoption, on and after the effective date, for the capitalization of the service cost component of net periodic pension cost and net periodic postretirement benefit cost in assets. In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities , which eliminates the requirement to separately measure and report hedge ineffectiveness and requires companies to recognize all elements of hedge accounting that impact earnings in the same income statement line item where the hedged item resides. The amendments include new alternatives for measuring the hedged item for fair value hedges of interest rate risk and ease the requirements for effectiveness testing, hedge documentation and applying the critical terms match method. Finally, the standard introduces new alternatives that permit companies to reduce the risk of material error if the shortcut method is misapplied. ASU 2017-12 is effective for the Company beginning January 1, 2019 and is required to be applied prospectively. The Company is currently evaluating the impact that ASU 2017-12 will have on our consolidated financial statements.

Acquisitions and Divestitures A

Acquisitions and Divestitures Acquisitions and Divestitures (Tables)	9 Months Ended
	Sep. 29, 2017
Discontinued Operations and Disposal Groups [Abstract]
Assets and Liabilities Held for Sale	The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our condensed consolidated balance sheets (in millions): September 29, December 31, 2016 Cash, cash equivalents and short-term investments $ 10 $ 49 Trade accounts receivable, less allowances 300 43 Inventories 181 264 Prepaid expenses and other assets 34 114 Equity method investments — 1 Other investments — 42 Other assets 7 17 Property, plant and equipment — net 1,145 1,780 Bottlers' franchise rights with indefinite lives 1,121 1,388 Goodwill 296 390 Other intangible assets 154 51 Allowance for reduction of assets held for sale (1,466 ) (1,342 ) Total assets $ 1,782 1 $ 2,797 2 Accounts payable and accrued expenses $ 381 $ 393 Accrued income taxes 4 13 Other liabilities 52 1 Deferred income taxes — 303 Total liabilities $ 437 1 $ 710 3 1 Consists of total assets and total liabilities relating to North America refranchising of $1,782 million and $437 million , respectively, which are included in the Bottling Investments operating segment. 2 Consists of total assets relating to North America refranchising of $1,247 million , China bottling operations of $1,533 million and other assets held for sale of $17 million , which are included in the Bottling Investments operating segment and Corporate. 3 Consists of total liabilities relating to North America refranchising of $224 million , China bottling operations of $483 million and other liabilities held for sale of $3 million , which are included in the Bottling Investments operating segment and Corporate. We determined that the operations included in the table above did not meet the criteria to be classified as discontinued operations under the applicable guidance.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 29, 2017
Investments [Abstracts]
Schedule of trading securities	The Company's trading securities were included in the following line items in our condensed consolidated balance sheets (in millions): September 29, December 31, 2016 Marketable securities $ 318 $ 282 Other assets 109 102 Total $ 427 $ 384
Available-for-sale securities and held-to-maturity securities	As of September 29, 2017 , available-for-sale securities consisted of the following (in millions): Gross Unrealized Estimated Cost Gains Losses Fair Value Available-for-sale securities: 1 Equity securities $ 1,326 $ 602 $ (35 ) $ 1,893 Debt securities 6,550 169 (21 ) 6,698 Total $ 7,876 $ 771 $ (56 ) $ 8,591 1 Refer to Note 14 for additional information related to the estimated fair value. As of December 31, 2016 , available-for-sale securities consisted of the following (in millions): Gross Unrealized Estimated Cost Gains Losses Fair Value Available-for-sale securities: 1 Equity securities $ 1,252 $ 425 $ (22 ) $ 1,655 Debt securities 4,700 89 (31 ) 4,758 Total $ 5,952 $ 514 $ (53 ) $ 6,413 1 Refer to Note 14 for additional information related to the estimated fair value.
Schedule of Realized Gain (Loss) [Table Text Block]	The sale and/or maturity of available-for-sale securities resulted in the following realized activity (in millions): Three Months Ended Nine Months Ended September 29, September 30, September 29, September 30, Gross gains $ 11 $ 21 $ 51 $ 131 Gross losses (7 ) (6 ) (21 ) (42 ) Proceeds 4,210 2,072 10,760 8,889
Investments by Balance Sheet Grouping	The Company's available-for-sale securities were included in the following line items in our condensed consolidated balance sheets (in millions): September 29, December 31, Cash and cash equivalents $ 1,682 $ 682 Marketable securities 4,820 3,769 Other investments 971 849 Other assets 1,118 1,113 Total $ 8,591 $ 6,413
Contractual maturity amounts of the investment securities	The contractual maturities of these available-for-sale securities as of September 29, 2017 , were as follows (in millions): Cost Estimated Fair Value Within 1 year $ 2,301 $ 2,353 After 1 year through 5 years 3,722 3,799 After 5 years through 10 years 208 223 After 10 years 319 323 Equity securities 1,326 1,893 Total $ 7,876 $ 8,591

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 29, 2017
Inventories
Inventories	Inventories consisted of the following (in millions): September 29, December 31, Raw materials and packaging $ 1,639 $ 1,565 Finished goods 741 844 Other 228 266 Total inventories $ 2,608 $ 2,675

Hedging Transactions and Deri26

Hedging Transactions and Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 29, 2017
Hedging Transactions and Derivative Financial Instruments
Derivative instruments, fair value, designated as hedging instruments	The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions): Fair Value 1,2 Derivatives Designated as Hedging Instruments Balance Sheet Location 1 September 29, December 31, 2016 Assets: Foreign currency contracts Prepaid expenses and other assets $ 210 $ 400 Foreign currency contracts Other assets 95 60 Interest rate contracts Other assets 71 105 Total assets $ 376 $ 565 Liabilities: Foreign currency contracts Accounts payable and accrued expenses $ 120 $ 40 Foreign currency contracts Other liabilities 8 54 Commodity contracts Accounts payable and accrued expenses — 1 Interest rate contracts Accounts payable and accrued expenses 33 36 Interest rate contracts Other liabilities 34 47 Total liabilities $ 195 $ 178 1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 14 for the net presentation of the Company's derivative instruments. 2 Refer to Note 14 for additional information related to the estimated fair value.
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]	The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions): Fair Value 1,2 Derivatives Not Designated as Hedging Instruments Balance Sheet Location 1 September 29, December 31, 2016 Assets: Foreign currency contracts Prepaid expenses and other assets $ 39 $ 284 Foreign currency contracts Other assets 25 — Commodity contracts Prepaid expenses and other assets 15 27 Commodity contracts Other assets 1 1 Other derivative instruments Prepaid expenses and other assets 8 4 Other derivative instruments Other assets 1 1 Total assets $ 89 $ 317 Liabilities: Foreign currency contracts Accounts payable and accrued expenses $ 59 $ 60 Foreign currency contracts Other liabilities 41 16 Commodity contracts Accounts payable and accrued expenses 16 16 Commodity contracts Other liabilities 1 1 Interest rate contracts Accounts payable and accrued expenses — 8 Interest rate contracts Other liabilities — 1 Other derivative instruments Accounts payable and accrued expenses 1 2 Other derivative instruments Other liabilities — 5 Total liabilities $ 118 $ 109 1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 14 for the net presentation of the Company's derivative instruments. 2 Refer to Note 14 for additional information related to the estimated fair value.
Derivative instruments, designated as hedging instruments, gain (loss) in statement of financial performance	The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the three months ended September 29, 2017 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (35 ) Net operating revenues $ 116 $ — 2 Foreign currency contracts (11 ) Cost of goods sold (4 ) — 2 Foreign currency contracts — Interest expense (2 ) — Foreign currency contracts 100 Other income (loss) — net 100 7 Interest rate contracts (1 ) Interest expense (9 ) — Commodity contracts — Cost of goods sold (1 ) — Total $ 53 $ 200 $ 7 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income. 2 Includes a de minimis amount of ineffectiveness in the hedging relationship. The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the nine months ended September 29, 2017 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (216 ) Net operating revenues $ 339 $ (1 ) Foreign currency contracts (27 ) Cost of goods sold 1 — 2 Foreign currency contracts — Interest expense (7 ) — Foreign currency contracts 113 Other income (loss) — net 152 7 Interest rate contracts (25 ) Interest expense (26 ) 2 Commodity contracts (1 ) Cost of goods sold — — Total $ (156 ) $ 459 $ 8 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income. 2 Includes a de minimis amount of ineffectiveness in the hedging relationship. The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the three months ended September 30, 2016 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (48 ) Net operating revenues $ 141 $ (2 ) Foreign currency contracts 9 Cost of goods sold 8 — Foreign currency contracts — Interest expense (2 ) — Foreign currency contracts 36 Other income (loss) — net 40 — Interest rate contracts 26 Interest expense (2 ) 3 Commodity contracts (1 ) Cost of goods sold — — Total $ 22 $ 185 $ 1 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income. The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the nine months ended September 30, 2016 (in millions): Gain (Loss) Recognized in OCI Location of Gain (Loss) Recognized in Income 1 Gain (Loss) Reclassified from AOCI into Income (Effective Portion) Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency contracts $ (348 ) Net operating revenues $ 419 $ (3 ) Foreign currency contracts (34 ) Cost of goods sold 41 (1 ) Foreign currency contracts — Interest expense (6 ) — Foreign currency contracts 25 Other income (loss) — net 38 — Interest rate contracts (226 ) Interest expense (6 ) 3 Commodity contracts — Cost of goods sold — — Total $ (583 ) $ 486 $ (1 ) 1 The Company records gains and losses reclassified from AOCI into income for the effective portion and the ineffective portion, if any, to the same line items in our condensed consolidated statements of income.
Derivative instruments, fair value hedges, gain (loss) recognized in income	The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions): Hedging Instruments and Hedged Items Location of Gain (Loss) Recognized in Income Gain (Loss) Recognized in Income 1 Three Months Ended September 29, September 30, Interest rate contracts Interest expense $ 19 $ — Fixed-rate debt Interest expense (15 ) (1 ) Net impact to interest expense $ 4 $ (1 ) Foreign currency contracts Other income (loss) — net $ (23 ) $ (67 ) Available-for-sale securities Other income (loss) — net 26 66 Net impact to other income (loss) — net $ 3 $ (1 ) Net impact of fair value hedging instruments $ 7 $ (2 ) 1 The net impacts represent the ineffective portions of the hedge relationships and the amounts excluded from the assessment of hedge effectiveness. The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions): Hedging Instruments and Hedged Items Location of Gain (Loss) Recognized in Income Gain (Loss) Recognized in Income 1 Nine Months Ended September 29, September 30, Interest rate contracts Interest expense $ (46 ) $ 398 Fixed-rate debt Interest expense 42 (364 ) Net impact to interest expense $ (4 ) $ 34 Foreign currency contracts Other income (loss) — net $ (66 ) $ (37 ) Available-for-sale securities Other income (loss) — net 72 34 Net impact to other income (loss) — net $ 6 $ (3 ) Net impact of fair value hedging instruments $ 2 $ 31 1 The net impacts represent the ineffective portions of the hedge relationships and the amounts excluded from the assessment of hedge effectiveness.
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions): Notional Amount Gain (Loss) Recognized in OCI as of Three Months Ended Nine Months Ended September 29, December 31, 2016 September 29, September 30, September 29, September 30, Foreign currency contracts $ 170 $ 100 $ (4 ) $ (9 ) $ (19 ) $ (235 ) Foreign currency denominated debt 13,118 11,113 (549 ) (67 ) (1,475 ) (323 ) Total $ 13,288 $ 11,213 $ (553 ) $ (76 ) $ (1,494 ) $ (558 )
Schedule of Derivative Instruments Not Designated as Hedging Instruments Gain (Loss) in Statement of Financial Performance [Table Text Block]	The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions): Three Months Ended Derivatives Not Designated Location of Gain (Loss) September 29, September 30, Foreign currency contracts Net operating revenues $ (5 ) $ (6 ) Foreign currency contracts Other income (loss) — net 47 — Interest rate contracts Interest expense — 2 Commodity contracts Net operating revenues 12 — Commodity contracts Cost of goods sold (15 ) (9 ) Commodity contracts Selling, general and administrative expenses 3 (1 ) Other derivative instruments Selling, general and administrative expenses 8 3 Other derivative instruments Other income (loss) — net 1 — Total $ 51 $ (11 ) The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions): Nine Months Ended Derivatives Not Designated Location of Gain (Loss) September 29, September 30, Foreign currency contracts Net operating revenues $ (23 ) $ (34 ) Foreign currency contracts Cost of goods sold — 4 Foreign currency contracts Other income (loss) — net 149 (116 ) Interest rate contracts Interest expense — 2 Commodity contracts Net operating revenues 7 3 Commodity contracts Cost of goods sold 13 68 Commodity contracts Selling, general and administrative expenses — 3 Other derivative instruments Selling, general and administrative expenses 33 11 Other derivative instruments Other income (loss) — net 2 (14 ) Total $ 181 $ (73 )

Comprehensive Income (Tables)

Comprehensive Income (Tables)	9 Months Ended
	Sep. 29, 2017
Comprehensive Income
AOCI attributable to the shareowners of The Coca Cola Company	AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions): September 29, December 31, 2016 Foreign currency translation adjustments $ (8,271 ) $ (9,780 ) Accumulated derivative net gains (losses) (80 ) 314 Unrealized net gains (losses) on available-for-sale securities 470 305 Adjustments to pension and other benefit liabilities (1,962 ) (2,044 ) Accumulated other comprehensive income (loss) $ (9,843 ) $ (11,205 )
Comprehensive Income (Loss), Apportioned between Shareowners of the Coca-Cola Company and Noncontrolling Interests [Text Block]	The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions): Nine Months Ended September 29, 2017 Shareowners of The Coca-Cola Company Noncontrolling Interests Total Consolidated net income $ 4,000 $ — $ 4,000 Other comprehensive income: Net foreign currency translation adjustments 1,509 2 1,511 Net gain (loss) on derivatives 1 (394 ) — (394 ) Net change in unrealized gain (loss) on available-for-sale securities 2 165 — 165 Net change in pension and other benefit liabilities 3 82 — 82 Total comprehensive income $ 5,362 $ 2 $ 5,364 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Refer to Note 3 for additional information related to the net unrealized gain or loss on available-for-sale securities. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities.
OCI attributable to the shareowners of The Coca-Cola Company	The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI (in millions): Three Months Ended September 29, 2017 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ 162 $ (174 ) $ (12 ) Reclassification adjustments recognized in net income (17 ) — (17 ) Gains (losses) on intra-entity transactions that are of a long-term-investment nature 1,063 — 1,063 Gains (losses) on net investment hedges arising during the period 1 (553 ) 211 (342 ) Net foreign currency translation adjustments 655 37 692 Derivatives: Gains (losses) arising during the period 54 (19 ) 35 Reclassification adjustments recognized in net income (207 ) 76 (131 ) Net gains (losses) on derivatives 1 (153 ) 57 (96 ) Available-for-sale securities: Unrealized gains (losses) arising during the period 20 (17 ) 3 Reclassification adjustments recognized in net income (4 ) 2 (2 ) Net change in unrealized gain (loss) on available-for-sale securities 2 16 (15 ) 1 Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period (120 ) 49 (71 ) Reclassification adjustments recognized in net income 193 (73 ) 120 Net change in pension and other benefit liabilities 3 73 (24 ) 49 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ 591 $ 55 $ 646 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 and Note 10 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. Nine Months Ended September 29, 2017 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ (793 ) $ (142 ) $ (935 ) Reclassification adjustments recognized in net income 103 (6 ) 97 Gains (losses) on intra-entity transactions that are of a long-term-investment nature 3,270 — 3,270 Gains (losses) on net investment hedges arising during the period 1 (1,494 ) 571 (923 ) Net foreign currency translation adjustments 1,086 423 1,509 Derivatives: Gains (losses) arising during the period (159 ) 56 (103 ) Reclassification adjustments recognized in net income (466 ) 175 (291 ) Net gains (losses) on derivatives 1 (625 ) 231 (394 ) Available-for-sale securities: Unrealized gains (losses) arising during the period 365 (123 ) 242 Reclassification adjustments recognized in net income (117 ) 40 (77 ) Net change in unrealized gain (loss) on available-for-sale securities 2 248 (83 ) 165 Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period (161 ) 73 (88 ) Reclassification adjustments recognized in net income 266 (96 ) 170 Net change in pension and other benefit liabilities 3 105 (23 ) 82 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ 814 $ 548 $ 1,362 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 and Note 10 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. Three Months Ended September 30, 2016 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ (130 ) $ 41 $ (89 ) Reclassification adjustments recognized in net income 242 (18 ) 224 Gains (losses) on net investment hedges arising during the period 1 (76 ) 29 (47 ) Net foreign currency translation adjustments 36 52 88 Derivatives: Gains (losses) arising during the period 22 (8 ) 14 Reclassification adjustments recognized in net income (186 ) 71 (115 ) Net gains (losses) on derivatives 1 (164 ) 63 (101 ) Available-for-sale securities: Unrealized gains (losses) arising during the period (98 ) 31 (67 ) Reclassification adjustments recognized in net income (19 ) 4 (15 ) Net change in unrealized gain (loss) on available-for-sale securities 2 (117 ) 35 (82 ) Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period 13 (2 ) 11 Reclassification adjustments recognized in net income 43 (15 ) 28 Net change in pension and other benefit liabilities 3 56 (17 ) 39 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ (189 ) $ 133 $ (56 ) 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities. Nine Months Ended September 30, 2016 Before-Tax Amount Income Tax After-Tax Amount Foreign currency translation adjustments: Translation adjustments arising during the period $ 332 $ 39 $ 371 Reclassification adjustments recognized in net income 368 (18 ) 350 Gains (losses) on net investment hedges arising during the period 1 (558 ) 214 (344 ) Reclassification adjustments for net investment hedges recognized in net income 1 77 (30 ) 47 Net foreign currency translation adjustments 219 205 424 Derivatives: Gains (losses) arising during the period (585 ) 221 (364 ) Reclassification adjustments recognized in net income (485 ) 183 (302 ) Net gains (losses) on derivatives 1 (1,070 ) 404 (666 ) Available-for-sale securities: Unrealized gains (losses) arising during the period 196 (46 ) 150 Reclassification adjustments recognized in net income (93 ) 22 (71 ) Net change in unrealized gain (loss) on available-for-sale securities 2 103 (24 ) 79 Pension and other benefit liabilities: Net pension and other benefit liabilities arising during the period 1 (1 ) — Reclassification adjustments recognized in net income 192 (64 ) 128 Net change in pension and other benefit liabilities 3 193 (65 ) 128 Other comprehensive income (loss) attributable to shareowners of The Coca-Cola Company $ (555 ) $ 520 $ (35 ) 1 Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments. 2 Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures. 3 Refer to Note 12 for additional information related to the Company's pension and other postretirement benefit liabilities.
Income statement location of adjustments reclassified from AOCI into income	The following table presents the amounts and line items in our condensed consolidated statements of income where adjustments reclassified from AOCI into income were recorded (in millions): Amount Reclassified from AOCI into Income Description of AOCI Component Financial Statement Line Item Three Months Ended September 29, 2017 Nine Months Ended September 29, 2017 Foreign currency translation adjustments: Divestitures, deconsolidations and other 1 Other income (loss) — net $ (17 ) $ 103 Income before income taxes (17 ) 103 Income taxes — (6 ) Consolidated net income $ (17 ) $ 97 Derivatives: Foreign currency contracts Net operating revenues $ (116 ) $ (338 ) Foreign currency and commodity contracts Cost of goods sold 5 (1 ) Foreign currency contracts Other income (loss) — net (107 ) (159 ) Divestitures, deconsolidations and other 1 Other income (loss) — net — 1 Foreign currency and interest rate contracts Interest expense 11 31 Income before income taxes (207 ) (466 ) Income taxes 76 175 Consolidated net income $ (131 ) $ (291 ) Available-for-sale securities: Divestitures, deconsolidations and other 1 Other income (loss) — net $ — $ (87 ) Sale of securities Other income (loss) — net (4 ) (30 ) Income before income taxes (4 ) (117 ) Income taxes 2 40 Consolidated net income $ (2 ) $ (77 ) Pension and other benefit liabilities: Curtailment charges (credits) 2 Other operating charges $ 1 $ (17 ) Settlement charges (credits) 2 Other operating charges 150 150 Divestitures, deconsolidations and other 1 Other income (loss) — net — 7 Recognized net actuarial loss (gain) * 46 139 Recognized prior service cost (credit) * (4 ) (13 ) Income before income taxes 193 266 Income taxes (73 ) (96 ) Consolidated net income $ 120 $ 170 1 Primarily related to the integration of Coca-Cola West Co., Ltd. ("CCW") and Coca-Cola East Japan Co., Ltd. ("CCEJ") to establish Coca-Cola Bottlers Japan Inc. ("CCBJI"). Refer to Note 10 . 2 The curtailment charges (credits) and settlement charges (credits) were primarily related to North America refranchising and the Company's productivity, restructuring and integration initiatives. * This component of AOCI is included in the Company's computation of net periodic benefit cost and is not reclassified out of AOCI into a single line item in our condensed consolidated statements of income in its entirety. Refer to Note 12 for additional information.

Changes in Equity (Tables)

Changes in Equity (Tables)	9 Months Ended
	Sep. 29, 2017
Changes in Equity [Abstract]
Changes in Equity	The following table provides a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and equity attributable to noncontrolling interests (in millions): Shareowners of The Coca-Cola Company Common Shares Outstanding Total Reinvested Earnings Accumulated Other Comprehensive Income (Loss) Common Stock Capital Surplus Treasury Stock Non- controlling Interests December 31, 2016 4,288 $ 23,220 $ 65,502 $ (11,205 ) $ 1,760 $ 14,993 $ (47,988 ) $ 158 Comprehensive income (loss) — 5,364 4,000 1,362 — — — 2 Dividends paid/payable to shareowners of The Coca-Cola Company — (4,743 ) (4,743 ) — — — — — Dividends paid to noncontrolling interests — (15 ) — — — — — (15 ) Deconsolidation of certain entities — (153 ) — — — — — (153 ) Purchases of treasury stock (69 ) (3,012 ) — — — — (3,012 ) — Impact related to stock compensation plans 43 1,453 — — — 709 744 — Other activities — 38 — — — (3 ) — 41 September 29, 2017 4,262 $ 22,152 $ 64,759 $ (9,843 ) $ 1,760 $ 15,699 $ (50,256 ) $ 33

Productivity, Integration and29

Productivity, Integration and Restructuring Initiatives (Tables)	9 Months Ended
	Sep. 29, 2017
Restructuring Cost and Reserve [Line Items]
Productivity and Reinvestment [Table Text Block]	The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts as of and for the three months ended September 29, 2017 (in millions): Accrued Balance June 30, 2017 Costs Incurred Three Months Ended September 29, 2017 Payments Noncash and Exchange Accrued Balance September 29, 2017 Severance pay and benefits $ 162 $ 43 $ (88 ) $ 2 $ 119 Outside services 11 19 (20 ) (1 ) 9 Other direct costs 16 67 (69 ) (3 ) 11 Total $ 189 $ 129 $ (177 ) $ (2 ) $ 139 The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts as of and for the nine months ended September 29, 2017 (in millions): Accrued Balance December 31, 2016 Costs Incurred Nine Months Ended September 29, 2017 Payments Noncash and Exchange Accrued Balance September 29, 2017 Severance pay and benefits $ 123 $ 143 $ (146 ) $ (1 ) $ 119 Outside services 6 62 (58 ) (1 ) 9 Other direct costs 22 150 (154 ) (7 ) 11 Total $ 151 $ 355 $ (358 ) $ (9 ) $ 139

Pension and Other Postretirem30

Pension and Other Postretirement Benefit Plans (Tables)	9 Months Ended
	Sep. 29, 2017
Pension and Other Postretirement Benefit Plans
Periodic benefit cost, pension and other postretirement benefit plans	Net periodic benefit cost for our pension and other postretirement benefit plans consisted of the following (in millions): Pension Benefits Other Benefits Three Months Ended September 29, September 30, September 29, September 30, Service cost $ 49 $ 59 $ 4 $ 6 Interest cost 76 79 7 8 Expected return on plan assets 1 (163 ) (161 ) (3 ) (3 ) Amortization of prior service cost (credit) — — (4 ) (5 ) Amortization of net actuarial loss 44 46 2 2 Net periodic benefit cost 6 23 6 8 Curtailment charges (credits) 2 2 — — — Settlement charges (credits) 2 150 — — — Special termination benefits 2 15 4 — — Other — — — 31 Total cost recognized in condensed consolidated statements of income $ 173 $ 27 $ 6 $ 39 1 The weighted-average expected long-term rates of return on plan assets used in computing 2017 net periodic benefit cost are 8.0 percent for pension benefits and 4.5 percent for other benefits. 2 The curtailment charges (credits), settlement charges (credits) and special termination benefits were primarily related to North America refranchising and the Company's productivity, restructuring and integration initiatives. Refer to Note 2 and Note 11 . Pension Benefits Other Benefits Nine Months Ended September 29, September 30, September 29, September 30, Service cost $ 149 $ 178 $ 13 $ 17 Interest cost 232 239 22 23 Expected return on plan assets 1 (487 ) (490 ) (9 ) (9 ) Amortization of prior service cost (credit) — (1 ) (13 ) (14 ) Amortization of net actuarial loss 133 138 6 5 Net periodic benefit cost 27 64 19 22 Curtailment charges (credits) 2 2 — (42 ) — Settlement charges (credits) 2 150 — — — Special termination benefits 2 72 17 — — Other — — — 31 Total cost recognized in condensed consolidated statements of income $ 251 $ 81 $ (23 ) $ 53 1 The weighted-average expected long-term rates of return on plan assets used in computing 2017 net periodic benefit cost are 8.0 percent for pension benefits and 4.5 percent for other benefits. 2 The curtailment charges (credits), settlement charges (credits) and special termination benefits were primarily related to North America refranchising and the Company's productivity, restructuring and integration initiatives. Refer to Note 2 and Note 11 .

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 29, 2017
Income taxes
Schedule of income tax expense (benefit) associated with significant operating and nonoperating items for the interim periods presented	The following table illustrates the income tax expense (benefit) associated with significant operating and nonoperating items for the interim periods presented (in millions): Three Months Ended Nine Months Ended September 29, September 30, September 29, September 30, Asset impairments $ — 1 $ — $ (164 ) 1 $ — Productivity and reinvestment program (44 ) 2 (20 ) 9 (127 ) 2 (65 ) 9 Other productivity, integration and restructuring initiatives — — — — 10 Transaction gains and losses (361 ) 3 (246 ) 11 172 4 (363 ) 12 Certain tax matters (40 ) 5 7 13 (110 ) 6 84 13 Other — net (12 ) 7 8 14 (41 ) 8 (38 ) 15 1 Related to charges of $50 million and $821 million during the three and nine months ended September 29, 2017 , respectively, due to the impairment of certain assets. Refer to Note 10 and Note 14 . 2 Related to charges of $129 million and $355 million during the three and nine months ended September 29, 2017 , respectively. These charges were due to the Company's productivity and reinvestment program. Refer to Note 11 . 3 Related to a net charge of $968 million which primarily consisted of $762 million of charges as a result of the refranchising of certain bottling territories in North America, $213 million related to costs incurred to refranchise certain of our bottling operations and $72 million primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements. These charges were partially offset by a $79 million gain related to the refranchising of our remaining China bottling operations and related cost method investment. Refer to Note 2 and Note 10 . 4 Related to a net charge of $1,551 million which primarily consisted of $1,473 million of net charges as a result of the refranchising of certain bottling territories in North America, $314 million of charges related to costs incurred to refranchise certain of our bottling operations, $287 million of charges primarily related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements and a $26 million charge related to our former German bottling operations. These charges were partially offset by a $445 million gain related to the merger of CCW and CCEJ, an $88 million gain related to the refranchising of our China bottling operations and related cost method investment and a $25 million gain related to Coca-Cola FEMSA, an equity method investee, issuing additional shares of its stock. Refer to Note 2 and Note 10 . 5 Related to $40 million of excess tax benefits associated with the Company's share-based compensation arrangements. 6 Related to $122 million of excess tax benefits associated with the Company's share-based compensation arrangements and the tax benefit associated with the reversal of valuation allowances in certain of the Company's foreign jurisdictions, both of which were partially offset by changes to our uncertain tax positions, including interest and penalties. 7 Related to charges of $35 million which primarily consisted of an $18 million charge related to tax litigation expense and a $16 million net charge due to our proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 10 . 8 Related to charges of $121 million which primarily consisted of a net charge of $38 million related to the extinguishment of long-term debt, a $43 million charge related to tax litigation expense and a net charge of $37 million due to our proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 10 . 9 Related to charges of $59 million and $187 million during the three and nine months ended September 30, 2016, respectively. These charges were due to the Company's productivity and reinvestment program. Refer to Note 10 and Note 11 . 10 Related to charges of $240 million during the nine months ended September 30, 2016. These charges were due to the integration of our German bottling operations. Refer to Note 10 and Note 11 . 11 Related to charges of $1,204 million which primarily consisted of $1,089 million of charges due to the refranchising of bottling territories in North America, $73 million related to costs incurred to refranchise our North America bottling territories, charges of $17 million related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements, a loss of $21 million related to the deconsolidation of our South African bottling operations and the $80 million tax impact resulting from the accrual of tax on temporary differences related to the investment in foreign subsidiaries that are now expected to reverse in the foreseeable future. Refer to Note 2 and Note 10 . 12 Related to a net charge of $561 million which primarily consisted of $1,657 million of charges due to the refranchising of bottling territories in North America, $170 million related to costs incurred to refranchise our North America bottling territories, charges of $17 million related to payments made to convert the bottling agreements for certain North America bottling partners' territories to a single form of CBA with additional requirements, a loss of $21 million related to the deconsolidation of our South African bottling operations and the $80 million tax impact resulting from the accrual of tax on temporary differences related to the investment in foreign subsidiaries that are now expected to reverse in the foreseeable future. These charges were partially offset by a $1,288 million net gain related to the deconsolidation of our German bottling operations and an $18 million net gain related to the disposal of our investment in Keurig. Refer to Note 2 and Note 10 . 13 Primarily related to changes to our uncertain tax positions, including interest and penalties. The components of the net change in uncertain tax positions were individually insignificant. 14 Related to charges of $99 million which included a $76 million write-down we recorded related to receivables from our bottling partner in Venezuela, a $14 million charge due to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees and a $9 million charge due to tax litigation expense. Refer to Note 10 . 15 Related to charges of $230 million which included a $100 million cash contribution to The Coca-Cola Foundation, a $76 million charge due to the write-down we recorded related to receivables from our bottling partner in Venezuela, a $35 million net charge due to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees and a $19 million charge due to tax litigation expense. Refer to Note 10 .

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 29, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets and liabilities measured at fair value on a recurring basis	The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions): September 29, 2017 Level 1 Level 2 Level 3 Other 4 Netting Adjustment 5 Fair Value Measurements Assets: Trading securities 1 $ 233 $ 123 $ 4 $ 67 $ — $ 427 Available-for-sale securities 1 1,892 6,532 167 3 — — 8,591 Derivatives 2 7 458 — — (358 ) 6 107 8 Total assets $ 2,132 $ 7,113 $ 171 $ 67 $ (358 ) $ 9,125 Liabilities: Derivatives 2 $ (12 ) $ (301 ) $ — $ — $ 232 7 $ (81 ) 8 Total liabilities $ (12 ) $ (301 ) $ — $ — $ 232 $ (81 ) 1 Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities. 2 Refer to Note 5 for additional information related to the composition of our derivative portfolio. 3 Primarily related to debt securities that mature in 2018. 4 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 3 . 5 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5 . 6 The Company is obligated to return $138 million in cash collateral it has netted against its net asset derivative position. 7 The Company has the right to reclaim $1 million in cash collateral it has netted against its net liability derivative position. 8 The Company's derivative financial instruments are recorded at fair value in our condensed consolidated balance sheets as follows: $ 107 million in the line item other assets and $ 81 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio. December 31, 2016 Level 1 Level 2 Level 3 Other 4 Netting Adjustment 5 Fair Value Measurements Assets: Trading securities 1 $ 202 $ 115 $ 4 $ 63 $ — $ 384 Available-for-sale securities 1 1,655 4,619 139 3 — — 6,413 Derivatives 2 4 878 — — (369 ) 6 513 8 Total assets $ 1,861 $ 5,612 $ 143 $ 63 $ (369 ) $ 7,310 Liabilities: Derivatives 2 $ 11 $ 276 $ — $ — $ (192 ) 7 $ 95 8 Total liabilities $ 11 $ 276 $ — $ — $ (192 ) $ 95 1 Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities. 2 Refer to Note 5 for additional information related to the composition of our derivative portfolio. 3 Primarily related to long-term debt securities that mature in 2018. 4 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 3 . 5 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5 . 6 The Company is obligated to return $201 million in cash collateral it has netted against its derivative position. 7 The Company has the right to reclaim $17 million in cash collateral it has netted against its derivative position. 8 The Company's derivative financial instruments are recorded at fair value in our condensed consolidated balance sheets as follows: $ 347 million in the line item prepaid expenses and other assets; $ 166 million in the line item other assets; $42 million in the line item accounts payable and accrued expenses; and $ 53 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.
Assets and liabilities measured at fair value on a Nonrecurring basis	The gains and losses on assets measured at fair value on a nonrecurring basis are summarized in the table below (in millions): Gains (Losses) Three Months Ended Nine Months Ended September 29, 2017 September 30, September 29, 2017 September 30, Assets held for sale 1 $ (307 ) $ (1,044 ) $ (1,819 ) $ (1,490 ) Intangible assets — — (442 ) 2 — Other long-lived assets — — (329 ) 3 — Valuation of shares in equity method investee — — 25 4 — Other-than-temporary impairment charge (50 ) 5 — (50 ) 5 — Total $ (357 ) $ (1,044 ) $ (2,615 ) $ (1,490 ) 1 The Company is required to record assets and liabilities that are held for sale at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. These losses related to refranchising activities in North America, which were calculated based on Level 3 inputs. Refer to Note 2. 2 The Company recognized an impairment charge of $375 million related to CCR goodwill. This impairment charge was determined by comparing the fair value of the reporting unit, based on Level 3 inputs, to its carrying value. The Company also recognized an impairment charge of $33 million related to certain U.S. bottlers' franchise rights. This charge was determined by comparing the fair value of the asset to its current carrying value. Each of these impairment charges were primarily a result of refranchising activities in North America and management's estimates of the proceeds that are expected to be received for the remaining bottling territories upon their refranchising. Additionally, the Company recorded impairment charges of $34 million related to Venezuelan intangible assets due to weaker sales and the volatility of foreign currency exchange rates resulting from continued political instability. The fair value of these assets was derived using discounted cash flow analyses based on Level 3 inputs. 3 The Company recognized impairment charges of $310 million related to CCR property, plant and equipment and $19 million related to CCR other assets primarily as a result of refranchising activities in North America. The fair value of these assets was derived using management's estimate of the proceeds that are expected to be received for the remaining bottling territories upon their refranchising. 4 The Company recognized a gain of $25 million as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment in Coca-Cola FEMSA. These gains were determined using Level 1 inputs. 5 The Company recognized an other-than-temporary impairment charge of $50 million related to one of our international equity method investees, primarily driven by foreign currency exchange rate fluctuations. The fair value of this investment was derived using discounted cash flow analyses based on Level 3 inputs.

Operating Segments (Tables)

Operating Segments (Tables)	9 Months Ended
	Sep. 29, 2017
Segment Reporting Information [Line Items]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Europe, Middle East & Africa Latin North Asia Pacific Bottling Corporate Eliminations Consolidated Nine Months Ended September 29, 2017 Net operating revenues: Third party $ 5,628 $ 2,857 $ 6,216 $ 3,807 $ 9,268 $ 122 $ — $ 27,898 Intersegment — 54 1,799 340 69 — (2,262 ) — Total net revenues 5,628 2,911 8,015 4,147 9,337 122 (2,262 ) 27,898 Operating income (loss) 2,884 1,625 1,967 1,835 (979 ) (1,152 ) — 6,180 Income (loss) before income taxes 2,958 1,627 1,711 1,853 (1,730 ) (614 ) — 5,805 Nine Months Ended September 30, 2016 Net operating revenues: Third party $ 5,369 $ 2,787 $ 4,759 $ 3,818 $ 15,631 $ 90 $ — $ 32,454 Intersegment 264 50 2,978 437 116 5 (3,850 ) — Total net revenues 5,633 2,837 7,737 4,255 15,747 95 (3,850 ) 32,454 Operating income (loss) 2,897 1,470 1,982 1,892 222 (1,192 ) — 7,271 Income (loss) before income taxes 2,950 1,485 1,978 1,903 (897 ) 202 — 7,621 Information about our Company's operations by operating segment is as follows (in millions): Europe, Middle East & Africa Latin North Asia Pacific Bottling Corporate Eliminations Consolidated As of and for the three months ended September 29, 2017 Net operating revenues: Third party $ 1,959 $ 1,009 $ 2,308 $ 1,345 $ 2,409 $ 48 $ — $ 9,078 Intersegment — 26 442 87 23 — (578 ) — Total net revenues 1,959 1,035 2,750 1,432 2,432 48 (578 ) 9,078 Operating income (loss) 936 563 646 577 (217 ) (385 ) — 2,120 Income (loss) before income taxes 962 561 583 588 (673 ) (347 ) — 1,674 Identifiable operating assets 5,475 1,909 17,224 2,146 6,433 34,567 — 67,754 Noncurrent investments 1,261 908 105 178 16,800 3,509 — 22,761 As of and for the three months ended September 30, 2016 Net operating revenues: Third party $ 1,852 $ 949 $ 1,661 $ 1,315 $ 4,809 $ 47 $ — $ 10,633 Intersegment — 16 1,003 145 31 — (1,195 ) — Total net revenues 1,852 965 2,664 1,460 4,840 47 (1,195 ) 10,633 Operating income (loss) 914 435 666 583 124 (451 ) — 2,271 Income (loss) before income taxes 922 447 653 589 (734 ) (449 ) — 1,428 Identifiable operating assets 4,337 1,964 16,406 2,257 17,390 33,546 — 75,900 Noncurrent investments 1,315 823 123 166 12,223 3,377 — 18,027 As of December 31, 2016 Identifiable operating assets $ 4,067 $ 1,785 $ 16,566 $ 2,024 $ 15,973 $ 29,606 $ — $ 70,021 Noncurrent investments 1,302 804 109 164 11,456 3,414 — 17,249

Summary of Significant Accoun34

Summary of Significant Accounting Policies Hyperinflationary Economies (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2016USD ($)	Sep. 29, 2017USD ($)	Sep. 30, 2016USD ($)	Mar. 28, 2014
Trademark impairment		$ 33
Venezuelan subsidiary
Official Exchange Rate Set by Government for Non Essential Goods				6.3
Accounts Receivable Write Down	$ 76		$ 76
DIPRO Rate	10		10
Corporate | Venezuelan subsidiary
Trademark impairment		$ 34

Summary of Significant Accoun35

Summary of Significant Accounting Policies Recently Issued Accounting Guidance (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended	12 Months Ended
	Mar. 30, 2018	Sep. 30, 2016	Sep. 30, 2016	Dec. 31, 2016
Accounting Standards Update 2015-17 [Member] | Prepaid Expenses and Other Current Assets [Member]
Impact of New Pronouncements
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				$ 80
Accounting Standards Update 2015-17 [Member] | Accounts Payable and Accrued Liabilities [Member]
Impact of New Pronouncements
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				(692)
Accounting Standards Update 2015-17 [Member] | Other Assets
Impact of New Pronouncements
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				(54)
Accounting Standards Update 2015-17 [Member] | Deferred Tax Asset [Domain]
Impact of New Pronouncements
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				$ 666
Accounting Standards Update 2016-09 [Member]
Impact of New Pronouncements
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income		$ 20	$ 140
New Accounting Pronouncement or Change in Accounting Principle, Effect of Cash Flow Reclassification			$ 140
Accounting Standards Update 2016-16 [Member]
Impact of New Pronouncements
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 2,800

Acquisitions and Divestitures (

Acquisitions and Divestitures (Details) - USD ($) $ / shares in Millions, $ in Millions	3 Months Ended				9 Months Ended
	Dec. 31, 2017	Sep. 29, 2017	Sep. 30, 2016	Apr. 01, 2016	Sep. 29, 2017	Sep. 30, 2016	Apr. 01, 2017	Dec. 31, 2016
Acquisition and investment activities
Proceeds from disposals of businesses, equity method investments and nonmarketable securities					$ 2,790	$ 745
Equity Method Investment, Ownership Percentage		17.00%			17.00%
Acquisitions of businesses, equity method investments and nonmarketable securities					$ 538	767
Total assets		$ 1,782			1,782			$ 2,797
Total liabilities		437			437			710
Disposal gain (loss) of a business net of transaction cost						1,288
North America [Member]
Acquisition and investment activities
Cost incurred to convert bottling agreement		72	$ 17		$ 287	17
Corporate
Acquisition and investment activities
Net Gains From Investee Transactions, Equity Investment Sales and other gains						18
AC Bebidas [Member]
Acquisition and investment activities
Equity interest fair value							$ 2,960
Payments to Acquire Equity Method Investments		$ 112
Equity Method Investment, Ownership Percentage		20.00%			20.00%
Coca-Cola European Partners [Member]
Acquisition and investment activities
Equity Method Investment, Ownership Percentage		18.00%			18.00%
CCBA [Member]
Acquisition and investment activities
Payments to Acquire Equity Method Investments						150
Equity Method Investment, Ownership Percentage		12.00%			12.00%
Acquisitions of businesses, equity method investments and nonmarketable securities	$ 3,150
CCBA's South African Subsidiary [Member]
Acquisition and investment activities
Equity Method Investment, Ownership Percentage		3.00%			3.00%
Keurig Green Mountain, Inc. [Member]
Acquisition and investment activities
Sale of Stock, Price Per Share				$ 0
Proceeds from Disposals of Investments				$ 2,380
Keurig Green Mountain, Inc. [Member] | Corporate
Acquisition and investment activities
Net Gains From Investee Transactions, Equity Investment Sales and other gains						18
Disposal Group Name [Domain]
Acquisition and investment activities
Cash, cash equivalents and short-term investments		$ 10			$ 10			49
Trade accounts receivable, less allowances		300			300			43
Inventories		181			181			264
Prepaid expenses and other assets		34			34			114
Equity method investments		0			0			1
Other Investments		0			0			42
Other assets		7			7			17
Property, plant and equipment - net		1,145			1,145			1,780
Bottlers' Franchise Rights with indefinite lives		1,121			1,121			1,388
Goodwill		296			296			390
Other intangible assets		154			154			51
Allowance for reduction of assets, held-for-sale		(1,466)			(1,466)			(1,342)
Total assets		1,782			1,782			2,797
Accounts payable and accrued expenses		381			381			393
Accrued income taxes		4			4			13
Other liabilities		52			52			1
Deferred income taxes		0			0			303
Total liabilities		437			437			710
Others [Member]
Acquisition and investment activities
Total assets								17
Total liabilities								3
North America Territory [Member]
Acquisition and investment activities
Proceeds from Sale of Productive Assets					1,814	732
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers		$ (762)	(1,089)		(2,533)	(1,657)
Agreement Term		10 years
Agreement Renewal Term		10 years
Total assets		$ 1,782			1,782			1,247
Total liabilities		437			437			224
North America Territory (Southwest) [Member]
Acquisition and investment activities
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers		1,060
CCEAG [Member]
Acquisition and investment activities
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers			1,400		(26)	1,323
Gain (Loss) on Derivative Used in Net Investment Hedge, Net of Tax			(77)
Disposal gain (loss) of a business net of transaction cost						1,288
CCEAG [Member] | Corporate
Acquisition and investment activities
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers					(26)	1,323
South African bottling operations [Domain] | Corporate
Acquisition and investment activities
Deconsolidation, Gain (Loss), Amount			$ (21)			(21)
China Bottling Operation [Member]
Acquisition and investment activities
Proceeds from disposals of businesses, equity method investments and nonmarketable securities					963
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers		79			88
Total assets								1,533
Total liabilities								$ 483
China Bottling Operation [Member] | Corporate
Acquisition and investment activities
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers		$ 79			88
Equity Method Investee [Member]
Acquisition and investment activities
Proceeds from Sale of Productive Assets					279	181
AC Bebidas [Member]
Acquisition and investment activities
Proceeds from Sale of Productive Assets					$ 216
Other income (loss) - net | Keurig Green Mountain, Inc. [Member]
Acquisition and investment activities
Net Gains From Investee Transactions, Equity Investment Sales and other gains						$ 18

Investments (Details)

Investments (Details) - USD ($) $ in Millions	Sep. 29, 2017	Dec. 31, 2016
Schedule of Trading Securities and Other Trading Assets [Line Items]
Total trading securities	$ 427	$ 384
Trading Securities
Trading Securities Unrealized Holding Gains (Losses)	74	39
Marketable Securities	318	282
Other Assets	$ 109	$ 102

Investments (Details 2)

Investments (Details 2) - USD ($) $ in Millions	Sep. 29, 2017	Dec. 31, 2016
Available-for-sale securities, by type
Available-for-sale Securities Fair Value	$ 8,591	$ 6,413
Available-for-sale Securities, Amortized Cost Basis	7,876	5,952
Available-for-sale Securities Gross Unrealized Gains	771	514
Available-for-sale Securities Gross Unrealized Losses	(56)	(53)
Equity Securities
Available-for-sale securities, by type
Available-for-sale Securities Fair Value	1,893	1,655
Available-for-sale Securities, Amortized Cost Basis	1,326	1,252
Available-for-sale Securities Gross Unrealized Gains	602	425
Available-for-sale Securities Gross Unrealized Losses	(35)	(22)
Debt Securities
Available-for-sale securities, by type
Available-for-sale Securities Fair Value	6,698	4,758
Available-for-sale Securities, Amortized Cost Basis	6,550	4,700
Available-for-sale Securities Gross Unrealized Gains	169	89
Available-for-sale Securities Gross Unrealized Losses	$ (21)	$ (31)

Investments (Details 4)

Investments (Details 4) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015
Available-for-sale and held-to-maturity securities by balance sheet line item
Cash and cash equivalents	$ 12,528	$ 11,147	$ 12,528	$ 11,147	$ 8,555	$ 7,309
Marketable securities	5,138		5,138		4,051
Other investments	1,117		1,117		989
Other assets	4,480		4,480		4,248
Available-for-sale Securities Fair Value	8,591		8,591		6,413
Proceeds from Sale of Available-for-sale Securities	4,210	2,072	10,760	8,889
Available-for-sale Securities Gross Gains	11	21	51	131
Available-for-sale Securities Gross Losses	(7)	$ (6)	(21)	$ (42)
Available-for-sale Securities [Member]
Available-for-sale and held-to-maturity securities by balance sheet line item
Cash and cash equivalents	1,682		1,682		682
Marketable securities	4,820		4,820		3,769
Other investments	971		971		849
Other assets	1,118		1,118		1,113
Available-for-sale Securities Fair Value	8,591		8,591		6,413
Solvency capital	$ 1,112		$ 1,112		$ 985

Investments (Details 5)

Investments (Details 5) - USD ($) $ in Millions	Sep. 29, 2017	Dec. 31, 2016
Investments [Abstracts]
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis	$ 2,301
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value	2,353
Available-for-sale Securities, Debt Maturities, after One Through Five Years, Amortized Cost Basis	3,722
Available-for-sale Securities, Debt Maturities, after One Through Five Years, Fair Value	3,799
Available-for-sale Securities, Debt Maturities, after Five Through Ten Years, Amortized Cost Basis	208
Available-for-sale Securities, Debt Maturities, after Five Through Ten Years, Fair Value	223
Available-for-sale Securities, Debt Maturities, after Ten Years, Amortized Cost Basis	319
Available-for-sale Securities, Debt Maturities, after Ten Years, Fair Value	323
Available-for-sale Securities, Amortized Cost Basis	7,876	$ 5,952
Available-for-sale Securities Fair Value	8,591	6,413
Cost Method Investments [Abstract]
Cost-method Investments, Aggregate Carrying Amount	146	140
Equity Securities [Member]
Investments [Abstracts]
Available-for-sale Securities, Amortized Cost Basis	1,326	1,252
Available-for-sale Securities Fair Value	$ 1,893	$ 1,655

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Sep. 29, 2017	Dec. 31, 2016
Inventory balances
Raw materials and packaging	$ 1,639	$ 1,565
Finished goods	741	844
Other	228	266
Total inventories	$ 2,608	$ 2,675

Hedging Transactions and Deri42

Hedging Transactions and Derivative Financial Instruments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 30, 2016	Dec. 31, 2016
Derivative Instrument Detail [Abstract]
Maximum Length of Time Hedged in Cash Flow Hedge (in years)	3 years
Net Investment Hedges
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	$ 13,288			$ 11,213
Foreign currency denominated debt | Net Investment Hedges
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	13,118			11,113
Foreign currency contracts | Cash Flow Hedging [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	4,495			6,074
Foreign currency contracts | Net Investment Hedges
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	170			100
Commodity contracts | Cash Flow Hedging [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	2			12
Available-for-sale Securities [Member] | Fair Value Hedging [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	1,002			1,163
Cross Currency Swap | Cash Flow Hedging [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	1,851			1,851
Interest Rate Swap [Member] | Cash Flow Hedging [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	500			1,500
Interest Rate Swap [Member] | Fair Value Hedging [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	8,123			6,158
Designated as Hedging Instrument [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	376			565
Derivative instruments, liabilities, fair value	195			178
Designated as Hedging Instrument [Member] | Foreign currency contracts | Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	210			400
Designated as Hedging Instrument [Member] | Foreign currency contracts | Other Assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	95			60
Designated as Hedging Instrument [Member] | Foreign currency contracts | Accounts Payable and Accrued Liabilities [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	120			40
Designated as Hedging Instrument [Member] | Foreign currency contracts | Other Liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	8			54
Designated as Hedging Instrument [Member] | Commodity contracts | Accounts Payable and Accrued Liabilities [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	0			1
Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Other Assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	71			105
Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Accounts Payable and Accrued Liabilities [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	33			36
Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Other Liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	34			47
Not Designated as Hedging Instrument [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	89			317
Derivative instruments, liabilities, fair value	118			109
Not Designated as Hedging Instrument [Member] | Foreign currency contracts
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	6,026			5,276
Not Designated as Hedging Instrument [Member] | Foreign currency contracts | Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	39			284
Not Designated as Hedging Instrument [Member] | Foreign currency contracts | Other Assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	25			0
Not Designated as Hedging Instrument [Member] | Foreign currency contracts | Accounts Payable and Accrued Liabilities [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	59			60
Not Designated as Hedging Instrument [Member] | Foreign currency contracts | Other Liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	41			16
Not Designated as Hedging Instrument [Member] | Commodity contracts
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	402			447
Not Designated as Hedging Instrument [Member] | Commodity contracts | Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	15			27
Not Designated as Hedging Instrument [Member] | Commodity contracts | Other Assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	1			1
Not Designated as Hedging Instrument [Member] | Commodity contracts | Accounts Payable and Accrued Liabilities [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	16			16
Not Designated as Hedging Instrument [Member] | Commodity contracts | Other Liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	1			1
Not Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Accounts Payable and Accrued Liabilities [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	0			8
Not Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Other Liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	0			1
Not Designated as Hedging Instrument [Member] | Other derivative instruments | Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	8			4
Not Designated as Hedging Instrument [Member] | Other derivative instruments | Other Assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, assets, fair value	1			1
Not Designated as Hedging Instrument [Member] | Other derivative instruments | Accounts Payable and Accrued Liabilities [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	1			2
Not Designated as Hedging Instrument [Member] | Other derivative instruments | Other Liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative instruments, liabilities, fair value	$ 0			$ 5
Venezuelan subsidiary
Fair Value, Derivatives Designated and Not Designated as Hedges
Accounts Receivable Write Down		$ 76	$ 76

Hedging Transactions and Deri43

Hedging Transactions and Derivative Financial Instruments (Details 2) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016	Dec. 31, 2016
Gains and (losses) related to derivative instruments
Anticipated gains (losses) cash flows hedges, estimated reclassification to earnings during next twelve months	$ 175
Fixed-rate debt
Gains and (losses) related to derivative instruments
Increase (Decrease) in carrying value due to hedge adjustments	25		$ 25
Cash Flow Hedges
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	53	$ 22	(156)	$ (583)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	200	185	459	486
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	7	1	8	(1)
Cash Flow Hedges | Interest Rate Swap [Member]
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	500		500		$ 1,500
Cash Flow Hedges | Foreign currency contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	4,495		4,495		6,074
Cash Flow Hedges | Foreign currency contracts | Net operating revenues
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	(35)	(48)	(216)	(348)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	116	141	339	419
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	(2)	(1)	(3)
Cash Flow Hedges | Foreign currency contracts | Cost of goods sold
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	(11)	9	(27)	(34)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	(4)	8	1	41
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0	(1)
Cash Flow Hedges | Foreign currency contracts | Interest Expense [Member]
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	0	0	0	0
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	(2)	(2)	(7)	(6)
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0	0
Cash Flow Hedges | Foreign currency contracts | Other Income (loss) - net
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	100	36	113	25
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	100	40	152	38
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	7	0	7	0
Cash Flow Hedges | Currency Swap [Member]
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	1,851		1,851		1,851
Cash Flow Hedges | Interest Rate Contract [Member] | Interest Expense [Member]
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	(1)	26	(25)	(226)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	(9)	(2)	(26)	(6)
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	3	2	3
Cash Flow Hedges | Commodity contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	2		2		12
Cash Flow Hedges | Commodity contracts | Cost of goods sold
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	0	(1)	(1)	0
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	(1)	0	0	0
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0	0
Fair Value Hedges
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	7	(2)	2	31
Fair Value Hedges | Interest Expense [Member]
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	4	(1)	(4)	34
Fair Value Hedges | Other Income (loss) - net
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	3	(1)	6	(3)
Fair Value Hedges | Fixed-rate debt | Interest Expense [Member]
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	(15)	(1)	42	(364)
Fair Value Hedges | Interest Rate Swap [Member]
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	8,123		8,123		6,158
Fair Value Hedges | Foreign currency contracts | Other Income (loss) - net
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	(23)	(67)	(66)	(37)
Fair Value Hedges | Available-for-sale Securities [Member]
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	1,002		1,002		1,163
Fair Value Hedges | Available-for-sale Securities [Member] | Other Income (loss) - net
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	26	66	72	34
Fair Value Hedges | Interest Rate Contract [Member] | Interest Expense [Member]
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	19	0	(46)	398
Net Investment Hedges
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	13,288		13,288		11,213
Gain (Loss) Recognized in OCI	(553)	(76)	(1,494)	(558)
Net Investment Hedges | Foreign currency contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	170		170		100
Gain (Loss) Recognized in OCI	(4)	(9)	(19)	(235)
Net Investment Hedges | Foreign currency denominated debt
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	13,118		13,118		11,113
Gain (Loss) Recognized in OCI	(549)	(67)	(1,475)	(323)
CCEAG [Member]
Gains and (losses) related to derivative instruments
Gain (Loss) on Derivative Used in Net Investment Hedge, Net of Tax				(77)
Designated as Hedging Instrument [Member]
Gains and (losses) related to derivative instruments
Derivative Liability, Fair Value, Gross Liability	195		195		178
Not Designated as Hedging Instrument [Member]
Gains and (losses) related to derivative instruments
Derivative Liability, Fair Value, Gross Liability	118		118		109
Derivative, Gain (Loss) on Derivative, Net	51	(11)	181	(73)
Not Designated as Hedging Instrument [Member] | Foreign currency contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	6,026		6,026		5,276
Not Designated as Hedging Instrument [Member] | Foreign currency contracts | Net operating revenues
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	(5)	(6)	(23)	(34)
Not Designated as Hedging Instrument [Member] | Foreign currency contracts | Cost of goods sold
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net			0	4
Not Designated as Hedging Instrument [Member] | Foreign currency contracts | Other Income (loss) - net
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	47	0	149	(116)
Not Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Interest Expense [Member]
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	0	2	0	2
Not Designated as Hedging Instrument [Member] | Commodity contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	402		402		$ 447
Not Designated as Hedging Instrument [Member] | Commodity contracts | Net operating revenues
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	12	0	7	3
Not Designated as Hedging Instrument [Member] | Commodity contracts | Cost of goods sold
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	(15)	(9)	13	68
Not Designated as Hedging Instrument [Member] | Commodity contracts | Selling, general and administrative expenses
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	3	(1)	0	3
Not Designated as Hedging Instrument [Member] | Other derivative instruments | Other Income (loss) - net
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	1	0	2	(14)
Not Designated as Hedging Instrument [Member] | Other derivative instruments | Selling, general and administrative expenses
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	$ 8	$ 3	$ 33	$ 11

Debt and Borrowing Arrangemen44

Debt and Borrowing Arrangements (Details) € in Millions, $ in Millions	3 Months Ended	9 Months Ended
	Sep. 29, 2017USD ($)	Sep. 29, 2017USD ($)	Sep. 29, 2017EUR (€)
Long-term debt
Issuance of long term debt		$ 1,000	€ 2,500
Carrying Value of Long-Term Debt	$ 3,967	3,967
Amount of debt retired or extinguished		417
Gain (Loss) on Extinguishment of Debt		(38)
Notes due on May 25, 2022 [Member]
Long-term debt
Issuance of long term debt		$ 500
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	2.20%	2.20%
Notes due on May 25, 2027 [Member]
Long-term debt
Issuance of long term debt		$ 500
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	2.90%	2.90%
Notes due on March 8, 2019
Long-term debt
Issuance of long term debt | €			1,500
Debt Instrument, Basis Spread on Variable Rate	0.25%
Notes due on March 9, 2021
Long-term debt
Issuance of long term debt | €			500
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	0.00%	0.00%
Notes due on March 8, 2024 [Member]
Long-term debt
Issuance of long term debt | €			€ 500
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	0.50%	0.50%
Notes due August 1, 2017 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	7.125%	7.125%
Amount of debt retired or extinguished		$ 206
Total principal notes due March 9, 2017 [Domain]
Long-term debt
Debt Instrument, Basis Spread on Variable Rate		0.15%	0.15%
Amount of debt retired or extinguished | €			€ 2,000
Notes due August 15, 2019
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	4.50%	4.50%
Amount of debt retired or extinguished		$ 95.6
Notes due February 1, 2022 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	8.50%	8.50%
Amount of debt retired or extinguished		$ 38.6
Notes due September 15, 2022 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	8.00%	8.00%
Amount of debt retired or extinguished		$ 11.7
Notes due September 15, 2023 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	6.75%	6.75%
Amount of debt retired or extinguished		$ 36.5
Notes due October 1, 2026 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	7.00%	7.00%
Amount of debt retired or extinguished		$ 9.9
Notes due November 15, 2026 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	6.95%	6.95%
Amount of debt retired or extinguished		$ 53.8
Notes due September 15, 2028 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	6.75%	6.75%
Amount of debt retired or extinguished		$ 41.3
Notes due October 15, 2036 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	6.70%	6.70%
Amount of debt retired or extinguished		$ 32
Notes due March 18, 2037 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	5.71%	5.71%
Amount of debt retired or extinguished		$ 3.4
Notes due January 15, 2038 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	6.75%	6.75%
Amount of debt retired or extinguished		$ 24.3
Notes due May 11, 2098 [Member]
Long-term debt
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	7.00%	7.00%
Amount of debt retired or extinguished		$ 4.7

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Oct. 02, 2015	Sep. 29, 2017	Dec. 31, 2016
Tax Years 2007-2009 [Member]
IRS Claim
IRS Claim	$ 3,400	$ 3,300
Net Increase (Decrease) in Sales and Transfer Prices and Production Costs	385
IRS Amended Claim	$ 135
Guarantees of indebtedness owed by third parties
Guarantees
Guarantees of indebtedness owed by third parties			$ 690
VIEs maximum exposures to loss			351
Risk Management Programs
Risk Management Programs
Self-insurance reserves			$ 514	$ 527

Comprehensive Income (Details)

Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016	Dec. 31, 2016
AOCI Attributable to the Shareowners of The Coca Cola Company
Accumulated other comprehensive income (loss)	$ (9,843)		$ (9,843)		$ (11,205)
Consolidated net income	1,444	$ 1,050	4,000	$ 6,003
Other comprehensive income:
Net foreign currency translation adjustment	693	86	1,511	415
Net gain (loss) on derivatives	(96)	(101)	(394)	(666)
Net unrealized gain (loss) on available-for-sale securities	1	(82)	165	79
Net change in pension and other benefit liabilities	49	39	82	128
TOTAL COMPREHENSIVE INCOME	2,091	992	5,364	5,959
Foreign currency translation adjustments:
Translation adjustment arising during the period	162	(130)	(793)	332
Reclassification adjustments recognized in net income	(17)	242	103	368
Gains (losses) on intra-entity transactions that are of a long-term-investment nature	1,063		3,270
Gains (losses) on net investment hedges arising during the period	(553)	(76)	(1,494)	(558)
Derivatives:
Reclassification adjustments recognized in net income	(207)		(466)
Available-for-sale securities:
Reclassification adjustments recognized in net income	(4)		(117)
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	193		266
Recognized prior service cost (credit)	(4)		(13)
Foreign currency translation adjustments:
Translation adjustment arising during the period	(174)	41	(142)	39
Reclassification adjustments recognized in net income	0	(18)	(6)	(18)
Gains (losses) on intra-entity transactions that are of a long-term-investment nature	0		0
Gains (losses) on net investment hedges arising during the period	211	29	571	214
Derivatives:
Reclassification adjustments recognized in net income	76		175
Available-for-sales securities:
Reclassification adjustments recognized in net income	2		40
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	(73)		(96)
Foreign currency translation adjustments:
Translation adjustment arising during the period	(12)	(89)	(935)	371
Reclassification adjustments recognized in net income	(17)	224	97	350
Gains (losses) on intra-entity transactions that are of a long-term-investment nature	1,063		3,270
Gains (losses) on net investments hedges arising during the period	(342)	(47)	(923)	(344)
Derivatives:
Reclassification adjustments recognized in net income	(131)		(291)
Available-for-sale securities:
Reclassification adjustments recognized in net income	(2)		(77)
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	120		170
Divestitures, deconsolidations and other [Member] | Other income (loss) - net
Foreign currency translation adjustments:
Reclassification adjustments recognized in net income	(17)		103
Derivatives:
Reclassification adjustments recognized in net income	0		1
Available-for-sale securities:
Reclassification adjustments recognized in net income	0		(87)
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	0		7
Foreign currency contracts | Other income (loss) - net
Derivatives:
Reclassification adjustments recognized in net income	(107)		(159)
Foreign currency contracts | Net operating revenues
Derivatives:
Reclassification adjustments recognized in net income	(116)		(338)
Foreign currency and commodities contracts [Member] | Cost of goods sold
Derivatives:
Reclassification adjustments recognized in net income	5		(1)
Foreign currency and interest rate contracts | Interest Expense [Member]
Derivatives:
Reclassification adjustments recognized in net income	11		31
Sale of securities | Other income (loss) - net
Available-for-sale securities:
Reclassification adjustments recognized in net income	(4)		(30)
Curtailment charge | Other operating charges
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	1		(17)
Settlement charges | Other operating charges
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	150		150
Recognized net actuarial loss (gain)
Pension and other benefit liabilities:
Comprehensive income reclassification of defined benefit plans for net prior service credit and actuarial gains or losses	46		139
Shareowners of The Coca-Cola Company
AOCI Attributable to the Shareowners of The Coca Cola Company
Foreign currency translation adjustments	(8,271)		(8,271)		(9,780)
Accumulated derivative net gains (losses)	(80)		(80)		314
Unrealized net gains (losses) on available-for-sale securities	470		470		305
Adjustments to pension and other benefits liabilities	(1,962)		(1,962)		(2,044)
Accumulated other comprehensive income (loss)	(9,843)		(9,843)		$ (11,205)
Consolidated net income			4,000
Other comprehensive income:
Net foreign currency translation adjustment			1,509
Net gain (loss) on derivatives			(394)
Net unrealized gain (loss) on available-for-sale securities			165
Net change in pension and other benefit liabilities			82
TOTAL COMPREHENSIVE INCOME			5,362
Foreign currency translation adjustments:
Net foreign currency translation adjustments	655	36	1,086	219
Derivatives:
Gains (losses) arising during the period	54	22	(159)	(585)
Reclassification adjustments recognized in net income	(207)	(186)	(466)	(485)
Net gain (loss) on derivatives	(153)	(164)	(625)	(1,070)
Available-for-sale securities:
Unrealized gains (losses) arising during the period	20	(98)	365	196
Reclassification adjustments recognized in net income	(4)	(19)	(117)	(93)
Net change in unrealized gain (loss) on available-for-sale securities	16	(117)	248	103
Pension and other benefit liabilities:
Net pension and other benefits arising during the period	(120)	13	(161)	1
Reclassification adjustments recognized in net income	193	43	266	192
Net change in pension and other benefit liabilities	73	56	105	193
Other Comprehensive Income (Loss) attributable to The Coca-Cola Company	591	(189)	814	(555)
Foreign currency translation adjustments:
Net foreign currency translation adjustments	37	52	423	205
Derivatives:
Gains (losses) arising during the period	(19)	(8)	56	221
Reclassification adjustments recognized in net income	76	71	175	183
Net gain (loss) on derivatives	57	63	231	404
Available-for-sales securities:
Unrealized gains (losses) arising during the period	(17)	31	(123)	(46)
Reclassification adjustments recognized in net income	2	4	40	22
Net change in unrealized gain (loss) on available-for-sale securities	(15)	35	(83)	(24)
Pension and other benefit liabilities:
Net pension and other benefits arising during the period	49	(2)	73	(1)
Reclassification adjustments recognized in net income	(73)	(15)	(96)	(64)
Net change in pension and other benefit liabilities	(24)	(17)	(23)	(65)
Other comprehensive income (loss) attributable to The Coca-Cola Company	55	133	548	520
Foreign currency translation adjustments:
Net foreign currency translation adjustments	692	88	1,509	424
Derivatives:
Gains (losses) arising during the period	35	14	(103)	(364)
Reclassification adjustments recognized in net income	(131)	(115)	(291)	(302)
Net gain (loss) on derivatives	(96)	(101)	(394)	(666)
Available-for-sale securities:
Unrealized gains (losses) arising during the period	3	(67)	242	150
Reclassification adjustments recognized in net income	(2)	(15)	(77)	(71)
Net change in unrealized gain (loss) on available-for-sale securities	1	(82)	165	79
Pension and other benefit liabilities:
Net pension and other benefits arising during the period	(71)	11	(88)	0
Reclassification adjustments recognized in net income	120	28	170	128
Net change in pension and other benefit liabilities	49	39	82	128
Other comprehensive income (loss) attributable to The Coca-Cola Company	$ 646	$ (56)	1,362	(35)
Noncontrolling Interests
AOCI Attributable to the Shareowners of The Coca Cola Company
Consolidated net income			0
Other comprehensive income:
Net foreign currency translation adjustment			2
Net gain (loss) on derivatives			0
Net unrealized gain (loss) on available-for-sale securities			0
Net change in pension and other benefit liabilities			0
TOTAL COMPREHENSIVE INCOME			$ 2
Net Investment Hedging [Member]
Foreign currency translation adjustments:
Reclassification adjustments recognized in net income				77
Foreign currency translation adjustments:
Reclassification adjustments recognized in net income				(30)
Foreign currency translation adjustments:
Reclassification adjustments recognized in net income				$ 47

Changes in Equity (Details)

Changes in Equity (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016	Dec. 31, 2016
Changes in Equity
Dividends Paid, shares			0
Other Activities, shares issued			0
December 31, 2016			$ 23,220
Comprehensive income (loss)	$ 2,091	$ 992	5,364	$ 5,959
Dividends paid/payable to shareowners of The Coca-Cola Company			(4,743)
Dividends paid to noncontrolling interests			(15)
Deconsolidation of certain entities			(153)
Purchases of treasury stock			(3,012)
Impact related to stock compensation plans			1,453
Other Activities			38
September 29, 2017	22,152		22,152
Reinvested Earnings
Changes in Equity
December 31, 2016			65,502
Comprehensive income (loss)			4,000
Dividends paid/payable to shareowners of The Coca-Cola Company			(4,743)
Dividends paid to noncontrolling interests			0
Deconsolidation of certain entities			0
Purchases of treasury stock			0
Impact related to stock compensation plans			0
Other Activities			0
September 29, 2017	64,759		$ 64,759
Accumulated Other Comprehensive Income (Loss)
Changes in Equity
Other Activities, shares issued			0
December 31, 2016			$ (11,205)
Comprehensive income (loss)			1,362
Dividends paid/payable to shareowners of The Coca-Cola Company			0
Dividends paid to noncontrolling interests			0
Deconsolidation of certain entities			0
Purchases of treasury stock			0
Impact related to stock compensation plans			0
Other Activities			0
September 29, 2017	$ (9,843)		$ (9,843)
Common Stock [Member]
Changes in Equity
Common Stock, Shares, Outstanding	4,262		4,262		4,288
Purchases of treasury stock, shares			(69)
Impact related to stock compensation plans, shares			43
December 31, 2016			$ 1,760
Comprehensive income (loss)			0
Dividends paid/payable to shareowners of The Coca-Cola Company			0
Dividends paid to noncontrolling interests			0
Deconsolidation of certain entities			0
Purchases of treasury stock			0
Impact related to stock compensation plans			0
Other Activities			0
September 29, 2017	$ 1,760		1,760
Capital Surplus
Changes in Equity
December 31, 2016			14,993
Comprehensive income (loss)			0
Dividends paid/payable to shareowners of The Coca-Cola Company			0
Dividends paid to noncontrolling interests			0
Deconsolidation of certain entities			0
Purchases of treasury stock			0
Impact related to stock compensation plans			709
Other Activities			(3)
September 29, 2017	15,699		15,699
Treasury Stock
Changes in Equity
December 31, 2016			(47,988)
Comprehensive income (loss)			0
Dividends paid/payable to shareowners of The Coca-Cola Company			0
Dividends paid to noncontrolling interests			0
Deconsolidation of certain entities			0
Purchases of treasury stock			(3,012)
Impact related to stock compensation plans			744
Other Activities			0
September 29, 2017	(50,256)		$ (50,256)
Noncontrolling Interests
Changes in Equity
Dividends Paid, shares			0
December 31, 2016			$ 158
Comprehensive income (loss)			2
Dividends paid/payable to shareowners of The Coca-Cola Company			0
Dividends paid to noncontrolling interests			(15)
Deconsolidation of certain entities			(153)
Purchases of treasury stock			0
Impact related to stock compensation plans			0
Other Activities			41
September 29, 2017	$ 33		$ 33

Significant Operating and Non48

Significant Operating and Nonoperating Items (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
Other Operating Charges
Other operating charges	$ 360	$ 222	$ 1,491	$ 830
Asset Impairment Charges	50	0	821	0
Trademark impairment			33
Tax litigation expenses	18	9	43	19
Costs incurred to refranchise of certain bottler interests		73		170
Noncapitalizable costs related to pending and closed transactions				37
Other Nonoperating Items
Gain (Loss) on Extinguishment of Debt			(38)
Equity Income (Loss) - Net
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	16	14	37	35
Other Income (Loss) - Net
Gain (Loss) on equity investees sale of stock	$ 0	0	25	0
Gain (Loss) related to integration of an equity method investee			$ 445
Equity Method Investment, Ownership Percentage	17.00%		17.00%
Corporate
Other Operating Charges
Asset Impairment Charges	$ 50		$ 50
Productivity, integration and restructuring initiatives	58	14	176	42
Tax litigation expenses	18		43
Cash Contribution Expense				100
Noncapitalizable costs related to pending and closed transactions				29
Other Nonoperating Items
Gain (Loss) on Extinguishment of Debt			(38)
Equity Income (Loss) - Net
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	2		4	3
Other Income (Loss) - Net
Gain (Loss) on equity investees sale of stock			25
Net Gains From Investee Transactions, Equity Investment Sales and other gains				18
Gain (Loss) related to integration of an equity method investee			445
Bottling investments [Member]
Other Operating Charges
Productivity, integration and restructuring initiatives	15	22	39	300
Costs incurred to refranchise of certain bottler interests	213	73	314	170
Noncapitalizable costs related to pending and closed transactions				8
Equity Income (Loss) - Net
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	14	14	29	32
Other Income (Loss) - Net
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	(762)	(1,089)	(1,473)	(1,657)
North America [Member]
Other Operating Charges
Productivity, integration and restructuring initiatives	47	22	131	80
Other Income (Loss) - Net
Cost incurred to convert bottling agreement	72	17	287	17
Productivity and Reinvestment [Member]
Other Operating Charges
Productivity, integration and restructuring initiatives	129	59	355	187
Integration of German Bottling and Distribution Operation [Member]
Other Operating Charges
Productivity, integration and restructuring initiatives				240
Venezuelan subsidiary
Other Operating Charges
Accounts Receivable Write Down		76		76
Venezuelan subsidiary | Corporate
Other Operating Charges
Trademark impairment			34
North America Territory [Member]
Other Operating Charges
Asset Impairment Charges			737
Costs incurred to refranchise of certain bottler interests		73		170
Other Income (Loss) - Net
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	(762)	(1,089)	(2,533)	(1,657)
China Bottling Operation [Member]
Other Income (Loss) - Net
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	79		88
China Bottling Operation [Member] | Corporate
Other Income (Loss) - Net
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	$ 79		88
CCEAG [Member]
Other Income (Loss) - Net
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers		1,400	(26)	1,323
CCEAG [Member] | Corporate
Other Income (Loss) - Net
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers			$ (26)	1,323
South African bottling operations [Domain] | Corporate
Other Income (Loss) - Net
Deconsolidation, Gain (Loss), Amount		$ (21)		$ (21)

Productivity, Integration and49

Productivity, Integration and Restructuring Initiatives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
Productivity and Reinvestment [Member]
Productivity, Integration and Restructuring Initiatives Disclosures
Accrued Balance, Beginning Balance	$ 189		$ 151
Cost incurred	129	$ 59	355	$ 187
Payments	(177)		(358)
Noncash and exchange	(2)		(9)
Accrued Balance, Ending Balance	139		139
Restructuring and related costs incurred to date	2,763		2,763
Productivity and Reinvestment [Member] | Severance pay and benefits
Productivity, Integration and Restructuring Initiatives Disclosures
Accrued Balance, Beginning Balance	162		123
Cost incurred	43		143
Payments	(88)		(146)
Noncash and exchange	2		(1)
Accrued Balance, Ending Balance	119		119
Productivity and Reinvestment [Member] | Outside Services [Member]
Productivity, Integration and Restructuring Initiatives Disclosures
Accrued Balance, Beginning Balance	11		6
Cost incurred	19		62
Payments	(20)		(58)
Noncash and exchange	(1)		(1)
Accrued Balance, Ending Balance	9		9
Productivity and Reinvestment [Member] | Other direct costs [Member]
Productivity, Integration and Restructuring Initiatives Disclosures
Accrued Balance, Beginning Balance	16		22
Cost incurred	67		150
Payments	(69)		(154)
Noncash and exchange	(3)		(7)
Accrued Balance, Ending Balance	11		11
Integration of German Bottling and Distribution Operation [Member]
Productivity, Integration and Restructuring Initiatives Disclosures
Cost incurred				$ 240
Restructuring and related costs incurred to date	$ 1,367		$ 1,367

Pension and Other Postretirem50

Pension and Other Postretirement Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
Net periodic pension and other Postretirement benefit cost
Contributions to pension plan			$ 88	$ 519
Pension plans, anticipated additional contributions for remainder of current fiscal year	$ 85		$ 85
Pension Benefits
Net periodic pension and other Postretirement benefit cost
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets	8.00%		8.00%
Service cost	$ 49	$ 59	$ 149	178
Interest cost	76	79	232	239
Expected return on plan assets	(163)	(161)	(487)	(490)
Amortization of prior service cost (credit)	0	0	0	(1)
Amortization of net actuarial loss	44	46	133	138
Net periodic benefit cost (credit)	6	23	27	64
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment	2	0	2	0
Defined Benefit Plan, Benefit Obligation, Payment for Settlement	150	0	150	0
Special termination benefits	15	4	72	17
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement	0	0	0	0
Total cost recognized in statements of income	$ 173	27	$ 251	81
Other Benefits
Net periodic pension and other Postretirement benefit cost
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets	4.50%		4.50%
Service cost	$ 4	6	$ 13	17
Interest cost	7	8	22	23
Expected return on plan assets	(3)	(3)	(9)	(9)
Amortization of prior service cost (credit)	(4)	(5)	(13)	(14)
Amortization of net actuarial loss	2	2	6	5
Net periodic benefit cost (credit)	6	8	19	22
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment	0	0	(42)	0
Defined Benefit Plan, Benefit Obligation, Payment for Settlement			0	0
Special termination benefits	0	0	0	0
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement	0	31	0	31
Total cost recognized in statements of income	$ 6	$ 39	$ (23)	$ 53

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
Income taxes
U.S. statutory rate (as a percent)	35.00%
Effective tax rate estimated for 2017 (as a percent)	24.00%		24.00%
Income tax expense	$ 230	$ 378	$ 1,805	$ 1,618
Effective tax rate (as a percent)	13.70%	26.50%	31.10%	21.20%
Tax expense (benefit) associated with significant operating and nonoperating items for the interim periods presented
Asset Impairments	$ 0	$ 0	$ (164)	$ 0
Productivity and reinvestment program	(44)	(20)	(127)	(65)
Other productivity, integration and restructuring initiatives	0	0	0	0
Transaction gains and losses	(361)	(246)	172	(363)
Certain tax matters	(40)	7	(110)	84
Other - Net	(12)	8	(41)	(38)
Unusual and/or infrequent items [Abstract]
Disposal gain (loss) of a business net of transaction cost				1,288
Asset Impairment Charges	50	0	821	0
Net charges	968	1,204	1,551	561
Excess tax benefit associated with share-based compensation	40		122
Costs incurred to refranchise of certain bottler interests		73		170
Other Tax Expense (Benefit)		80		80
Unusual or Infrequent Event Charges	35	99	121	230
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	16	14	37	35
Gain (Loss) on Extinguishment of Debt			(38)
Tax litigation expenses	18	9	43	19
Gain (Loss) related to integration of an equity method investee			445
Gain (Loss) on equity investees sale of stock	0	0	25	0
Productivity and Reinvestment [Member]
Unusual and/or infrequent items [Abstract]
Productivity, integration and restructuring initiatives	129	59	355	187
Integration of German Bottling and Distribution Operation [Member]
Unusual and/or infrequent items [Abstract]
Productivity, integration and restructuring initiatives				240
Corporate
Unusual and/or infrequent items [Abstract]
Productivity, integration and restructuring initiatives	58	14	176	42
Asset Impairment Charges	50		50
Net Gains From Investee Transactions, Equity Investment Sales and other gains				18
Cash Contribution Expense				100
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	2		4	3
Gain (Loss) on Extinguishment of Debt			(38)
Tax litigation expenses	18		43
Gain (Loss) related to integration of an equity method investee			445
Gain (Loss) on equity investees sale of stock			25
Bottling investments [Member]
Unusual and/or infrequent items [Abstract]
Productivity, integration and restructuring initiatives	15	22	39	300
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	(762)	(1,089)	(1,473)	(1,657)
Costs incurred to refranchise of certain bottler interests	213	73	314	170
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	14	14	29	32
North America [Member]
Unusual and/or infrequent items [Abstract]
Productivity, integration and restructuring initiatives	47	22	131	80
Cost incurred to convert bottling agreement	72	17	287	17
Venezuelan subsidiary
Unusual and/or infrequent items [Abstract]
Accounts Receivable Write Down		76		76
CCEAG [Member]
Unusual and/or infrequent items [Abstract]
Disposal gain (loss) of a business net of transaction cost				1,288
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers		1,400	(26)	1,323
CCEAG [Member] | Corporate
Unusual and/or infrequent items [Abstract]
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers			(26)	1,323
China Bottling Operation [Member]
Unusual and/or infrequent items [Abstract]
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	79		88
China Bottling Operation [Member] | Corporate
Unusual and/or infrequent items [Abstract]
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	$ 79		$ 88
South African bottling operations [Domain] | Corporate
Unusual and/or infrequent items [Abstract]
Deconsolidation, Gain (Loss), Amount		$ (21)		(21)
Keurig Green Mountain, Inc. [Member] | Corporate
Unusual and/or infrequent items [Abstract]
Net Gains From Investee Transactions, Equity Investment Sales and other gains				$ 18

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Sep. 29, 2017	Dec. 31, 2016
Assets and liabilities measured at fair value on a recurring basis
Trading Securities	$ 427	$ 384
Available-for-sale securities	8,591	6,413
Derivative, Collateral, Obligation to Return Cash	138	201
Derivative, Collateral, Right to Reclaim Cash	1	17
Level 1
Assets and liabilities measured at fair value on a recurring basis
Trading Securities	233	202
Available-for-sale securities	1,892	1,655
Derivatives, assets	7	4
Total assets	2,132	1,861
Derivatives, liabilities	(12)	11
Total liabilities	(12)	11
Level 2
Assets and liabilities measured at fair value on a recurring basis
Trading Securities	123	115
Available-for-sale securities	6,532	4,619
Derivatives, assets	458	878
Total assets	7,113	5,612
Derivatives, liabilities	(301)	276
Total liabilities	(301)	276
Level 3
Assets and liabilities measured at fair value on a recurring basis
Trading Securities	4	4
Available-for-sale securities	167	139
Derivatives, assets	0	0
Total assets	171	143
Derivatives, liabilities	0	0
Total liabilities	0	0
Other [Member]
Assets and liabilities measured at fair value on a recurring basis
Trading Securities	67	63
Available-for-sale securities	0	0
Derivatives, assets	0	0
Total assets	67	63
Derivatives, liabilities	0	0
Total liabilities	0	0
Netting Adjustment
Assets and liabilities measured at fair value on a recurring basis
Trading Securities	0	0
Available-for-sale securities	0	0
Derivatives, assets	(358)	(369)
Total assets	(358)	(369)
Derivatives, liabilities	232	(192)
Total liabilities	232	(192)
Fair Value Measurements
Assets and liabilities measured at fair value on a recurring basis
Trading Securities	427	384
Available-for-sale securities	8,591	6,413
Derivatives, assets	107	513
Total assets	9,125	7,310
Derivatives, liabilities	(81)	95
Total liabilities	(81)	95
Prepaid expenses and other assets | Fair Value Measurements
Assets and liabilities measured at fair value on a recurring basis
Derivatives, assets		347
Other Assets | Fair Value Measurements
Assets and liabilities measured at fair value on a recurring basis
Derivatives, assets	107	166
Accounts payable and accrued expenses | Fair Value Measurements
Assets and liabilities measured at fair value on a recurring basis
Derivatives, liabilities		42
Other Liabilities | Fair Value Measurements
Assets and liabilities measured at fair value on a recurring basis
Derivatives, liabilities	$ 81	$ 53

Fair Value Measurements (Deta53

Fair Value Measurements (Details 2) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
Nonrecurring fair value measurements
Assets held for sale	$ (307)	$ (1,044)	$ (1,819)	$ (1,490)
Intangible Assets	0	0	(442)	0
Other long-lived assets	0	0	(329)	0
Valuation of shares in equity method investee	0	0	25	0
Asset Impairment Charges	(50)	0	(821)	0
Total	(357)	$ (1,044)	(2,615)	$ (1,490)
Impairment Loss			375
Trademark and franchise rights impairment			33
Property, Plant and Equipment impairment			310
Other Asset Impairment Charges			19
Bottling investments [Member]
Nonrecurring fair value measurements
Impairment Loss			737
Corporate
Nonrecurring fair value measurements
Valuation of shares in equity method investee			25
Asset Impairment Charges	$ (50)		(50)
Venezuelan subsidiary | Corporate
Nonrecurring fair value measurements
Trademark and franchise rights impairment			$ 34

Fair Value Measurements (Deta54

Fair Value Measurements (Details 3) - USD ($) $ in Millions	Sep. 29, 2017	Dec. 31, 2016
Other fair value disclosures
Long-term debt, including the current portion, carrying amount	$ 35,702	$ 33,211
Long-term debt, including the current portion, fair value	$ 36,375	$ 33,752

Operating Segments (Details)

Operating Segments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016	Dec. 31, 2016
Net operating revenues:
Third party	$ 9,078	$ 10,633	$ 27,898	$ 32,454
Intersegment	0	0	0	0
Total net revenues	9,078	10,633	27,898	32,454
Operating Income (Loss)	2,120	2,271	6,180	7,271
Income (loss) before income taxes	1,674	1,428	5,805	7,621
Identifiable operating assets	67,754	75,900	67,754	75,900	$ 70,021
Noncurrent investments	22,761	18,027	22,761	18,027	17,249
Costs incurred to refranchise of certain bottler interests		73		170
Tax litigation expenses	18	9	43	19
Noncapitalizable costs related to pending and closed transactions				37
Impairment Loss			375
Asset Impairment Charges	50	0	821	0
Gain (Loss) on equity investees sale of stock	0	0	25	0
Gain (Loss) related to integration of an equity method investee			445
Trademark impairment			33
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	16	14	37	35
Gain (Loss) on Extinguishment of Debt			(38)
Venezuelan subsidiary
Net operating revenues:
Accounts Receivable Write Down		76		76
Europe, Middle East & Africa [Member]
Net operating revenues:
Third party	1,959	1,852	5,628	5,369
Intersegment	0	0	0	264
Total net revenues	1,959	1,852	5,628	5,633
Operating Income (Loss)	936	914	2,884	2,897
Income (loss) before income taxes	962	922	2,958	2,950
Identifiable operating assets	5,475	4,337	5,475	4,337	4,067
Noncurrent investments	1,261	1,315	1,261	1,315	1,302
Productivity, integration and restructuring initiatives	6	2	2	6
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees			4
Latin America [Member]
Net operating revenues:
Third party	1,009	949	2,857	2,787
Intersegment	26	16	54	50
Total net revenues	1,035	965	2,911	2,837
Operating Income (Loss)	563	435	1,625	1,470
Income (loss) before income taxes	561	447	1,627	1,485
Identifiable operating assets	1,909	1,964	1,909	1,964	1,785
Noncurrent investments	908	823	908	823	804
Productivity, integration and restructuring initiatives	2		3
Restructuring Reserve, Accrual Adjustment		(1)		(2)
Latin America [Member] | Venezuelan subsidiary
Net operating revenues:
Accounts Receivable Write Down		76		76
North America [Member]
Net operating revenues:
Third party	2,308	1,661	6,216	4,759
Intersegment	442	1,003	1,799	2,978
Total net revenues	2,750	2,664	8,015	7,737
Operating Income (Loss)	646	666	1,967	1,982
Income (loss) before income taxes	583	653	1,711	1,978
Identifiable operating assets	17,224	16,406	17,224	16,406	16,566
Noncurrent investments	105	123	105	123	109
Productivity, integration and restructuring initiatives	47	22	131	80
Cost incurred to convert bottling agreement	72	17	287	17
Asia Pacific
Net operating revenues:
Third party	1,345	1,315	3,807	3,818
Intersegment	87	145	340	437
Total net revenues	1,432	1,460	4,147	4,255
Operating Income (Loss)	577	583	1,835	1,892
Income (loss) before income taxes	588	589	1,853	1,903
Identifiable operating assets	2,146	2,257	2,146	2,257	2,024
Noncurrent investments	178	166	178	166	164
Productivity, integration and restructuring initiatives	1		4	1
Bottling investments [Member]
Net operating revenues:
Third party	2,409	4,809	9,268	15,631
Intersegment	23	31	69	116
Total net revenues	2,432	4,840	9,337	15,747
Operating Income (Loss)	(217)	124	(979)	222
Income (loss) before income taxes	(673)	(734)	(1,730)	(897)
Identifiable operating assets	6,433	17,390	6,433	17,390	15,973
Noncurrent investments	16,800	12,223	16,800	12,223	11,456
Productivity, integration and restructuring initiatives	15	22	39	300
Costs incurred to refranchise of certain bottler interests	213	73	314	170
Noncapitalizable costs related to pending and closed transactions				8
Impairment Loss			737
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	(762)	(1,089)	(1,473)	(1,657)
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	14	14	29	32
Corporate
Net operating revenues:
Third party	48	47	122	90
Intersegment	0	0	0	5
Total net revenues	48	47	122	95
Operating Income (Loss)	(385)	(451)	(1,152)	(1,192)
Income (loss) before income taxes	(347)	(449)	(614)	202
Identifiable operating assets	34,567	33,546	34,567	33,546	29,606
Noncurrent investments	3,509	3,377	3,509	3,377	3,414
Productivity, integration and restructuring initiatives	58	14	176	42
Tax litigation expenses	18		43
Noncapitalizable costs related to pending and closed transactions				29
Cash Contribution Expense				100
Asset Impairment Charges	50		50
Gain (Loss) on equity investees sale of stock			25
Gain (Loss) related to integration of an equity method investee			445
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees	2		4	3
Gain (Loss) on Extinguishment of Debt			(38)
Net Gains From Investee Transactions, Equity Investment Sales and other gains				18
Corporate | Venezuelan subsidiary
Net operating revenues:
Trademark impairment			34
Intersegment Eliminations [Member]
Net operating revenues:
Third party	0	0	0	0
Intersegment	(578)	(1,195)	(2,262)	(3,850)
Total net revenues	(578)	(1,195)	(2,262)	(3,850)
Operating Income (Loss)	0	0	0	0
Income (loss) before income taxes	0	0	0	0
Identifiable operating assets	0	0	0	0	0
Noncurrent investments	0	0	0	0	$ 0
South African bottling operations [Domain] | Corporate
Net operating revenues:
Deconsolidation, Gain (Loss), Amount		(21)		(21)
China Bottling Operation [Member]
Net operating revenues:
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	79		88
China Bottling Operation [Member] | Corporate
Net operating revenues:
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers	$ 79		88
CCEAG [Member]
Net operating revenues:
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers		$ 1,400	(26)	1,323
CCEAG [Member] | Corporate
Net operating revenues:
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers			$ (26)	$ 1,323

Subsequent Event Subsequent Eve

Subsequent Event Subsequent Event (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Dec. 31, 2017	Sep. 29, 2017	Sep. 30, 2016
Subsequent Event [Line Items]
Acquisitions of businesses, equity method investments and nonmarketable securities		$ 538	$ 767
CCBA [Member]
Subsequent Event [Line Items]
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	54.50%
Acquisitions of businesses, equity method investments and nonmarketable securities	$ 3,150